EurekaMag Full Text Articles Chapter 56,831

Hole, C.R.; Wormley, F.L. 2012: Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models. Frontiers in Microbiology 3: 291

Pantaleo, G.; Lévy, Y. 2013: Vaccine and immunotherapeutic interventions. Current Opinion in HIV and Aids 8(3): 236-242

Labaille, J.; Lion, A.; Boissel, E.; Trapp, S.; Nair, V.; Rasschaert, D.; Dambrine, G. 2015: Vaccine and oncogenic strains of gallid herpesvirus 2 contain specific subtype variations in the 5' region of the latency-associated transcript that evolve in vitro and in vivo. Archives of Virology 160(1): 161-171

Rancitelli, P.; Hofmann, A.; Burks, A.W. 2011: Vaccine approaches for food allergy. Current Topics in Microbiology and Immunology 352: 55-69

Campfield, B.; Chen, K.; Kolls, J.K. 2014: Vaccine approaches for multidrug resistant Gram negative infections. Current Opinion in Immunology 28: 84-89

Müller-Schiffmann, A.; Korth, C. 2008: Vaccine approaches to prevent and treat prion infection : progress and challenges. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 22(1): 45-52

Ochoa, T.R.ón. 2010: Prendas-Ngangas-Enquisos: turbulence and the influence of the dead in Cuban-Kongo material culture. Cultural Anthropology: Journal of the Society for Cultural Anthropology 25(3): 387-420

Kennedy, A.; Basket, M.; Sheedy, K. 2011: Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles survey. Pediatrics 127 Suppl. 1: S92-S99

Lett, D. 2007: Vaccine autism link discounted, but effect of "study" is unknown. Cmaj: Canadian Medical Association Journal 177(8): 841

Finkelstein, S.N.; Hedberg, K.J.; Hopkins, J.A.; Hashmi, S.; Larson, R.C. 2011: Vaccine availability in the United States during the 2009 H1N1 outbreak. American Journal of Disaster Medicine 6(1): 23-30

Ulrich, R.G. 2008: Vaccine based on a ubiquitous cysteinyl protease and streptococcal pyrogenic exotoxin a protects against Streptococcus pyogenes sepsis and toxic shock. Journal of Immune Based Therapies and Vaccines 6: 8

McEnery, R.; Kresge, K.Jill. 2010: Vaccine briefs. Iavi Report: Newsletter on International Aids Vaccine Research 14(6): 18-19

Michel, L.V.; Kalmeta, B.; McCreary, M.; Snyder, J.; Craig, P.; Pichichero, M.E. 2011: Vaccine candidate P6 of nontypable Haemophilus influenzae is not a transmembrane protein based on protein structural analysis. Vaccine 29(8): 1624-1627

McEnery, R. 2010: Vaccine candidate targeting dendritic cells enters clinical trial. Iavi Report: Newsletter on International Aids Vaccine Research 14(4): 23

Khan, M.N.; Pichichero, M.E. 2012: Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. Vaccine 30(18): 2900-2907

Wade, N. 1976: Vaccine cells found mostly contaminated. Science 194(4260): 41

Pellegrino, A.; Busellu, G.; Cucchi, A.; Cavallaro, A.; Gabutti, G. 2010: Vaccine co-administration in paediatric age: the experience of the Local Health Unit of Cuneo-1 (Ambito di Cuneo), Italy. Acta Bio-Medica: Atenei Parmensis 81(3): 204-209

Rogers, B.; Dennison, K.; Adepoju, N.; Dowd, S.; Uedoi, K. 2010: Vaccine cold chain: Part 2. Training personnel and program management. Aaohn Journal: Official Journal of the American Association of Occupational Health Nurses 58(9): 391-400; Quiz 401-2

Rogers, B.; Dennison, K.; Adepoju, N.; Dowd, S.; Uedoi, K. 2010: Vaccine cold chain: part 1. proper handling and storage of vaccine. Aaohn Journal: Official Journal of the American Association of Occupational Health Nurses 58(8): 337-334; Quiz: 345-346

McEnery, R. 2009: Vaccine considerations for H1N1. Iavi Report: Newsletter on International Aids Vaccine Research 13(3): 14

Cima, G. 2012: Vaccine could reduce wild horse overpopulation. Journal of the American Veterinary Medical Association 240(8): 921-922

Goff, S.L.; Mazor, K.M.; Gagne, S.J.; Corey, K.C.; Blake, D.R. 2011: Vaccine counseling: a content analysis of patient-physician discussions regarding human papilloma virus vaccine. Vaccine 29(43): 7343-7349

Delelis-Fanien, A-S.; Séité, F.; Priner, M.; Paccalin, M. 2009: Vaccine coverage against influenza and pneumococcal infections in patients aged 65 and over: a survey on 299 outpatients. La Revue de Medecine Interne 30(8): 656-660

Lob-Levyt, J. 2009: Vaccine coverage and the GAVI Alliance Immunization Services Support initiative. Lancet 373(9659): 209

Thébaud, Véronique.; Lietard, C.; Ktaiche, D. 2009: Vaccine coverage for 10-11 year-old children in Finistère, France in 2004: comparison with national average. Sante Publique 21(1): 55-64

Gaudelus, J. 2010: Vaccine coverage in children. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 17(6): 955-957

Raschilas, F. 2011: Vaccine coverage in the elderly. Soins. Gerontologie 2011(92): 30-33

Loulergue, P.; Fonteneau, L.; Armengaud, J-Baptiste.; Momcilovic, S.; Levy-Brühl, D.; Launay, O.; Guthmann, J-Paul.; Armengaud, J-Baptiste.; Fonteneau, L.; Fournier, S.; Guthmann, J-Paul.; Hanslik, T.; Launay, O.; Levy-Brühl, D.; Loulergue, P.; Vittecoq, D.; Wyplosz, B. 2013: Vaccine coverage of healthcare students in hospitals of the Paris region in 2009: the Studyvax survey. Vaccine 31(26): 2835-2838

Bós, A.José.Gonçalves.; Mirandola, A.Ribeiro. 2013: Vaccine coverage related to lower mortality for respiratory diseases. Ciencia and Saude Coletiva 18(5): 1459-1462

Field, R.I. 2008: Vaccine declinations present new challenges for public health. P and T: a Peer-Reviewed Journal for Formulary Management 33(9): 542-543

Kuo-Haller, P.; Cu, Y.; Blum, J.; Appleton, J.A.; Saltzman, W.M. 2010: Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity. Molecular Pharmaceutics 7(5): 1585-1595

Correia-Pinto, J.F.; Csaba, N.; Alonso, M.J. 2013: Vaccine delivery carriers: insights and future perspectives. International Journal of Pharmaceutics 440(1): 27-38

Dhanasooraj, D.; Kumar, R.Ajay.; Mundayoor, S. 2013: Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles. International Journal of Nanomedicine 8: 835-843

Ma, Y.; Tao, W.; Krebs, S.J.; Sutton, W.F.; Haigwood, N.L.; Gill, H.S. 2014: Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity. Pharmaceutical Research 31(9): 2393-2403

Gregory, A.E.; Titball, R.; Williamson, D. 2013: Vaccine delivery using nanoparticles. Frontiers in Cellular and Infection Microbiology 3: 13

Simerska, P.; McGeary, R.P.; Abdel-Aal, A.-B.M.; Moyle, P.M.; Olive, C.; Good, M.F.; Toth, I. 2009: Vaccine delivery utilizing liposaccharides. Advances in Experimental Medicine and Biology 611: 345-346

Toth, I.; Moyle, P.M.; Simerska, P.; Fujita, Y.; Olive, C.; Good, M.F. 2009: Vaccine delivery: synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidate. Advances in Experimental Medicine and Biology 611: 347-349

D'Onofrio, A.; Manfredi, P. 2010: Vaccine demand driven by vaccine side effects: dynamic implications for SIR diseases. Journal of Theoretical Biology 264(2): 237-252

Koup, R.A.; Douek, D.C. 2011: Vaccine design for CD8 T lymphocyte responses. Cold Spring Harbor Perspectives in Medicine 1(1): A007252

Chen, J.-R.; Ma, C.; Wong, C.-H. 2011: Vaccine design of hemagglutinin glycoprotein against influenza. Trends in Biotechnology 29(9): 426-434

Sur, D.; Manna, B.; Chakrabarty, N.; Kaljee, L.M.; Riel, R.; Pach, A.; Kanungo, S.; Deen, J.; Ochiai, R.L.; Clemens, J.; Bhattacharya, S.K. 2009: Vaccine desirability during an effectiveness trial of the typhoid fever polysaccharide Vi vaccine in Kolkata India. Human Vaccines 5(9): 614-620

Vogel, U.; Claus, H. 2011: Vaccine development against Neisseria meningitidis. Microbial Biotechnology 4(1): 20-31

Gauci, C.; Jayashi, C.és.; Lightowlers, M.W. 2013: Vaccine development against the Taenia solium parasite: the role of recombinant protein expression in Escherichia coli. Bioengineered 4(5): 343-347

Gupta, S.S.; Nair, G.B.; Arora, N.K.; Ganguly, N.K. 2013: Vaccine development and deployment: opportunities and challenges in India. Vaccine 31(Suppl 2): B43-B53

Greenwood, B. 2014: The use of a placebo in vaccine trials. Lancet 383(9935): 2101-2102

Vincent, J-Louis. 2014: Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update. Future Microbiology 9(4): 457-463

Waye, A.; Jacobs, P.; Schryvers, A.B. 2013: Vaccine development costs: a review. Expert Review of Vaccines 12(12): 1495-1501

Murphy, T.F. 2009: Vaccine development for Moraxella catarrhalis: rationale, approaches and challenges. Expert Review of Vaccines 8(6): 655-658

Döring, G. 2012: Vaccine development for patients with cystic fibrosis. Expert Review of Vaccines 11(3): 259-261

Leitner, G.; Krifucks, O.; Kiran, M.D.; Balaban, N. 2011: Vaccine development for the prevention of staphylococcal mastitis in dairy cows. Veterinary Immunology and Immunopathology 142(1-2): 25-35

Nicolle, L. 1993: Vaccine development in Canada. Canadian Journal of Infectious Diseases 4(2): 73-74

Harro, J.M.; Peters, B.M.; O'May, G.A.; Archer, N.; Kerns, P.; Prabhakara, R.; Shirtliff, M.E. 2010: Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. Fems Immunology and Medical Microbiology 59(3): 306-323

Coombes, R. 2009: Vaccine disputes. Bmj 338: B2435

Kobayashi, T.-H. 2011: Vaccine does make sense, until used. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 131(12): 1743-1744

Mekalanos, J.J. 2013: Vaccine economics: what price human life?. Science Translational Medicine 5(204): 204ed16

Poland, C.M.; Poland, G.A. 2011: Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education. Vaccine 29(37): 6145-6148

Anonymous 2010: Vaccine effective in preventing TB in HIV-positive patients. Aids Policy and Law 25(4): 4

Kwong, J.C.; Campitelli, M.A.; Gubbay, J.B.; Peci, A.; Winter, A-Luise.; Olsha, R.; Turner, R.; Rosella, L.C.; Crowcroft, N.S. 2013: Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 57(6): 820-827

Eisenberg, K.W.; Szilagyi, P.G.; Fairbrother, G.; Griffin, M.R.; Staat, M.; Shone, L.P.; Weinberg, G.A.; Hall, C.B.; Poehling, K.A.; Edwards, K.M.; Lofthus, G.; Fisher, S.G.; Bridges, C.B.; Iwane, M.K. 2008: Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 122(5): 911-919

Cochran, L.W.; Black, S.; Klein, N.P.; Dekker, C.L.; Lewis, E.; Reingold, A.L. 2010: Vaccine effectiveness against laboratory-confirmed influenza in infants: a matched case control study. Human Vaccines 6(9)

Suzuki, M.; Minh, L.Nhat.; Yoshimine, H.; Inoue, K.; Yoshida, L.Myint.; Morimoto, K.; Ariyoshi, K. 2014: Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011-2012 Season. PloS one 9(2): e88813

Menniti-Ippolito, F.; Da Cas, R.; Traversa, G.; Santuccio, C.; Felicetti, P.; Tartaglia, L.; Trotta, F.; Di Pietro, P.; Barabino, P.; Renna, S.; Riceputi, L.; Tovo, P.-A.; Gabiano, C.; Urbino, A.; Baroero, L.; Le Serre, D.; Virano, S.; Perilongo, G.; Daverio, M.; Gnoato, E.; Maretti, M.; Galeazzo, B.; Rubin, G.; Scanferla, S.; Da Dalt, L.; Stefani, C.; Zerbinati, C.; Chiappini, E.; Sollai, S.; De Martino, M.; Mannelli, F.; Becciani, S.; Giacalone, M.; Montano, S.; Remaschi, G.; Stival, A.; Furbetta, M.; Abate, P.; Leonardi, I.; Pirozzi, N.; Raucci, U.; Reale, A.; Rossi, R.; Russo, C.; Mancinelli, L.; Manuela, O.; Carlo, C.; Mores, N.; Romagnoli, C.; Chiaretti, A.; Compagnone, A.; Riccardi, R.; Delogu, G.; Sali, M.; Prete, V.; Tipo, V.; Dina 2014: Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy. Vaccine 32(35): 4466-4470

Tafuri, S.; Martinelli, D.; Prato, R.; Germinario, C. 2013: Vaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMV. Human Vaccines and Immunotherapeutics 9(1): 184-188

Staat, M.Allen.; Griffin, M.R.; Donauer, S.; Edwards, K.M.; Szilagyi, P.G.; Weinberg, G.A.; Hall, C.B.; Prill, M.M.; Chaves, S.S.; Bridges, C.B.; Poehling, K.A.; Fairbrother, G. 2011: Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007. Vaccine 29(48): 9005-9011

Lang, P.-O.; Govind, S.; Mitchell, W.A.; Siegrist, C.-A.; Aspinall, R. 2011: Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience. Ageing Research Reviews 10(3): 389-395

Simpson, C.R.; Ritchie, L.D.; Robertson, C.; Sheikh, A.; McMenamin, J. 2010: Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. Health Technology Assessment 14(34): 313-346

Castilla, Jús.; Martínez-Artola, Víctor.; Salcedo, E.; Martínez-Baz, Ián.; Cenoz, M.García.; Guevara, M.; Alvarez, N.; Irisarri, Fátima.; Morán, J.; Barricarte, A.; Artajo, P.; Bernaola, E.; Chamorro, J.; Fanlo, P.; Gil, F.; Gost, J.; Maraví, E.; Pérez, C.; Ruiz, M.; Sola, J.; Reina, G.; Núñez, J.; Navascués, A.; Ortega, M.; Torres, M.; Zamora, M.J.; Reparaz, F.; Petit, A. 2012: Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study. Vaccine 30(2): 195-200

Castilla, J.; Martínez-Baz, I.; Navascués, A.; Fernandez-Alonso, M.; Reina, G.; Guevara, M.; Chamorro, J.; Ortega, M.T.; Albéniz, E.; Pozo, F.; Ezpeleta, C.; Abad, I.; Aldaz, P.; Álvarez, E.; Alvarez, N.; Arana, J.J.; Arceiz, I.; Arina, E.; Arribas, I.; Artajo, M.D.; Azagra, B.; Bartolome, F.C.; Bolea, C.; Brugos, A.; Cano, B.; Castresana, M.V.; Cenoz, J.C.; Cia, F.; Compains, B.; Cortés, F.; Churío, B.; Cuevas, P.C.; Da Costa, E.M.; Díez Espino, J.; Doiz, M.; Escribano, F.J.; Esparza, M.J.; Etayo, V.; Fernández Alfaro, C.; Flamarique, B.; Gamboa, J.; Garcés, M.L.; García Blanco, L.; German, A.B.; Giner, A.; Goñi, N.; Guillorme, M.J.; Guiu, J.O.; Gurbindo, J.C.; Guruchaga, M.J.; Heras, J.A.; Hijos, M.C.; Huidobro, J.; Indurain, S 2014: Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 19(6)

Pebody, R..G.; Andrews, N.; McMenamin, J.; Durnall, H.; Ellis, J.; Thompson, C.I.; Robertson, C.; Cottrell, S.; Smyth, B.; Zambon, M.; Moore, C.; Fleming, D.M.; Watson, J.M. 2013: Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 18(5)

Palmu, A.A.; Jokinen, J.; Nieminen, H.; Syrjänen, R.; Ruokokoski, E.; Puumalainen, T.; Moreira, M.; Schuerman, L.; Borys, D.; Kilpi, T.M. 2014: Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial. LANCET. Respiratory Medicine 2(9): 717-727

Hanquet, G.; Valenciano, M.; Simondon, Fçois.; Moren, A. 2013: Vaccine effects and impact of vaccination programmes in post-licensure studies. Vaccine 31(48): 5634-5642

Grgić, H.; Hunter, D.B.; Hunton, P.; Nagy, E. 2009: Vaccine efficacy against Ontario isolates of infectious bronchitis virus. Canadian Journal of Veterinary Research 73(3): 212-216

Rodríguez, D.; González-Aseguinolaza, G.; Rodríguez, J.R.; Vijayan, A.; Gherardi, M.; Rueda, P.; Casal, J.Ignacio.; Esteban, M. 2012: Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium. Plos one 7(4): E34445

Kitikoon, P.; Vincent, A.L.; Jones, K.R.; Nilubol, D.; Yu, S.; Janke, B.H.; Thacker, B.J.; Thacker, E.L. 2009: Vaccine efficacy and immune response to swine influenza virus challenge in pigs infected with porcine reproductive and respiratory syndrome virus at the time of SIV vaccination. Veterinary Microbiology 139(3-4): 235-244

Kato, G.; Kato, K.; Saito, K.; Pe, Y.; Kondo, H.; Aoki, T.; Hirono, I. 2011: Vaccine efficacy of Mycobacterium bovis BCG against Mycobacterium sp. infection in amberjack Seriola dumerili. Fish and Shellfish Immunology 30(2): 467-472

Matsuo, K.; Okamoto, H.; Kawai, Y.; Quan, Y.-S.; Kamiyama, F.; Hirobe, S.; Okada, N.; Nakagawa, S. 2014: Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease. Journal of Neuroimmunology 266(1-2): 1-11

Vitek, W.S.; Akers, A.; Meyn, L.A.; Switzer, G.E.; Lee, B.Y.; Beigi, R.H. 2011: Vaccine eligibility and acceptance among ambulatory obstetric and gynecologic patients. Vaccine 29(11): 2024-2028

Weddle, G.; Jackson, M.Anne. 2014: Vaccine eligibility in hospitalized children: spotlight on a unique healthcare opportunity. Journal of Pediatric Health Care: Official Publication of National Association of Pediatric Nurse Associates and Practitioners 28(2): 148-154

Kahane, P.; Arzimanoglou, A. 2007: Vaccine encephalopathy: a myth collapses?. Presse Medicale 36(10 Part 1): 1339-1340

Weinberg, G.A.; Szilagyi, P.G. 2010: Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. Journal of Infectious Diseases 201(11): 1607-1610

Kino, Y. 2008: Vaccine excipients. Nihon Rinsho. Japanese Journal of Clinical Medicine 66(10): 1933-1937

Andersson, C.R.år.; Vene, S.; Insulander, M.; Lindquist, L.; Lundkvist, A.; Günther, G.ör. 2010: Vaccine failures after active immunisation against tick-borne encephalitis. Vaccine 28(16): 2827-2831

Sheppeard, V.; Forssman, B.; Ferson, M.J.; Moreira, C.; Campbell-Lloyd, S.; Dwyer, D.E.; McAnulty, J.M. 2009: Vaccine failures and vaccine effectiveness in children during measles outbreaks in New South Wales, March-May 2006. Communicable Diseases Intelligence Quarterly Report 33(1): 21-26

Rybicki, E.P.; Williamson, A.-L.; Meyers, A.; Hitzeroth, I.I. 2011: Vaccine farming in Cape Town. Human Vaccines 7(3): 339-348

Sobczyk, E. 2009: Vaccine finance resources for physicians. Pediatrics 124 Suppl. 5: S573-S576

O'Leary, S.T.; Allison, M.A.; Lindley, M.C.; Crane, L.A.; Hurley, L.P.; Brtnikova, M.; Beaty, B.L.; Babbel, C.I.; Jimenez-Zambrano, A.; Berman, S.; Kempe, A. 2014: Vaccine financing from the perspective of primary care physicians. Pediatrics 133(3): 367-374

Lee, G.M.; Lieu, T.A. 2009: Vaccine financing in the United States: an emerging crisis. Archives of Pediatrics and Adolescent Medicine 163(5): 485-487

Cardozo, T.; Wang, S.; Jiang, X.; Kong, X.-P.; Hioe, C.; Krachmarov, C. 2014: Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopes. Vaccine 32(39): 4916-4924

Ross, J.A.; Hulbert, K.F. 1941: Treatment of 100 War Wounds and Burns. British Medical Journal 1(4190): 618-621

Anonymous 1936: Vaccine for Whooping-Cough. British Medical Journal 1(3919): 316

Kosten, T.R.; Domingo, C.B.; Shorter, D.; Orson, F.; Green, C.; Somoza, E.; Sekerka, R.; Levin, F.R.; Mariani, J.J.; Stitzer, M.; Tompkins, D.A.; Rotrosen, J.; Thakkar, V.; Smoak, B.; Kampman, K. 2014: Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug and Alcohol Dependence 140: 42-47

Naz, R.K. 2014: Vaccine for human contraception targeting sperm Izumo protein and YLP12 dodecamer peptide. Protein Science: a Publication of the Protein Society 23(7): 857-868

Pandey, R.; Quan, W.Y.; Hong, F.; Jie, S.L. 2009: Vaccine for hypertension: modulating the renin-angiotensin system. International Journal of Cardiology 134(2): 160-168

Esposito, S.; Principi, N. 2014: Vaccine for prevention of influenza in children. New England Journal of Medicine 370(12): 1167

Jain, V.K.; Rivera, L.; Zaman, K.; Espos, R.A.; Sirivichayakul, C.; Quiambao, B.P.; Rivera-Medina, D.M.; Kerdpanich, P.; Ceyhan, M.; Dinleyici, E.C.; Cravioto, A.; Yunus, M.; Chanthavanich, P.; Limkittikul, K.; Kurugol, Z.; Alhan, E.; Caplanusi, A.; Durviaux, S.; Boutet, P.; Ofori-Anyinam, O.; Chandrasekaran, V.; Dbaibo, G.; Innis, B.L. 2013: Vaccine for prevention of mild and moderate-to-severe influenza in children. New England Journal of Medicine 369(26): 2481-2491

Schwartz, M.; Baruch, K. 2012: Vaccine for the mind: Immunity against self at the choroid plexus for erasing biochemical consequences of stressful episodes. Human Vaccines and Immunotherapeutics 8(10): 1465-1468

Pydi, S.S.; Bandaru, A.R.; Venkatasubramanian, S.; Jonnalagada, S.; Valluri, V.L. 2011: Vaccine for tuberculosis: up-regulation of IL-15 by Ag85A and not by ESAT-6. Tuberculosis 91(2): 136-139

Bounds, C.E.; Hu, J.; Cladel, N.M.; Balogh, K.; Christensen, N.D. 2011: Vaccine generated immunity targets an HPV16 E7 HLA-A2.1-restricted CD8(+) T cell epitope relocated to an early gene or a late gene of the cottontail rabbit papillomavirus (CRPV) genome in HLA-A2.1 transgenic rabbits. Vaccine 29(6): 1194-1200

Kim, T.Hyong.; Johnstone, J.; Loeb, M. 2011: Vaccine herd effect. Scandinavian Journal of Infectious Diseases 43(9): 683-689

Dubé, E.; Vivion, M.; MacDonald, N.E. 2015: Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Review of Vaccines 14(1): 99-117

Dubé, E.; Laberge, C.; Guay, M.; Bramadat, P.; Roy, R.éa.; Bettinger, J. 2013: Vaccine hesitancy: an overview. Human Vaccines and Immunotherapeutics 9(8): 1763-1773

Nolan, T.J.; O'Connor, M.B.; Bond, U.; Swan, J.; Phelan, M.J. 2013: Vaccine history knowledge of subcutaneous anti-TNF receiving rheumatology patients. Rheumatology International 33(7): 1907-1908

Mamelund, S.-E.; Riise Bergsaker, M.A. 2011: Vaccine history, gender and influenza vaccination in a household context. Vaccine 29(51): 9441-9450

Artenstein, A.W.; Poland, G.A. 2012: Vaccine history: the past as prelude to the future. Vaccine 30(36): 5299-5301

Fritsche, P.J.; Helbling, A.; Ballmer-Weber, B.K. 2010: Vaccine hypersensitivity--update and overview. Swiss Medical Weekly 140(17-18): 238-246

Boffey, P.M. 1976: Vaccine imbroglio: the rise and fall of a scientist-critic. Science 194(4269): 1021-1025

Filho, O.A.; Megid, J.; Geronutti, L.; Ratti, J.; Almeida, M.F.A.; Kataoka, A.P.A.G.; Martorelli, L.F.A. 2012: Vaccine immune response and interference of colostral antibodies in calves vaccinated against rabies at 2, 4 and 6 months of age born from antirabies revaccinated females. Research in Veterinary Science 92(3): 396-400

Nanjappa, S.G.; Klein, B.S. 2014: Vaccine immunity against fungal infections. Current Opinion in Immunology 28: 27-33

Hung, C.-Y.; Gonzalez, A.; Wüthrich, M.; Klein, B.S.; Cole, G.T. 2011: Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17). Infection and Immunity 79(11): 4511-4522

Lugoboni, F.; Mezzelani, P.; Quaglio, G. 2009: Vaccine immunogenicity in injecting drug users. Lancet. Infectious Diseases 9(11): 652

Baral, S.; Sherman, S.G.; Millson, P.; Beyrer, C. 2007: Vaccine immunogenicity in injecting drug users: a systematic review. Lancet. Infectious Diseases 7(10): 667-674

Bartlett, B.L.; Pellicane, A.J.; Tyring, S.K. 2009: Vaccine immunology. Dermatologic Therapy 22(2): 104-109

Lubaroff, D.M.; Vaena, D.; Brown, J.A.; Zehr, P.; Griffith, K.C.; Brown, E.; Eastman, J.; Nepple, K.; Kattula, A.; Williams, R.D. 2014: Vaccine immunotherapy for prostate cancer: from mice to men. Immunologic Research 59(1-3): 229-235

Curigliano, G.; Spitaleri, G.; Dettori, M.; Locatelli, M.; Scarano, E.; Goldhirsch, A. 2007: Vaccine immunotherapy in breast cancer treatment: promising, but still early. Expert Review of Anticancer Therapy 7(9): 1225-1241

Miyashita, T.; Shah, F.A.; Marti, G.; Wang, J.; Armstrong, T.; Bonde, P.; Gibson, M.K.; Yoshimura, K.; Montgomery, E.A.; Duncan, M.D.; Jaffee, E.M.; Harmon, J.W. 2008: Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a Pre-Barrett's esophagus setting. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 12(1): 2-7; Discussion: 7-9

Miyashita, T.; Shah, F.A.; Marti, G.P.; Armstrong, T.D.; Wang, J.; Bonde, P.; Gibson, M.K.; Yoshimura, K.; Montgomery, E.A.; Duncan, M.; Jaffee, E.M.; Harmon, J.W. 2008: Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a post-Barrett's esophagus setting. Digestive Diseases and Sciences 53(11): 2858-2867

Shapiro, A.J.; Esther, C.R.; Leigh, M.W.; Dellon, E.P. 2013: Vaccine induced Hepatitis a and B protection in children at risk for cystic fibrosis associated liver disease. Vaccine 31(6): 906-911

Bialuk, I.; Whitney, S.; Andresen, V.; Florese, R.H.; Nacsa, J.; Cecchinato, V.; Valeri, V.W.; Heraud, J.-M.; Gordon, S.; Parks, R.W.; Montefiori, D.C.; Venzon, D.; Demberg, T.; Guroff, M.R.-; Landucci, G.; Forthal, D.N.; Franchini, G. 2011: Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques. Vaccine 30(1): 78-94

Kang, J.H.; Cha, S.-H. 2013: Vaccine industrialization in Korea: focus on major improvements and future direction. Clinical and Experimental Vaccine Research 2(1): 1-3

De Araújo, T.M.E.; Lino, F.ío.S.; do Nascimento, D.J.C.; da Costa, F.S.R. 2007: Vaccine influenza: knowledge, attitudes and practices of elderly in Teresina. Revista Brasileira de Enfermagem 60(4): 439-443

He, Y.; Rappuoli, R.; De Groot, A.S.; Chen, R.T. 2010: Vaccine informatics. Journal of Biomedicine and Biotechnology 2010: 765762

Anonymous 2010: Vaccine initiative money reallocated; emphasis placed on research and mother-to-child transmission. Hiv/Aids Policy and Law Review 15(1): 9-10

Petousis-Harris, H. 2008: Vaccine injection technique and reactogenicity--evidence for practice. Vaccine 26(50): 6299-6304

Widdus, R. 2010: Vaccine innovation done differently. Bulletin of the World Health Organization 88(12): 880

Yaqub, O.; Nightingale, P. 2012: Vaccine innovation, translational research and the management of knowledge accumulation. Social Science and Medicine 75(12): 2143-2150

Kumru, O.S.; Joshi, S.B.; Smith, D.E.; Middaugh, C.R.; Prusik, T.; Volkin, D.B. 2014: Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies. Biologicals: Journal of the International Association of Biological Standardization 42(5): 237-259

Gupta, N.; Puliyel, J.M. 2009: Vaccine introduction where incidence of Hib meningitis is 0.007%: decision-making based on health economic or ideology?. Indian Journal of Medical Research 129(3): 339-340

Roberts, L. 2010: Vaccine introduction. the beginning of the end for Africa's devastating meningitis outbreaks?. Science 330(6010): 1466-1467

Salmon, D.A.; Pan, W.K.Y.; Omer, S.B.; Navar, A.M.; Orenstein, W.; Marcuse, E.K.; Taylor, J.; deHart, M.P.; Stokley, S.; Carter, T.; Halsey, N.A. 2008: Vaccine knowledge and practices of primary care providers of exempt vs. vaccinated children. Human Vaccines 4(4): 286-291

Mellon, G.; Rigal, L.; Partouche, H.; Aoun, O.; Jaury, P.; Joannard, N.; Guthmann, J.P.; Cochereau, D.; Caumes, E.; Bricaire, F.; Salmon-Céron, D. 2014: Vaccine knowledge in students in Paris, France, and surrounding regions. Canadian Journal of Infectious Diseases and Medical Microbiology 25(3): 141-146

Kraemer, J.D.; Gostin, L.O. 2011: Vaccine liability in the Supreme Court: forging a social compact. JAMA 305(18): 1900-1901

Ratzan, S.C. 2011: Vaccine literacy: a new shot for advancing health. Journal of Health Communication 16(3): 227-229

Lantos, J.D.; Jackson, M.Anne. 2013: Vaccine mandates are justifiable because we are all in this together. American Journal of Bioethics: Ajob 13(9): 1-2

Dyer, C. 2011: Vaccine manufacturers cannot be sued over design defects, US Supreme Court rules. Bmj 342: D1292

Hendrix, K.S.; Finnell, S.Maria.E.; Zimet, G.D.; Sturm, L.A.; Lane, K.A.; Downs, S.M. 2014: Vaccine message framing and parents' intent to immunize their infants for MMR. Pediatrics 134(3): E675-E683

Fossum, E.; Grødeland, G.; Terhorst, D.; Tveita, A.A.; Vikse, E.; Mjaaland, S.; Henri, S.; Malissen, B.; Bogen, B. 2015: Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus. European Journal of Immunology 45(2): 624-635

Clift, K.; Rizzolo, D. 2014: Vaccine myths and misconceptions. Jaapa: Official Journal of the American Academy of Physician Assistants 27(8): 21-25; Quiz 26

Murele, B.; Vaz, R.; Gasasira, A.; Mkanda, P.; Erbeto, T.; Okeibunor, J. 2014: Vaccine perception among acceptors and non-acceptors in Sokoto State, Nigeria. Vaccine 32(26): 3323-3327

Schuldt, N.J.; Aldhamen, Y.A.; Appledorn, D.M.; Seregin, S.S.; Kousa, Y.; Godbehere, S.; Amalfitano, A. 2011: Vaccine platforms combining circumsporozoite protein and potent immune modulators, rEA or EAT-2, paradoxically result in opposing immune responses. Plos one 6(8): E24147

Safi, H.; Wheeler, J.G.; Reeve, G.R.; Ochoa, E.; Romero, J.é R.; Hopkins, R.; Ryan, K.W.; Jacobs, R.F. 2012: Vaccine policy and Arkansas childhood immunization exemptions: a multi-year review. American Journal of Preventive Medicine 42(6): 602-605

Jick, H.; Chamberlin, D.P.; Hagberg, K.W. 2010: Vaccine policy and incidence of influenza. Epidemiology 21(2): 270-271

Troy, S.B.; Musingwini, G.; Halpern, M.S.; Huang, C.; Stranix-Chibanda, L.; Kouiavskaia, D.; Shetty, A.K.; Chumakov, K.; Nathoo, K.; Maldonado, Y.A. 2013: Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants. Journal of Infectious Diseases 208(4): 672-678

Mustafa, A.S. 2009: Vaccine potential of Mycobacterium tuberculosis-specific genomic regions: in vitro studies in humans. Expert Review of Vaccines 8(10): 1309-1312

Walpita, P.; Barr, J.; Sherman, M.; Basler, C.F.; Wang, L. 2011: Vaccine potential of Nipah virus-like particles. Plos one 6(4): E18437

Kim, T.; Son, C.; Lee, J.; Kim, K. 2012: Vaccine potential of an attenuated Pasteurella multocida that expresses only the N-terminal truncated fragment of P. multocida toxin in pigs. Canadian Journal of Veterinary Research 76(1): 69-71

Khan, A.A.; Jabeen, M.; Chauhan, A.; Owais, M. 2012: Vaccine potential of cytosolic proteins loaded fibrin microspheres of Cryptococcus neoformans in BALB/c mice. Journal of Drug Targeting 20(5): 453-466

Guo, D.; Wang, H.; Zeng, D.; Li, X.; Fan, X.; Li, Y. 2011: Vaccine potential of hemocyanin from Oncomelania hupensis against Schistosoma japonicum. Parasitology International 60(3): 242-246

Kueakhai, P.; Changklungmoa, N.; Riengrojpitak, S.; Chaichanasak, P.; Meemon, K.; Chaithirayanon, K.; Chantree, P.; Sansri, V.; Itagaki, T.; Sobhon, P. 2013: Vaccine potential of recombinant saposin-like protein 2 against Fasciolosis gigantica in mice. Vaccine 31(47): 5518-5523

Olugbile, S.; Kulangara, C.; Bang, G.; Bertholet, S.; Suzarte, E.; Villard, V.; Frank, G.; Audran, R.; Razaname, A.; Nebie, I.; Awobusuyi, O.; Spertini, F.; Kajava, A.V.; Felger, I.; Druilhe, P.; Corradin, G. 2009: Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c. Infection and Immunity 77(12): 5701-5709

Craciun, G.; Martin, D.; Togoe, I.; Tudor, L.; Manaila, E.; Ighigeanu, D.; Matei, C. 2009: Vaccine preparation by radiation processing. Journal of Microwave Power and Electromagnetic Energy: a Publication of the International Microwave Power Institute 43(2): 65-70

Wright, P.F. 2008: Vaccine preparedness--are we ready for the next influenza pandemic?. New England Journal of Medicine 358(24): 2540-2543

Pereira, C.C.; Bishai, D. 2010: Vaccine presentation in the USA: economics of prefilled syringes versus multidose vials for influenza vaccination. Expert Review of Vaccines 9(11): 1343-1349

Elias, J.; Schouls, L.M.; van de Pol, I.; Keijzers, W.C.; Martin, D.R.; Glennie, A.; Oster, P.; Frosch, M.; Vogel, U.; van der Ende, A. 2010: Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany. Emerging Infectious Diseases 16(3): 465-472

Zhang, Q.; Guo, Z.; MacDonald, N.E. 2011: Vaccine preventable community-acquired pneumonia in hospitalized children in Northwest China. Pediatric Infectious Disease Journal 30(1): 7-10

Gessner, B.D.; Feikin, D.R. 2014: Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy. Vaccine 32(26): 3133-3138

Menzies, R.; Turnour, C.; Chiu, C.; McIntyre, P. 2008: Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Communicable Diseases Intelligence Quarterly Report 32 Suppl: S2-67

Naidu, L.; Chiu, C.; Habig, A.; Lowbridge, C.; Jayasinghe, S.; Wang, H.; McIntyre, P.; Menzies, R. 2013: Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010. Communicable Diseases Intelligence Quarterly Report 37 Suppl: S1-95

Brotherton, J.; Wang, H.; Schaffer, A.; Quinn, H.; Menzies, R.; Hull, B.; Lawrence, G.; Wood, J.; Wood, N.; Rosewell, A.; Newall, A.; MacIntyre, R.; Macartney, K.; Gidding, H.; McIntyre, P.; Booy, R. 2007: Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence Quarterly Report 31 Suppl: S1-152

Menzies, R.I.; Singleton, R.J. 2009: Vaccine preventable diseases and vaccination policy for indigenous populations. Pediatric Clinics of North America 56(6): 1263-1283

Chiu, C.; Dey, A.; Wang, H.; Menzies, R.; Deeks, S.; Mahajan, D.; Macartney, K.; Brotherton, J.; Jardine, A.; Quinn, H.; Jelfs, J.; Booy, R.; Lawrence, G.; Jayasinghe, S.; Roberts-Witteveen, A.; Senanayake, S.; Wood, N.; McIntyre, P. 2010: Vaccine preventable diseases in Australia, 2005 to 2007. Communicable Diseases Intelligence Quarterly Report 34 Supp: S1-167

Boggild, A.K.; Castelli, F.; Gautret, P.; Torresi, J.; von Sonnenburg, F.; Barnett, E.D.; Greenaway, C.A.; Lim, P-Lian.; Schwartz, E.; Wilder-Smith, A.; Wilson, M.E.; Carosi, G.; Brown, G.; Sagara, H.; Keystone, J.S.; Kain, K.C.; Loutan, L.; Chappuis, Fçois.; Pandey, P.; Schlagenhauf, P.; Weber, R.; Steffen, R.; Kozarsky, P.E.; Franco-Paredes, C.; Parola, P.; Simon, F.; Delmont, J.; Hale, D.C.; Gelman, S.S.; Jensenius, M.; Haulman, N.Jean.; Roesel, D.; Jong, E.C.; Gurtman, A.; Chen, L.H.; Gkrania-Klotsas, E.; Kanagawa, S.; Licitra, C.; Crespo, A 2010: Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network. Vaccine 28(46): 7389-7395

Weisberg, S.Shoshana. 2007: Vaccine preventable diseases: current perspectives in historical context, Part I. Disease-A-Month: Dm 53(9): 422-466

Weisberg, S.Shoshana. 2007: Vaccine preventable diseases: current perspectives in historical context, Part II. Disease-A-Month: Dm 53(10): 467-528

MacNeil, A.; Dietz, V.; Cherian, T. 2014: Vaccine preventable diseases: time to re-examine global surveillance data?. Vaccine 32(20): 2315-2320

Zhang, Q.Li.; Wan, C.Min.; MacDonald, N.E. 2009: Vaccine preventable infections and multiple organ dysfunction syndrome in critically ill children in China. Pediatric Infectious Disease Journal 28(3): 182-185

Ruggeri, F.Maria.; Fiore, L. 2012: Vaccine preventable viral diseases and risks associated with waterborne transmission. Annali Dell'istituto Superiore di Sanita 48(4): 460-472

Pinquier, D.; Gagneur, A.; Guen, C.Gras-Le.; Blandin, S.; Stephan, J-L.; Régnier, F.; Picherot, G.; Brissaud, O.; Marpeau, L.; Marret, S.; Reinert, P. 2008: Vaccine prevention in perinatal health care: parents, children and professionals. Gynecologie Obstetrique and Fertilite 36(4): 461-468

Weiner, L.M.; Surana, R.; Murray, J. 2010: Vaccine prevention of cancer: can endogenous antigens be targeted?. Cancer Prevention Research 3(4): 410-415

Pass, R.F.; Zhang, C.; Evans, A.; Simpson, T.; Andrews, W.; Huang, M-Li.; Corey, L.; Hill, J.; Davis, E.; Flanigan, C.; Cloud, G. 2009: Vaccine prevention of maternal cytomegalovirus infection. New England Journal of Medicine 360(12): 1191-1199

Pace, D. 2010: Vaccine prevention of meningococcal disease in adolescents and travellers. International Health 2(4): 229-230

Walbert, H. 2010: Vaccine prevention--an indispensible income supplement. MMW Fortschritte der Medizin 152(23): 11

Jacobson, S.H. 2012: Vaccine pricing: how can we get it right?. Expert Review of Vaccines 11(10): 1163-1165

Collin, N.; de Radiguès, X. 2009: Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 27(38): 5184-5186

Loza-Rubio, E.; Rojas-Anaya, E. 2010: Vaccine production in plant systems--an aid to the control of viral diseases in domestic animals: a review. Acta Veterinaria Hungarica 58(4): 511-522

Tarbet, E.Bart.; Dorward, J.T.; Day, C.W.; Rashid, K.A. 2013: Vaccine production training to develop the workforce of foreign institutions supported by the BARDA influenza vaccine capacity building program. Vaccine 31(12): 1646-1649

Genzel, Y.; Rödig, J.; Rapp, E.; Reichl, U. 2014: Vaccine production: upstream processing with adherent or suspension cell lines. Methods in Molecular Biology 1104: 371-393

Esposito, S.; Principi, N. 2014: Vaccine profile of 4CMenB: a four-component Neisseria meningitidis serogroup B vaccine. Expert Review of Vaccines 13(2): 193-202

Aaby, P.; Whittle, H.; Benn, C.Stabell. 2012: Vaccine programmes must consider their effect on general resistance. Bmj 344: E3769

Burki, T.K. 2011: Vaccine progress reveals resource gaps in developing countries. LANCET. Infectious Diseases 11(3): 165-166

Haneveld, J.K. 2012: Vaccine promotion foundation D10 supports farmers in Malawi. Tijdschrift Voor Diergeneeskunde 137(3): 191-192

Shepard, C.C. 1947: Vaccine prophylaxis of Rocky Mountain spotted fever. New York State Journal of Medicine 47(14): 1589

Pokrovskiĭ, V.I.; Mikheeva, I.V. 2010: Vaccine prophylaxis of infectious diseases in adults. Terapevticheskii Arkhiv 82(11): 5-10

Aksenova, V.A.; Levi, D.T.; Fonina, E.V.; Vundtsettel', N.N. 2009: Vaccine prophylaxis of tuberculosis: implication and problems. Problemy Tuberkuleza i Boleznei Legkikh 1: 10-16

Ermolenko, M.V.; Mikheeva, I.V.; Voronin, E.M.; Saltykova, T.S.; Afonina, N.M. 2013: Vaccine prophylaxis of varicella: tactics and perspectives. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1: 85-88

Gurina, N.M.; Svedentsov, E.P.; Shardakov, V.I.; Cherepanova, V.V. 2008: Vaccine prophylaxis of viral hepatitis B in patients with acute leukemia. Terapevticheskii Arkhiv 80(7): 27-29

Das, A.; Ali, N. 2012: Vaccine prospects of killed but metabolically active Leishmania against visceral leishmaniasis. Expert Review of Vaccines 11(7): 783-785

Hosie, M.J.; Beatty, J.A. 2007: Vaccine protection against feline immunodeficiency virus. Australian Veterinary Journal 85(8): 302-303

Sipo, I.; Knauf, M.; Fechner, H.; Poller, W.; Planz, O.; Kurth, R.; Norley, S. 2011: Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV). Vaccine 29(8): 1690-1699

Rauch, S.; Gough, P.; Kim, H.K.; Schneewind, O.; Missiakas, D. 2014: Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection. Infection and Immunity 82(11): 4889-4898

Pappalardo, F.; Pennisi, M.; Castiglione, F.; Motta, S. 2010: Vaccine protocols optimization: in silico experiences. Biotechnology Advances 28(1): 82-93

Silvaggio, J.L.; Van Otterloo, J.; Curran, E.A.; Whitney, E.A.S.; Weiss, P.S.; Seib, K.; Omer, S.B. 2014: Vaccine providers' perspectives on impact, challenges, and response during the California 2010 pertussis outbreak. Human Vaccines and Immunotherapeutics 10(1): 199-207

Patil, R.R. 2014: Vaccine quality and safety: scrutinizing the reported 3-fold increase in adverse effects following immunization (Aefi) in India. Human Vaccines and Immunotherapeutics 10(3): 755-756

Moore, D.L. 2014: Vaccine recommendations for children and youth for the 2014/2015 influenza season. Paediatrics and Child Health 19(8): 440-444

McColloster, P.J.; Martin-de-Nicolas, A. 2014: Vaccine refrigeration: thinking outside of the box. Human Vaccines and Immunotherapeutics 10(4): 1126-1128

Bégué, P. 2012: Vaccine refusal and implications for public health in 2012. Bulletin de l'Academie Nationale de Medecine 196(3): 603

Saint-Victor, D.S.; Omer, S.B. 2013: Vaccine refusal and the endgame: walking the last mile first. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 368(1623): 20120148

Gromek, J. 2013: Vaccine refusal by parents. Advance for Nps and Pas 4(8): 18-20; 22

McCarthy, M. 2013: Vaccine refusal may have contributed to California's 2010 pertussis outbreak, study finds. Bmj 347: F6109

Omer, S.B.; Salmon, D.A.; Orenstein, W.A.; deHart, M.Patricia.; Halsey, N. 2009: Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. New England Journal of Medicine 360(19): 1981-1988

Pebody, R. 2012: Vaccine registers--experiences from Europe and elsewhere. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 17(17)

Kaić, B.; Gjenero-Margan, I.; Brzović, M.; Lakoseljac, D.; Aleraj, B.; Nemeth-Blazić, T.; Kolarić, B.; Macolić-Sarinić, V.; Simunović, A.; Pavlić, J. 2007: Vaccine regulations in Croatia. Collegium Antropologicum 31(Suppl 2): 117-120

Bharti, B.; Grewal, A.; Kalia, R.; Pathak, P. 2010: Vaccine related reactogenicity for primary immunization: a randomized controlled trial of 23(wider) vs. 25(narrower) gauge needles with same lengths. Indian Journal of Pediatrics 77(11): 1241-1246

De Groot, A.S.; Moise, L. 2007: Vaccine renaissance--from basic research to implementation. Medicine and Health Rhode Island 90(10): 300

Ellis, R.W.; Riedmann, E.M. 2010: Vaccine research and development. Human Vaccines 6(11): 865

Jerse, A.E.; Deal, C.D. 2013: Vaccine research for gonococcal infections: where are we?. Sexually Transmitted Infections 89(Suppl 4): Iv63-Iv68

Anonymous 2008: Vaccine research going back to square one. Aids Reader 18(4): 166 208

Anonymous 2008: Vaccine research groups declare collaboration. Aids Policy and Law 23(6): 1

Abrams, A.; Kredo, T. 2013: Vaccine research, adolescents and Africa. Human Vaccines and Immunotherapeutics 9(1): 108-111

Homma, A.; Tanuri, A.; Duarte, A.J.S.; Marques, E.; de Almeida, A.; Martins, R.; Silva-Junior, J.B.; Possas, C. 2013: Vaccine research, development, and innovation in Brazil: a translational science perspective. Vaccine 31 Suppl. 2: B54-B60

Leach-Kemon, K.; Graves, C.M.; Johnson, E.K.; Lavado, R.F.; Hanlon, M.; Haakenstad, A. 2014: Vaccine resource tracking systems. Bmc Health Services Research 14: 421

Ravikumar, R.; Anolik, J.; Looney, R.J. 2007: Vaccine responses in patients with rheumatoid arthritis. Current Rheumatology Reports 9(5): 407-415

Kivitz, A.J.; Schechtman, J.; Texter, M.; Fichtner, A.; de Longueville, M.; Chartash, E.K. 2014: Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial. Journal of Rheumatology 41(4): 648-657

Baxter, D. 2010: Vaccine responsiveness in premature infants. Human Vaccines 6(6): 506-511

Aspinall, R.; Lang, P.O. 2014: Vaccine responsiveness in the elderly: best practice for the clinic. Expert Review of Vaccines 13(7): 885-894

Jansen, K.U.; Girgenti, D.Q.; Scully, I.L.; Anderson, A.S. 2013: Vaccine review: "Staphyloccocus aureus vaccines: problems and prospects". Vaccine 31(25): 2723-2730

Nicolosi, L.; Vittucci, A.; Mancini, R.; Bozzola, E.; Cagigi, A.; Grandin, A.; Villani, A. 2014: Vaccine risk assessment in children with a referred reaction to a previous vaccine dose: 2009-2011 retrospective report at the Bambino Gesu' children hospital, Rome, Italy. Italian journal of pediatrics 40: 31

Fisher, M.C. 2008: Vaccine safety. Pediatric Infectious Disease Journal 27(9): 827-830

Weisser, K.; Barth, I.; Keller-Stanislawski, B. 2009: Vaccine safety. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 52(11): 1053-1064

Labadie, J. 2011: Vaccine safety. International Journal of Risk and Safety in Medicine 23(2): 113-115

Blodörn, K.; Hägglund, S.; Fix, J.; Dubuquoy, C.; Makabi-Panzu, B.; Thom, M.; Karlsson, P.; Roque, J.-L.; Karlstam, E.; Pringle, J.; Eléouët, J.-F.ço.; Riffault, S.; Taylor, G.; Valarcher, J.F.ço. 2014: Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies. Plos one 9(6): E100392

Klar, S.; Harris, T.; Wong, K.; Fediurek, J.; Deeks, S.L. 2014: Vaccine safety implications of Ontario, Canada's switch from DTaP-IPV to Tdap-IPV for the pre-school booster. Vaccine 32(48): 6360-6363

Klein, N.P. 2011: Vaccine safety in special populations. Human Vaccines 7(2): 269-271

Fowler, G.L.; Weintraub, E.; Kennedy, A.; Luman, E.T.; Shui, I.; Khromava, A.; Kohl, K.; Gust, D.A. 2008: Vaccine safety perceptions and experience with adverse events following immunization in Uzbekistan. Public Health 122(4): 412-416

Thompson, C.A. 2014: Vaccine safety signal from spontaneous system not supported by active surveillance. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 71(17): 1432-1433

Wharton, M. 2010: Vaccine safety: current systems and recent findings. Current Opinion in Pediatrics 22(1): 88-93

Chatterjee, A. 2008: Vaccine safety: genuine concern or a legacy of unfounded skepticism?. Expert Review of Vaccines 7(3): 275-277

Biere, B.; Schweiger, B.; Nitsche, A. 2009: Influenza a H1N1 diagnostics: the first, the fastest, and the most reliable. LANCET. Infectious Diseases 9(12): 721-722

Suk, J.E. 2010: Vaccine safety: misinformed about the misinformed. Lancet. Infectious Diseases 10(3): 144

Embree, J.; Tan, B. 2002: Vaccine schedules. Canadian Journal of Infectious Diseases 13(6): 358-360

Foster, S.L. 2007: Vaccine schedules: revisions for 2007. Journal of the American Pharmacists Association: Japha 47(2): 296-297

Mosselman, F.; Weenink, D.; Lindegaard, M.R. 2018: Weapons, Body Postures, and the Quest for Dominance in Robberies: a Qualitative Analysis of Video Footage. Journal of Research in Crime and Delinquency 55(1): 3-26

Howell, A. 2005: Anastrozole: a new gold standard of hormonal treatment for breast cancer?. Women's Health 1(3): 309-322

Qin, H.; Cha, S.-c.; Neelapu, S.S.; Lou, Y.; Wei, J.; Liu, Y.-J.; Kwak, L.W. 2009: Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity. Blood 114(19): 4142-4149

Saha, A.; Chowdhury, M.I.; Nazim, M.; Alam, M.M.; Ahmed, T.; Hossain, M.B.; Hore, S.K.; Sultana, G.N.N.; Svennerholm, A.-M.; Qadri, F. 2013: Vaccine specific immune response to an inactivated oral cholera vaccine and EPi vaccines in a high and low arsenic area in Bangladeshi children. Vaccine 31(4): 647-652

Schofield, T.L. 2009: Vaccine stability study design and analysis to support product licensure. Biologicals: Journal of the International Association of Biological Standardization 37(6): 387-396; Discussion: 421-423

Kristensen, D.; Chen, D.; Cummings, R. 2011: Vaccine stabilization: research, commercialization, and potential impact. Vaccine 29(41): 7122-7124

Phillips, K.L.; Hayney, M.S. 2007: Vaccine storage and handling: maximizing effectiveness while reducing cost. Journal of the American Pharmacists Association: Japha 47(4): 536-538

Lee, S.; Lim, H-Sul.; Kim, O.; Nam, J.; Kim, Y.; Woo, H.; Noh, W.; Kim, K. 2012: Vaccine storage practices and the effects of education in some private medical institutions. Journal of Preventive Medicine and Public Health 45(2): 78-89

Sabry, A.; Hauk, P.J.; Jing, H.; Su, H.C.; Stence, N.V.; Mirsky, D.M.; Nagel, M.A.; Abbott, J.K.; Dragone, L.L.; Armstrong-Wells, J.; Curtis, D.J.; Cohrs, R.; Schmid, D.S.; Gilden, D.; Gelfand, E.W. 2014: Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency. Journal of Allergy and Clinical Immunology 133(4): 1225-1227

Jaramillo Ortiz, J.é M.; Del Médico Zajac, M.ía.P.; Zanetti, F.A.; Molinari, M.ía.P.; Gravisaco, M.ía.J.é; Calamante, G.; Wilkowsky, S.E. 2014: Vaccine strategies against Babesia bovis based on prime-boost immunizations in mice with modified vaccinia Ankara vector and recombinant proteins. Vaccine 32(36): 4625-4632

Zhong, J.; Khanna, R. 2007: Vaccine strategies against human cytomegalovirus infection. Expert Review of AntI-Infective Therapy 5(3): 449-459

McShane, H. 2009: Vaccine strategies against tuberculosis. Swiss Medical Weekly 139(11-12): 156-160

Jackson, C.; Ruzevick, J.; Brem, H.; Lim, M. 2013: Vaccine strategies for glioblastoma: progress and future directions. ImmunoTherapy 5(2): 155-167

Gao, X.; Li, X.; Li, M.; Fu, S.; Wang, H.; Lu, Z.; Cao, Y.; He, Y.; Zhu, W.; Zhang, T.; Gould, E.A.; Liang, G. 2014: Vaccine strategies for the control and prevention of Japanese encephalitis in Mainland China, 1951-2011. PLoS neglected tropical diseases 8(8): e3015

Lefebvre, J.S.; Haynes, L. 2013: Vaccine strategies to enhance immune responses in the aged. Current Opinion in Immunology 25(4): 523-528

Park, C.G. 2014: Vaccine strategies utilizing C-type lectin receptors on dendritic cells in vivo. Clinical and Experimental Vaccine Research 3(2): 149-154

Graham, P. 2007: Vaccine study faces HIV testing roadblocks. Women participants meet with medical establishment callousness. Positively Aware: the Monthly Journal of the Test Positive Aware Network 18(4): 29-30

Desfeux, C.; Maurice, S.; Henry, J.P.; Lejeune, B.; Gouyon, P.H. 1996: Evolution of reproductive systems in the genus Silene. PROCEEDINGS. Biological Sciences 263(1369): 409-414

Kaufmann, J.R.; Miller, R.; Cheyne, J. 2011: Vaccine supply chains need to be better funded and strengthened, or lives will be at risk. Health Affairs 30(6): 1113-1121

Muzumdar, J.M.; Cline, R.R. 2009: Vaccine supply, demand, and policy: a primer. Journal of the American Pharmacists Association: Japha 49(4): E87-E99

Mitka, M. 2007: Vaccine takes aim at hypertension. JAMA 298(24): 2854-2855

Gulland, A. 2014: Vaccine tests to begin in Ebola countries this year. Bmj 349: G6466

Sakakibara, M.; Kanto, T. 2011: Vaccine therapies against digestive-system cancers. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(9): 1662-1669

Wen, Y.; Wang, X.; Wang, B.; Yuan, Z. 2014: Vaccine therapies for chronic hepatitis B: can we go further?. Frontiers of Medicine 8(1): 17-23

Sayegh, E.T.; Oh, T.; Fakurnejad, S.; Bloch, O.; Parsa, A.T. 2014: Vaccine therapies for patients with glioblastoma. Journal of Neuro-Oncology 119(3): 531-546

Avigan, D. 2008: Vaccine therapy and adoptive immunotherapy in hematologic malignancies. Best Practice and Research. Clinical Haematology 21(3): 373-374

Ramsay, A.G.; Gribben, J.G. 2008: Vaccine therapy and chronic lymphocytic leukaemia. Best Practice and Research. Clinical Haematology 21(3): 421-436

Neelapu, S.S.; Kwak, L.W. 2007: Vaccine therapy for B-cell lymphomas: next-generation strategies. HEMATOLOGY. American Society of Hematology. Education Program 2007: 243-249

Nakatsuji, T.; Rasochova, L.; Huang, C.-M. 2008: Vaccine therapy for P. acnes-associated diseases. Infectious Disorders Drug Targets 8(3): 160-165

Chi, M.; Dudek, A.Z. 2011: Vaccine therapy for metastatic melanoma: systematic review and meta-analysis of clinical trials. Melanoma Research 21(3): 165-174

Salman, B.; Zhou, D.; Jaffee, E.M.; Edil, B.H.; Zheng, L. 2013: Vaccine therapy for pancreatic cancer. Oncoimmunology 2(12): E26662

Sonpavde, G.; Spencer, D.M.; Slawin, K.M. 2007: Vaccine therapy for prostate cancer. Urologic Oncology 25(6): 451-459

Amato, R.J. 2008: Vaccine therapy for renal cancer. Expert Review of Vaccines 7(7): 925-935

Albright, C.; Garst, J. 2007: Vaccine therapy in non-small-cell lung cancer. Current Oncology Reports 9(4): 241-246

Van Poppel, H.; Joniau, S.; Van Gool, S.W. 2009: Vaccine therapy in patients with renal cell carcinoma. European Urology 55(6): 1333-1342

Saka, M.; Amano, T.; Kajiwara, K.; Yoshikawa, K.; Ideguchi, M.; Nomura, S.; Fujisawa, H.; Kato, S.; Fujii, M.; Ueno, K.; Hinoda, Y.; Suzuki, M. 2010: Vaccine therapy with dendritic cells transfected with Il13ra2 mRNA for glioma in mice. Journal of Neurosurgery 113(2): 270-279

Anonymous 2010: Vaccine to combat chronic stress. Human vaccines 6(9)

Swenson, D.L.; Wang, D.; Luo, M.; Warfield, K.L.; Woraratanadharm, J.; Holman, D.H.; Dong, J.Y.; Pratt, W.D. 2008: Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections. Clinical and Vaccine Immunology: Cvi 15(3): 460-467

Lentz, W.J. 1946: Vaccine to save water buffalo for field work rushed to China. Veterinary Extension Quarterly 103: 13

Cheng, M.H. 2007: Aboriginal workers key to indigenous health in Australia. Lancet 370(9598): 1533-1536

Bánfalvi, A. 2009: Vaccine troubles: symptoms of disease or health?. Lege Artis Medicinae: Uj Magyar Orvosi Hirmondo 19(12): 808-809

Siegrist, C-Anne. 2010: Vaccine update 2009: questions around the safety of the influenza A (H1N1) vaccine. Revue Medicale Suisse 6(231): 67-70

Campos-Outcalt, D. 2010: Vaccine update 2010: keeping up with the changes. Cleveland Clinic Journal of Medicine 77(4): 255-263

Lyons, K.M.; Laible, B.R. 2011: Vaccine update. Adult travel immunizations: update for pharmacists. Journal of the American Pharmacists Association: Japha 51(3): 440-442

Campos-Outcalt, D. 2008: Vaccine update: new CDC recommendations from 2007. Journal of Family Practice 57(3): 181-184

Campos-Outcalt, D. 2013: Vaccine update: the latest from ACIP. Journal of Family Practice 62(3): 137-144

Puliyel, J. 2013: Vaccine uptake rather than disease mitigation seems to be aim of universal hepatitis B vaccination in the UK. Bmj 347: F5187

Principi, N.; Esposito, S. 2014: Vaccine use in primary immunodeficiency disorders. Vaccine 32(30): 3725-3731

Cima, G. 2010: Vaccine use up since Salmonella outbreak. Journal of the American Veterinary Medical Association 237(12): 1356-1357

Arya, S.C.; Agarwal, N. 2012: Vaccine vial monitors in adverse field environment. Indian Journal of Medical Research 136(5): 881

Guichard, S.; Hymbaugh, K.; Burkholder, B.; Diorditsa, S.; Navarro, C.; Ahmed, S.; Rahman, M.M. 2010: Vaccine wastage in Bangladesh. Vaccine 28(3): 858-863

Sakure, S.; Negi, V.D.; Mitra, S.K.; Nandakumar, K.S.; Chakravortty, D. 2008: Vaccine with herbal adjuvant--a better cocktail to combat the infection. Vaccine 26(27-28): 3387-3388

Karimi, M.; Raee, A.; Baghianimoghadam, B.; Fallahzadeh, M.Hossein. 2013: Vaccine-Induced Anti-HBs Level in 5-6 Year-Old Malnourished Children. Hepatitis Monthly 13(2): E7048

Gillett, H.T. 1913: Vaccine-Therapy in Chronic Bronchitis. British medical journal 1(2721): 387-388

Patel, N.C.; Hertel, P.M.; Estes, M.K.; de la Morena, M.; Petru, A.M.; Noroski, L.M.; Revell, P.A.; Hanson, I.Celine.; Paul, M.E.; Rosenblatt, H.M.; Abramson, S.L. 2010: Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. New England Journal of Medicine 362(4): 314-319

Martin, L.E.R.; Wiggans, K.T.; Wennogle, S.A.; Curtis, K.; Chandrashekar, R.; Lappin, M.R. 2014: Vaccine-associated Leptospira antibodies in client-owned dogs. Journal of Veterinary Internal Medicine 28(3): 789-792

Gauger, P.C.; Loving, C.L.; Lager, K.M.; Janke, B.H.; Kehrli, M.E.; Roth, J.A.; Vincent, A.L. 2013: Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009. Viral Immunology 26(5): 314-321

Homer, D.R. 2010: Vaccine-associated fibrosarcoma. Australian Veterinary Journal 88(5): 159

Gumber, S.; Wakamatsu, N. 2011: Vaccine-associated fibrosarcoma with keloidal differentiation in a cat. Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians Inc 23(5): 1061-1064

Chouliaras, G.; Spoulou, V.; Quinlivan, M.; Breuer, J.; Theodoridou, M. 2010: Vaccine-associated herpes zoster ophthalmicus [correction of opthalmicus] and encephalitis in an immunocompetent child. Pediatrics 125(4): E969-E972

Choe, Y.J.; Eom, H.S.; Bae, G.-R. 2014: Vaccine-associated measles in the low-incidence country of Korea over a 10-year period. Japanese Journal of Infectious Diseases 67(3): 180-183

Trimble, R.; Atkins, J.; Quigg, T.C.; Burns, C.C.; Wallace, G.S.; Thomas, M.; Mangla, A.T.; Infante, A.J. 2014: Vaccine-associated paralytic poliomyelitis and BCG-osis in an immigrant child with severe combined immunodeficiency syndrome - Texas, 2013. MMWR. Morbidity and mortality weekly report 63(33): 721-724

Hosoda, M.; Inoue, H.; Miyazawa, Y.; Kusumi, E.; Shibuya, K. 2012: Vaccine-associated paralytic poliomyelitis in Japan. Lancet 379(9815): 520

Asahina, N.; Matsunami, Y.; Sueda, K.; Shiraishi, H.; Saitoh, S. 2010: Vaccine-associated paralytic poliomyelitis in a non-immunocompromised infant. Pediatrics International: Official Journal of the Japan Pediatric Society 52(5): 838-841

Parvaneh, N.; Shahmahmoudi, S.; Tabatabai, H.; Zahraei, M.; Mousavi, T.; Esteghamati, A.-R.; Gooya, M.M.; Mamishi, S.; Nategh, R.; Kew, O.M. 2007: Vaccine-associated paralytic poliomyelitis in a patient with MHC class Ii deficiency. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 39(2): 145-148

Al-Mendalawi, M.D. 2008: Vaccine-associated paralytic poliomyelitis in a pre-vaccinated infant. Saudi Medical Journal 29(11): 1678; author reply 1678-9

Higashigawa, M.; Maegawa, K.; Honma, H.; Yoshino, A.; Onozato, K.; Nashida, Y.; Fujiwara, T.; Inoue, M. 2010: Vaccine-associated paralytic poliomyelitis in an infant with perianal abscesses. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 16(5): 356-359

Shahmahmoodi, S.; Mamishi, S.; Aghamohammadi, A.; Aghazadeh, N.; Tabatabaie, H.; Gooya, M.Mehdi.; Zahraei, S.Mohsen.; Mousavi, T.; Yousefi, M.; Farrokhi, K.; Mohammadpour, M.; Ashrafi, M.Reza.; Nategh, R.; Parvaneh, N. 2010: Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995-2008. Emerging infectious diseases 16(7): 1133-1136

Landaverde, J.Mauricio.; Trumbo, S.Pierson.; Danovaro-Holliday, M.Carolina.; Cochi, S.E.; Gandhi, R.; Ruiz-Matus, Cémoc. 2014: Vaccine-associated paralytic poliomyelitis in the postelimination era in Latin America and the Caribbean, 1992-2011. Journal of infectious diseases 209(9): 1393-1402

Oishi, M.; Kawai, M.; Ogasawara, J.-I.; Koga, M.; Kanda, T. 2012: Vaccine-associated paralytic poliomyelitis showing biphasic motor paresis. Rinsho Shinkeigaku 52(10): 744-749

Ilic, M.D.; Obradovic, S.D. 2014: Vaccine-associated paralytic poliomyelitis: a case report. Japanese Journal of Infectious Diseases 67(2): 135-136

Platt, L.R.; Estívariz, C.ón.F.; Sutter, R.W. 2014: Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. Journal of Infectious Diseases 210(Suppl 1): S380-S389

Bayer, D.K.; Martinez, C.A.; Sorte, H.S.; Forbes, L.R.; Demmler-Harrison, G.J.; Hanson, I.C.; Pearson, N.M.; Noroski, L.M.; Zaki, S.R.; Bellini, W.J.; Leduc, M.S.; Yang, Y.; Eng, C.M.; Patel, A.; Rodningen, O.K.; Muzny, D.M.; Gibbs, R.A.; Campbell, I.M.; Shaw, C.A.; Baker, M.W.; Zhang, V.; Lupski, J.R.; Orange, J.S.; Seeborg, F.O.; Stray-Pedersen, A. 2014: Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clinical and Experimental Immunology 178(3): 459-469

Leffers, N.; Daemen, T.; Boezen, H.M.; Melief, K.J.M.; Nijman, H.W. 2011: Vaccine-based clinical trials in ovarian cancer. Expert Review of Vaccines 10(6): 775-784

Thomas, A.A.; Fisher, J.L.; Ernstoff, M.S.; Fadul, C.E. 2013: Vaccine-based immunotherapy for glioblastoma. Cns Oncology 2(4): 331-349

De Bie, S.; Verhamme, K.M.C.; Straus, S.M.J.M.; Stricker, B.H.C.; Sturkenboom, M.C.J.M. 2012: Vaccine-based subgroup analysis in VigiBase: effect on sensitivity in paediatric signal detection. Drug Safety 35(4): 335-346

Robichaud, P.; Hawken, S.; Beard, L.; Morra, D.; Tomlinson, G.; Wilson, K.; Keelan, J. 2012: Vaccine-critical videos on YouTube and their impact on medical students' attitudes about seasonal influenza immunization: a pre and post study. Vaccine 30(25): 3763-3770

Hemming, M.; Vesikari, T. 2012: Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis. Pediatric Infectious Disease Journal 31(9): 992-994

Liu, X.; Yang, X.; Lee, C.A.; Moustafa, I.M.; Smidansky, E.D.; Lum, D.; Arnold, J.J.; Cameron, C.E.; Boehr, D.D. 2013: Vaccine-derived mutation in motif D of poliovirus RNA-dependent RNA polymerase lowers nucleotide incorporation fidelity. Journal of Biological Chemistry 288(45): 32753-32765

MacLennan, C.A.; Huissoon, A.P.; Kumararatne, D.S. 2011: Vaccine-derived poliomyelitis 12 years after infection. New England Journal of Medicine 365(14): 1355; Author Reply 1355

Lusi, E.A.; Guarascio, P. 2014: Vaccine-derived poliomyelitis and postpolio syndrome: an Italian Cutter Incident. Jrsm Open 5(1): 2042533313511241

Minor, P. 2009: Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication. Vaccine 27(20): 2649-2652

Burns, C.C.; Diop, O.M.; Sutter, R.W.; Kew, O.M. 2014: Vaccine-derived polioviruses. Journal of Infectious Diseases 210(Suppl 1): S283-S293

Anonymous 2009: Vaccine-derived polioviruses detected worldwide, January 2008-June 2009. Releve Epidemiologique Hebdomadaire 84(38): 390-396

Anonymous 2011: Vaccine-derived polioviruses detected worldwide, July 2009 − March 2011. Releve Epidemiologique Hebdomadaire 86(27): 277-288

Anonymous 2014: Vaccine-derived polioviruses detected worldwide, July 2012–December 2013. Releve Epidemiologique Hebdomadaire 89(12): 117-127

Tan, Z.; Zhou, J.; Cheung, A.K.L.; Yu, Z.; Cheung, K.-W.; Liang, J.; Wang, H.; Lee, B.K.; Man, K.; Liu, L.; Yuen, K.-Y.; Chen, Z. 2014: Vaccine-elicited CD8+ T cells cure mesothelioma by overcoming tumor-induced immunosuppressive environment. Cancer Research 74(21): 6010-6021

Brocca-Cofano, E.; McKinnon, K.; Demberg, T.; Venzon, D.; Hidajat, R.; Xiao, P.; Daltabuit-Test, M.; Patterson, L.J.; Robert-Guroff, M. 2011: Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia. Vaccine 29(17): 3310-3319

Tran, K.; Poulsen, C.; Guenaga, J.; de Val, N.; de Val Alda, N.; Wilson, R.; Sundling, C.; Li, Y.; Stanfield, R.L.; Wilson, I.A.; Ward, A.B.; Karlsson Hedestam, G.B.; Wyatt, R.T. 2014: Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign. Proceedings of the National Academy of Sciences of the United States of America 111(7): E738-E747

Woldemariam, K.M.; Yen, G.G. 2010: Vaccine-enhanced artificial immune system for multimodal function optimization. IEEE Transactions on Systems man and Cybernetics. Part B Cybernetics: a Publication of the IEEE Systems man and Cybernetics Society 40(1): 218-228

Terahara, K.; Ishii, H.; Nomura, T.; Takahashi, N.; Takeda, A.; Shiino, T.; Tsunetsugu-Yokota, Y.; Matano, T. 2014: Vaccine-induced CD107a+ CD4+ T cells are resistant to depletion following AIDS virus infection. Journal of Virology 88(24): 14232-14240

Takeda, K.; Dow, S.W.; Miyahara, N.; Kodama, T.; Koya, T.; Taube, C.; Joetham, A.; Park, J.-W.; Dakhama, A.; Kedl, R.M.; Gelfand, E.W. 2009: Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation. Journal of Immunology 183(1): 181-190

Yates, N.L.; Liao, H.-X.; Fong, Y.; deCamp, A.; Vandergrift, N.A.; Williams, W.T.; Alam, S.M.; Ferrari, G.; Yang, Z.-y.; Seaton, K.E.; Berman, P.W.; Alpert, M.D.; Evans, D.T.; O'Connell, R.J.; Francis, D.; Sinangil, F.; Lee, C.; Nitayaphan, S.; Rerks-Ngarm, S.; Kaewkungwal, J.; Pitisuttithum, P.; Tartaglia, J.; Pinter, A.; Zolla-Pazner, S.; Gilbert, P.B.; Nabel, G.J.; Michael, N.L.; Kim, J.H.; Montefiori, D.C.; Haynes, B.F.; Tomaras, G.D. 2014: Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Science Translational Medicine 6(228): 228ra39

Cooper, C.J.; Metch, B.; Dragavon, J.; Coombs, R.W.; Baden, L.R.; Allen, M.; Alexander, S.; Ducar, C.; Fix, A.; Holt, R.; Karuna, S.; Meyer, G.; Robertson, M.; Rybczyk, K.; Shikiar, R.; Wakefield, S.; Wecker, M. 2010: Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients. JAMA 304(3): 275-283

Van Braeckel, E.; Koutsoukos, M.; Bourguignon, P.; Clement, F.éd.ér.; McNally, L.; Leroux-Roels, G. 2011: Vaccine-induced HIV seropositivity: a problem on the rise. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 50(4): 334-337

Dennison, S.M.; Anasti, K.M.; Jaeger, F.H.; Stewart, S.M.; Pollara, J.; Liu, P.; Kunz, E.L.; Zhang, R.; Vandergrift, N.; Permar, S.; Ferrari, G.; Tomaras, G.D.; Bonsignori, M.; Michael, N.L.; Kim, J.H.; Kaewkungwal, J.; Nitayaphan, S.; Pitisuttithum, P.; Rerks-Ngarm, S.; Liao, H.-X.; Haynes, B.F.; Alam, S.M. 2014: Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide. Journal of Virology 88(16): 9406-9417

Friedrich, D.; Jalbert, E.; Dinges, W.L.; Sidney, J.; Sette, A.; Huang, Y.; McElrath, M.J.; Horton, H. 2011: Vaccine-induced HIV-specific CD8+ T cells utilize preferential HLA alleles and target-specific regions of HIV-1. Journal of Acquired Immune Deficiency Syndromes 58(3): 248-252

Zolla-Pazner, S.; deCamp, A.; Gilbert, P.B.; Williams, C.; Yates, N.L.; Williams, W.T.; Howington, R.; Fong, Y.; Morris, D.E.; Soderberg, K.A.; Irene, C.; Reichman, C.; Pinter, A.; Parks, R.; Pitisuttithum, P.; Kaewkungwal, J.; Rerks-Ngarm, S.; Nitayaphan, S.; Andrews, C.; O'Connell, R.J.; Yang, Z.-y.; Nabel, G.J.; Kim, J.H.; Michael, N.L.; Montefiori, D.C.; Liao, H.-X.; Haynes, B.F.; Tomaras, G.D. 2014: Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection. Plos one 9(2): E87572

French, M.A.; Tanaskovic, S.; Law, M.G.; Lim, A.; Fernandez, S.; Ward, L.D.; Kelleher, A.D.; Emery, S. 2010: Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcgammaRIIa genotype. Aids 24(13): 1983-1990

Lauer, G.M.; Chung, R.T. 2007: Vaccine-induced T-cell responses against HCV: one step taken, more to follow. Gastroenterology 132(4): 1626-1628

D'Orsogna, L.J.A.; van Besouw, N.M.; van der Meer-Prins, E.M.W.; van der Pol, P.; Franke-van Dijk, M.; Zoet, Y.M.; van der Slik, A.; Weimar, W.; van Kooten, C.; Mulder, A.; Roelen, D.L.; Doxiadis, I.I.N.; Claas, F.H.J. 2011: Vaccine-induced allo-HLA-reactive memory T cells in a kidney transplantation candidate. Transplantation 91(6): 645-651

Khurana, S.; Loving, C.L.; Manischewitz, J.; King, L.R.; Gauger, P.C.; Henningson, J.; Vincent, A.L.; Golding, H. 2013: Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease. Science Translational Medicine 5(200): 200ra114

Derrick, S.C.; Yabe, I.M.; Yang, A.; Morris, S.L. 2011: Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells. Vaccine 29(16): 2902-2909

Iweala, O.I.; Smith, D.W.; Matharu, K.S.; Sada-Ovalle, I.; Nguyen, D.D.; Dekruyff, R.H.; Umetsu, D.T.; Behar, S.M.; Nagler, C.R. 2009: Vaccine-induced antibody isotypes are skewed by impaired CD4 T cell and invariant NKT cell effector responses in MyD88-deficient mice. Journal of Immunology 183(4): 2252-2260

Von Mensdorff-Pouilly, S. 2010: Vaccine-induced antibody responses in patients with carcinoma. Expert Review of Vaccines 9(6): 579-594

Dolfi, D.V.; Mansfield, K.D.; Kurupati, R.K.; Kannan, S.; Doyle, S.A.; Ertl, H.C.J.; Schmader, K.E.; Wherry, E.J. 2013: Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans. Plos one 8(10): E77164

Wilson, N.A.; Keele, B.F.; Reed, J.S.; Piaskowski, S.M.; MacNair, C.E.; Bett, A.J.; Liang, X.; Wang, F.; Thoryk, E.; Heidecker, G.J.; Citron, M.P.; Huang, L.; Lin, J.; Vitelli, S.; Ahn, C.D.; Kaizu, M.; Maness, N.J.; Reynolds, M.R.; Friedrich, T.C.; Loffredo, J.T.; Rakasz, E.G.; Erickson, S.; Allison, D.B.; Piatak, M.; Lifson, J.D.; Shiver, J.W.; Casimiro, D.R.; Shaw, G.M.; Hahn, B.H.; Watkins, D.I. 2009: Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. Journal of Virology 83(13): 6508-6521

Abel, K.; Martinez, J.; Yue, Y.; Lacey, S.F.; Wang, Z.; Strelow, L.; Dasgupta, A.; Li, Z.; Schmidt, K.A.; Oxford, K.L.; Assaf, B.; Longmate, J.A.; Diamond, D.J.; Barry, P.A. 2011: Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques. Journal of Virology 85(6): 2878-2890

Meunier, J.-C.; Gottwein, J.M.; Houghton, M.; Russell, R.S.; Emerson, S.U.; Bukh, J.; Purcell, R.H. 2011: Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus. Journal of Infectious Diseases 204(8): 1186-1190

Van Duikeren, S.; Fransen, M.F.; Redeker, A.; Wieles, B.; Platenburg, G.; Krebber, W.-J.; Ossendorp, F.; Melief, C.J.M.; Arens, R. 2012: Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors. Journal of Immunology 189(7): 3397-3403

Haq, K.; Abdul-Careem, M.F.; Shanmuganthan, S.; Thanthrige-Don, N.; Read, L.R.; Sharif, S. 2010: Vaccine-induced host responses against very virulent Marek's disease virus infection in the lungs of chickens. Vaccine 28(34): 5565-5572

Ochs, M.M.; Bartlett, W.; Briles, D.E.; Hicks, B.; Jurkuvenas, A.; Lau, P.; Ren, B.; Millar, A. 2008: Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae. Microbial Pathogenesis 44(3): 204-214

Kremer, K.; van-der-Werf, M.J.; Au, B.K.Y.; Anh, D.D.; Kam, K.M.; van-Doorn, H.R.; Borgdorff, M.W.; van-Soolingen, D. 2009: Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains. Emerging Infectious Diseases 15(2): 335-339

Kollmann, T.R.; Levy, O.; Hanekom, W. 2013: Vaccine-induced immunity in early life. Vaccine 31(21): 2481-2482

Pichichero, M.E. 2008: Vaccine-induced immunologic memory and pace of pathogenesis: predicting the need for boosters. Expert Review of Vaccines 7(9): 1299-1303

Paine, N.J.; Ring, C.; Bosch, J.A.; Drayson, M.T.; Aldred, S.; Veldhuijzen van Zanten, J.J.C.S. 2014: Vaccine-induced inflammation attenuates the vascular responses to mental stress. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 93(3): 340-348

Neal, L.M.; McCarthy, E.A.; Morris, C.R.; Mantis, N.J. 2011: Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA. Vaccine 29(4): 681-689

Lin, W-Hsuan.W.; Pan, C-Hsiung.; Adams, R.J.; Laube, B.L.; Griffin, D.E. 2014: Vaccine-induced measles virus-specific T cells do not prevent infection or disease but facilitate subsequent clearance of viral RNA. Mbio 5(2): E01047

Foquet, L.; Hermsen, C.C.; van Gemert, G-Jan.; Van Braeckel, E.; Weening, K.E.; Sauerwein, R.; Meuleman, P.; Leroux-Roels, G. 2014: Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. Journal of Clinical Investigation 124(1): 140-144

Sui, Y.; Hogg, A.; Wang, Y.; Frey, B.; Yu, H.; Xia, Z.; Venzon, D.; McKinnon, K.; Smedley, J.; Gathuka, M.; Klinman, D.; Keele, B.F.; Langermann, S.; Liu, L.; Franchini, G.; Berzofsky, J.A. 2014: Vaccine-induced myeloid cell population dampens protective immunity to SIV. Journal of Clinical Investigation 124(6): 2538-2549

Plested, J.S.; Granoff, D.M. 2008: Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B. Clinical and Vaccine Immunology: Cvi 15(5): 799-804

Tomaras, G.D.; Ferrari, G.; Shen, X.; Alam, S.M.; Liao, H.-X.; Pollara, J.; Bonsignori, M.; Moody, M.A.; Fong, Y.; Chen, X.; Poling, B.; Nicholson, C.O.; Zhang, R.; Lu, X.; Parks, R.; Kaewkungwal, J.; Nitayaphan, S.; Pitisuttithum, P.; Rerks-Ngarm, S.; Gilbert, P.B.; Kim, J.H.; Michael, N.L.; Montefiori, D.C.; Haynes, B.F. 2013: Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. Proceedings of the National Academy of Sciences of the United States of America 110(22): 9019-9024

Kapczynski, D.R.; Gonder, E.; Liljebjelke, K.; Lippert, R.; Petkov, D.; Tilley, B. 2009: Vaccine-induced protection from egg production losses in commercial turkey breeder hens following experimental challenge with a triple-reassortant H3N2 avian influenza virus. Avian Diseases 53(1): 7-15

Verstrepen, B.E.; Oostermeijer, H.; Fagrouch, Z.; van Heteren, M.; Niphuis, H.; Haaksma, T.; Kondova, I.; Bogers, W.M.; de Filette, M.; Sanders, N.; Stertman, L.; Magnusson, S.; Lőrincz, O.; Lisziewicz, J.; Barzon, L.; Palù, G.; Diamond, M.S.; Chabierski, S.; Ulbert, S.; Verschoor, E.J. 2014: Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus. Plos one 9(11): E112568

Hostnik, P.; Picard-Meyer, E.; Rihtarič, D.; Toplak, I.; Cliquet, F. 2014: Vaccine-induced rabies in a red fox (Vulpes vulpes): isolation of vaccine virus in brain tissue and salivary glands. Journal of Wildlife Diseases 50(2): 397-401

Peltola, H.; Pelkonen, T.; Bernardino, L.; Monteiro, L.; Silvestre, S.d.C.ção.; Anjos, E.; Cruzeiro, M.L.; Pitkäranta, A.; Roine, I. 2014: Vaccine-induced waning of Haemophilus influenzae empyema and meningitis, Angola. Emerging Infectious Diseases 20(11): 1887-1890

Engram, J.C.; Dunham, R.M.; Makedonas, G.; Vanderford, T.H.; Sumpter, B.; Klatt, N.R.; Ratcliffe, S.J.; Garg, S.; Paiardini, M.; McQuoid, M.; Altman, J.D.; Staprans, S.I.; Betts, M.R.; Garber, D.A.; Feinberg, M.B.; Silvestri, G. 2009: Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression. Journal of Immunology 183(1): 706-717

Hess Michelini, R.; Manzo, T.; Sturmheit, T.; Basso, V.; Rocchi, M.; Freschi, M.; Listopad, J.; Blankenstein, T.; Bellone, M.; Mondino, A. 2013: Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T-cell transplantation. Cancer Research 73(15): 4641-4652

Büyüktimkin, B.; Wang, Q.; Kiptoo, P.; Stewart, J.M.; Berkland, C.; Siahaan, T.J. 2012: Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis. Molecular Pharmaceutics 9(4): 979-985

Pelegrin, M.; Gros, L.; Piechaczyk, M. 2013: Vaccine-like effects of antiviral monoclonal antibodies: a novel therapeutic perspective?. Medecine Sciences: M/S 29(5): 457-460

Putrianti, E.D.; Silvie, O.; Kordes, M.; Borrmann, S.; Matuschewski, K. 2009: Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. Journal of Infectious Diseases 199(6): 899-903

Borisevich, S.V.; Marennikova, S.S.; Stovba, L.F.; Makhlaĭ, A.A.; Loginova, S.Ia.; Terent'ev, A.I.; Krotkov, V.T.; Perekrest, V.V.; Krasnianskiĭ, V.P. 2014: Vaccine-like viruses: peculiarities of circulation in the South America. Voprosy Virusologii 59(2): 10-14

Chaturvedi, A.K.; Hameed, R.S.; Wozniak, K.L.; Hole, C.R.; Leopold Wager, C.M.; Weintraub, S.T.; Lopez-Ribot, J.L.; Wormley, F.L. 2014: Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice. Plos one 9(8): E104316

Slifka, M.K. 2014: Vaccine-mediated immunity against dengue and the potential for long-term protection against disease. Frontiers in Immunology 5: 195

Ardiani, A.; Gameiro, S.R.; Palena, C.; Hamilton, D.H.; Kwilas, A.; King, T.H.; Schlom, J.; Hodge, J.W. 2014: Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process. Cancer Research 74(7): 1945-1957

Ng, G.Z.; Chionh, Y.-T.; Sutton, P. 2014: Vaccine-mediated protection against Helicobacter pylori is not associated with increased salivary cytokine or mucin expression. Helicobacter 19(1): 48-54

Johnson, M.G.; Bradley, K.K.; Mendus, S.; Burnsed, L.; Clinton, R.; Tiwari, T. 2013: Vaccine-preventable disease among homeschooled children: two cases of tetanus in Oklahoma. Pediatrics 132(6): E1686-E1689

Nguyen, G.T.; Altshuler, M. 2011: Vaccine-preventable diseases and foreign-born populations. Primary Care 38(4): 633

Ulloa-Gutierrez, R.; Miño, G.; Odio, C.; Avila-Aguero, Mía.L.; Brea, Jé. 2011: Vaccine-preventable diseases and their impact on Latin American children. Expert review of vaccines 10(12): 1671-1673

Herman, J.S.; Hill, D.R. 2012: Vaccine-preventable diseases and their prophylaxis. Infectious Disease Clinics of North America 26(3): 595-608

Kightlinger, L. 2013: Vaccine-preventable diseases and vaccination rates in South Dakota. South Dakota Medicine: the Journal of the South Dakota State Medical Association Spec No: 84-89

Wicker, S.; Maltezou, H.C. 2014: Vaccine-preventable diseases in Europe: where do we stand?. Expert Review of Vaccines 13(8): 979-987

O'Dowd, M.E. 2013: Vaccine-preventable diseases still pose a threat to our communities. Md Advisor: a Journal for new Jersey Medical Community 6(3): 21-23

Hinman, A.R.; Orenstein, W.A.; Schuchat, A. 2011: Vaccine-preventable diseases, immunizations, and MMWR--1961-2011. MMWR supplements 60(4): 49-57

Hinman, A.R.; Orenstein, W.A.; Schuchat, A. 2011: Vaccine-preventable diseases, immunizations, and the Epidemic Intelligence Service. American Journal of Epidemiology 174(11 Suppl): S16-S22

Esposito, S.; Durando, P.; Bosis, S.; Ansaldi, F.; Tagliabue, C.; Icardi, G. 2014: Vaccine-preventable diseases: from paediatric to adult targets. European Journal of Internal Medicine 25(3): 203-212

Kramarz, P.; Lopalco, P.L.; Huitric, E.; Pastore Celentano, L. 2014: Vaccine-preventable diseases: the role of the European Centre for Disease Prevention and Control. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 20 Suppl. 5: 2-6

Steffen, R.; Behrens, R.H.; Hill, D.R.; Greenaway, C.; Leder, K. 2015: Vaccine-preventable travel health risks: what is the evidence--what are the gaps?. Journal of Travel Medicine 22(1): 1-12

Galindo, B.M.; Concepción, D.; Galindo, M.A.; Pérez, A.; Saiz, Jús. 2012: Vaccine-related adverse events in Cuban children, 1999-2008. MEDICC review 14(1): 38-43

Bazzano, A.; Zeldin, A.; Schuster, E.; Barrett, C.; Lehrer, D. 2012: Vaccine-related beliefs and practices of parents of children with autism spectrum disorders. American Journal on Intellectual and Developmental Disabilities 117(3): 233-242

Kalichman, S.C.; Kegler, C. 2015: Vaccine-related internet search activity predicts H1N1 and HPV vaccine coverage: implications for vaccine acceptance. Journal of Health Communication 20(3): 259-265

Santoro, N.; Grandone, A. 2008: Vaccine-related pain: picking up the child soon after the injection reduces the time of crying. Archives of Disease in Childhood 93(5): 449-450

Bernstein, P.; Furuya, Y.; Steinberg, S.; Scully, B.; Larussa, P.; Gershon, A.A. 2011: Vaccine-related varicella-zoster rash in a hospitalized immunocompetent patient. American Journal of Infection Control 39(3): 247-249

Bhattacharjee, B. 1947: Vaccine-shock treatment for gonorrhoeal arthritis. Medical World 65(6): 252-254

Cherukuri, A.; Servat, E.; Woo, J. 2012: Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets. Vaccine 30(2): 237-246

Jacobs, J.F.M.; Aarntzen, E.H.J.G.; Sibelt, L.A.G.; Blokx, W.A.; Boullart, A.C.I.; Gerritsen, M.-J.; Hoogerbrugge, P.M.; Figdor, C.G.; Adema, G.J.; Punt, C.J.A.; de Vries, I.J.M. 2009: Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients. Cancer Immunology Immunotherapy: Cii 58(1): 145-151

Ota, K.; Kim, V.; Lavi, S.; Ford-Jones, E.L.; Tipples, G.; Scolnik, D.; Tellier, R. 2008: Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old. Pediatric Infectious Disease Journal 27(9): 847-848

Büyüktimkin, B.; Manikwar, P.; Kiptoo, P.K.; Badawi, A.H.; Stewart, J.M.; Siahaan, T.J. 2013: Vaccinelike and prophylactic treatments of EAE with novel I-domain antigen conjugates (IDAC): targeting multiple antigenic peptides to APC. Molecular Pharmaceutics 10(1): 297-306

Douek, D.C.; Nabel, G.J. 2011: Vaccines. Immunological Reviews 239(1): 5-7

Stone, R. 2018: Weapons in waiting. Science 359(6371): 24

Anonymous 2009: Vaccines Against Meningococcus - An update of the progresses in meningitis prevention. Proceeding of the Meningococcus Scientific Exchange Meeting. Siena, Italy. July 1-3, 2008. Vaccine 27 Suppl. 2: B1-125

Bristol, L.D. 1937: Vaccines Against the Common Cold -Are They of Value in the Industrial Health Program?. American Journal of Public Health and the Nation's Health 27(10): 987-990

Hort, E.C. 1913: Vaccines and Fever. British medical journal 1(2719): 265-270

Mukhopadhyay, T.K. 2010: Vaccines Europe 2009. Expert Review of Vaccines 9(2): 125-128

Jones, S.Dana. 2009: Vaccines Europe--Informa Conference. Vaccine scale-up and manufacturing. 2-3 December 2008, Brussels, Belgium. IDrugs: the investigational drugs journal 12(2): 87-91

Leishman, W.B. 1918: Vaccines for Influenza. British medical journal 2(3017): 470

Pirie, J.H. 1913: Vaccines in the Treatment of Chronic Bronchitis and of Asthma. British medical journal 1(2737): 1268-1271

McCrea, E.D. 1928: Vaccines in the Treatment of Gonorrhoea. British medical journal 1(3513): 755-756

Leuzzi, R.; Adamo, R.; Scarselli, M. 2014: Vaccines against Clostridium difficile. Human Vaccines and Immunotherapeutics 10(6): 1466-1477

Nagahama, M. 2013: Vaccines against Clostridium perfringens alpha-toxin. Current Pharmaceutical Biotechnology 14(10): 913-917

Yoon, H.Jung.; Clemons, K.V. 2013: Vaccines against Coccidioides. Korean Journal of Internal Medicine 28(4): 403-407

Poland, G.A. 2011: Vaccines against Lyme disease: what happened and what lessons can we learn?. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 52(Suppl 3): S253-S258

Patarroyo, M.A.; Calderón, D.; Moreno-Pérez, D.A. 2012: Vaccines against Plasmodium vivax: a research challenge. Expert Review of Vaccines 11(10): 1249-1260

Jongert, E.; Roberts, C.W.; Gargano, N.; Förster-Waldl, E.; Förster-Wald, E.; Petersen, E. 2009: Vaccines against Toxoplasma gondii: challenges and opportunities. Memorias do Instituto Oswaldo Cruz 104(2): 252-266

Zhang, N.-Z.; Chen, J.; Wang, M.; Petersen, E.; Zhu, X.-Q. 2013: Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Review of Vaccines 12(11): 1287-1299

Liu, Q.; Singla, L.D.; Zhou, H. 2012: Vaccines against Toxoplasma gondii: status, challenges and future directions. Human Vaccines and Immunotherapeutics 8(9): 1305-1308

Nilsson, J.; Wigren, M.; Shah, P.K. 2013: Vaccines against atherosclerosis. Expert Review of Vaccines 12(3): 311-321

Florin-Christensen, M.; Suarez, C.E.; Rodriguez, A.E.; Flores, D.A.; Schnittger, L. 2014: Vaccines against bovine babesiosis: where we are now and possible roads ahead. Parasitology 2014: 1-30

Denis, M.; Wedlock, D.N.; Lacy-Hulbert, S.J.; Hillerton, J.E.; Buddle, B.M. 2009: Vaccines against bovine mastitis in the New Zealand context: what is the best way forward?. New Zealand Veterinary Journal 57(3): 132-140

Hunter, P. 2014: Vaccines against cancer: Despite setbacks, attempts to harness the patient's immune system to fight tumor cells show promise in clinical trials. Embo Reports 15(5): 485-488

Rogers, L.J.; Eva, L.J.; Luesley, D.M. 2008: Vaccines against cervical cancer. Current Opinion in Oncology 20(5): 570-574

Monath, T.P. 2013: Vaccines against diseases transmitted from animals to humans: a one health paradigm. Vaccine 31(46): 5321-5338

Kinsey, B. 2014: Vaccines against drugs of abuse: where are we now?. Therapeutic Advances in Vaccines 2(4): 106-117

Hoelscher, M.; Gangappa, S.; Zhong, W.; Jayashankar, L.; Sambhara, S. 2008: Vaccines against epidemic and pandemic influenza. Expert Opinion on Drug Delivery 5(10): 1139-1157

Jerse, A.E.; Bash, M.C.; Russell, M.W. 2014: Vaccines against gonorrhea: current status and future challenges. Vaccine 32(14): 1579-1587

Valenzuela, M.T. 2009: Vaccines against hepatitis a and B in Chile. Revista Medica de Chile 137(6): 844-851

Hoeller Obrigkeit, D.; Baron, J.M. 2007: Vaccines against herpex simplex virus infections. What's new. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 58(5): 465-466

Sergeeva, M.V.; Romanova, I.R. 2013: Vaccines against highly pathogenic influenza viruses of the avian origin. Voprosy Virusologii 58(4): 4-9

De Giovanni, C.; Nicoletti, G.; Quaglino, E.; Landuzzi, L.; Palladini, A.; Ianzano, M.Lucia.; Dall'Ora, M.; Grosso, V.; Ranieri, D.; Laranga, R.; Croci, S.; Amici, A.; Penichet, M.L.; Iezzi, M.; Cavallo, F.; Nanni, P.; Lollini, P-Luigi. 2014: Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2. Breast Cancer Research: Bcr 16(1): R10

Palena, C.; Schlom, J. 2010: Vaccines against human carcinomas: strategies to improve antitumor immune responses. Journal of Biomedicine and Biotechnology 2010: 380697

Böhles, N.; Böhles, N.; Busch, K.; Busch, K.; Hensel, M.; Hensel, M. 2014: Vaccines against human diarrheal pathogens: current status and perspectives. Human Vaccines and Immunotherapeutics 10(6): 1522-1535

Sharma, S. 2008: Vaccines against human papilloma virus and cervical cancer: an overview. Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive and Social Medicine 33(3): 143-145

Van Rossum, T.G.J.; de Melker, H.E.; Houweling, H.; Voordouw, A.C.G.; Meijer, C.J.L.M.; Helmerhorst, T.J.M.; Kretzschmar, M.; Berkhof, J.; van der Noordaa, J. 2008: Vaccines against human papillomavirus (HPV); between registration and implementation. Nederlands Tijdschrift Voor Geneeskunde 152(17): 987-992

García Carrancá, A.; Galván, S.C. 2007: Vaccines against human papillomavirus: perspectives for controlling cervical cancer. Expert Review of Vaccines 6(4): 497-510

Vonka, Vír.; Hamsíková, E. 2007: Vaccines against human papillomaviruses--a major breakthrough in cancer prevention. Central European Journal of Public Health 15(4): 131-139

Valdespino-Gomez, J.L.; Garcia-Garcia, L.; de León-Rosales, S.P. 2009: Vaccines against influenza a (H1N1) pandemic. Archives of Medical Research 40(8): 693-704

Poland, G.A.; Sambhara, S. 2008: Vaccines against influenza a (H5N1): evidence of progress. Journal of Infectious Diseases 198(5): 629-631

Dharmendra; Dharmendra 2012: The immunological skin tests in leprosy. Part I. the isolation of a protein antigen of Mycobacterium leprae. 1942. Indian Journal of Medical Research 136(3)

Titball, R.W. 2008: Vaccines against intracellular bacterial pathogens. Drug Discovery Today 13(13-14): 596-600

MacLennan, C.A.; Martin, L.B.; Micoli, F. 2014: Vaccines against invasive Salmonella disease: current status and future directions. Human Vaccines and Immunotherapeutics 10(6): 1478-1493

Adler, B. 2015: Vaccines against leptospirosis. Current Topics in Microbiology and Immunology 387: 251-272

Mueller, I.; Genton, B.; Betuela, I.; Alpers, M.P. 2010: Vaccines against malaria: perspectives from Papua new Guinea. Human Vaccines 6(1): 17-20

Holst, J.; Oster, P.; Arnold, R.; Tatley, M.V.; Næss, L.M.; Aaberge, I.S.; Galloway, Y.; McNicholas, A.; O'Hallahan, J.; Rosenqvist, E.; Black, S. 2013: Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future. Human Vaccines and Immunotherapeutics 9(6): 1241-1253

Anton, B.; Salazar, A.; Flores, A.; Matus, M.; Marin, R.; Hernandez, J-Alberto.; Leff, P. 2009: Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors. Human Vaccines 5(4): 214-229

Holmgren, J.; Svennerholm, A.-M. 2012: Vaccines against mucosal infections. Current Opinion in Immunology 24(3): 343-353

Bottazzi, M.Elena. 2014: Vaccines against neglected tropical diseases: promising interventions to rescue the poorest populations in the Americas. ImmunoTherapy 6(2): 117-119

Monney, T.; Hemphill, A. 2014: Vaccines against neosporosis: what can we learn from the past studies?. Experimental Parasitology 140: 52-70

Cerny, E.H.; Cerny, T. 2009: Vaccines against nicotine. Human Vaccines 5(4): 200-205

Röhn, T.A.; Bachmann, M.F. 2010: Vaccines against non-communicable diseases. Current Opinion in Immunology 22(3): 391-396

Huber, V.C.; McCullers, J.A. 2008: Vaccines against pandemic influenza: what can be done before the next pandemic?. Pediatric Infectious Disease Journal 27(10 Suppl): S113-S117

Choi, J.-I.; Seymour, G.J. 2010: Vaccines against periodontitis: a forward-looking review. Journal of Periodontal and Implant Science 40(4): 153-163

Sen, A.; Saravanan, P.; Balamurugan, V.; Rajak, K.K.; Sudhakar, S.B.; Bhanuprakash, V.; Parida, S.; Singh, R.K. 2010: Vaccines against peste des petits ruminants virus. Expert Review of Vaccines 9(7): 785-796

MacLennan, C.A.; Saul, A. 2014: Vaccines against poverty. Proceedings of the National Academy of Sciences of the United States of America 111(34): 12307-12312

Alexander-Miller, M.A. 2014: Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges. Journal of Immunology 193(11): 5363-5369

Osterhaus, A.D.M.E.; Poland, G.A. 2008: Vaccines against seasonal and avian influenza: recent advances. Vaccine 26(Suppl 4): D1-D2

Minor, P.D. 2010: Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 50(4): 560-565

Broutet, N.; Fruth, U.; Deal, C.; Gottlieb, S.L.; Rees, H.; Bavoil, P.; Bolan, G.; Brot-man, R.; Broutet, N.; Brunham, R.C.; Cameron, C.E.; Carlton, J.; Chandra-Mouli, V.; Chen, X.-S.; Chirenje, Z.M.; Deal, C.; Dodet, B.; Figueroa, P.; Fruth, U.; Garnett, G.; Ghanem, K.; Gottlieb, S.; Gravitt, P.; Guillen, G.; Hawkes, S.; Hofstetter, A.; Jaoko, W.; Jerse, A.E.; Johnston, C.; Low, N.; Mabey, D.; MacDonald, N.; Mhalu, F.; Meheus, A.é; Newman, L.; Ravel, J.; Rees, H.; Rompalo, A.M.; Rosenthal, K.L.; Rosenthal, S.; Russell, M.W.; Shattock, R.; Stanberry, L.; Timms, P.; Vanrompay, D.; Vicari, A.; Wi, T. 2014: Vaccines against sexually transmitted infections: the way forward. Vaccine 32(14): 1630-1637

Kosten, T.; Domingo, C.; Orson, F.; Kinsey, B. 2014: Vaccines against stimulants: cocaine and MA. British Journal of Clinical Pharmacology 77(2): 368-374

Anonymous 2011: Vaccines against tick-borne encephalitis: WHO position paper. Releve Epidemiologique Hebdomadaire 86(24): 241-256

Who Publication 2011: Vaccines against tick-borne encephalitis: WHO position paper--recommendations. Vaccine 29(48): 8769-8770

Gopal, R.; Khader, S.A. 2013: Vaccines against tuberculosis: moving forward with new concepts. Expert Review of Vaccines 12(8): 829-831

Ottenhoff, T.H.M.; Kaufmann, S.H.E. 2012: Vaccines against tuberculosis: where are we and where do we need to go?. Plos Pathogens 8(5): E1002607

Barry, E.M.; Cole, L.E.; Santiago, A.E. 2009: Vaccines against tularemia. Human Vaccines 5(12): 832-838

Carrion, R.; Patterson, J.L. 2011: Vaccines against viral hemorrhagic fevers: non-human primate models. Human Vaccines 7(6): 667-673

Jilg, W. 2011: Vaccines against viral hepatitis a to E. what do we have, what effect can they have?. Pharmazie in Unserer Zeit 40(1): 36-43

Mazurat, N. 2010: Vaccines and acute myocardial infarction. Journal 76: A174

Robinson, K.; Oyston, P. 2012: Vaccines and adjuvants--special issue. Journal of medical microbiology 61(Pt 7): 887-888

Poling, J.S. 2008: Vaccines and autism revisited. New England Journal of Medicine 359(6): 655; Author Reply 656

Gerber, J.S.; Offit, P.A. 2009: Vaccines and autism: a tale of shifting hypotheses. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 48(4): 456-461

Harappanahally, G.V.; Trask, C.L.; Mandelbaum, D.E. 2007: Vaccines and autism: an update. Medicine and Health Rhode Island 90(10): 308-310

Orbach, H.; Agmon-Levin, N.; Zandman-Goddard, G. 2010: Vaccines and autoimmune diseases of the adult. Discovery Medicine 9(45): 90-97

De Martino, M.; Chiappini, E.; Galli, L. 2013: Vaccines and autoimmunity. International Journal of Immunopathology and Pharmacology 26(2): 283-290

Batista-Duharte, A. 2012: Vaccines and autoimmunity: a strange association under debate. Revista Peruana de Medicina Experimental y Salud Publica 29(2): 265-271

Ferreira, I.; Isenberg, D. 2014: Vaccines and biologics. Annals of the Rheumatic Diseases 73(8): 1446-1454

Corbel, M.J.; Cortes Castillo, M.d.L.A. 2009: Vaccines and biosimilarity: a solution or a problem?. Expert Review of Vaccines 8(10): 1439-1449

Colomer, R. 2008: Vaccines and breast cancer. Medicina Clinica 131(18): 692-693

Garrido López, Bén.Carmen.; Navarro Compain, Mía.Victoria.; Navarro Sarabia, F. 2011: Vaccines and chemo-prophylaxis in rhemautoid arthritis: is a vaccine calendar necessary?. Reumatologia clinica 7(6): 412-416

You, H.; McManus, D.P. 2015: Vaccines and diagnostics for zoonotic schistosomiasis japonica. Parasitology 142(2): 271-289

Caballero, O.L.; Simpson, A.J.G.; Neville, A.M. 2014: Vaccines and early breast cancer. Cell Cycle 13(9): 1359

Gendrel, D. 2007: Vaccines and exposed occupations. Medecine Sciences: M/S 23(4): 417-422

Principi, N.; Esposito, S. 2013: Vaccines and febrile seizures. Expert Review of Vaccines 12(8): 885-892

Nossal, G.J.V. 2011: Vaccines and future global health needs. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 366(1579): 2833-2840

Greenwood, B.; Salisbury, D.; Hill, A.V.S. 2011: Vaccines and global health. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 366(1579): 2733-2742

Van der Zeijst, B.A.M. 2008: Vaccines and global stability: achievements and challenges. Expert Review of Vaccines 7(10): 1457-1460

Scott, J.W.; Macisaac, K. 2004: Vaccines and hurricanes don't mix. Paediatrics and Child Health 9(7): 453-456

Christensen, N.D.; Budgeon, L.R. 2014: Vaccines and immunization against human papillomavirus. Current Problems in Dermatology 45: 252-264

Anonymous 2011: Vaccines and immunizations. Journal of practical nursing 61(3): 14-20

Beasley, D.W.C. 2011: Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus. ImmunoTherapy 3(2): 269-285

Aldrich, J.F.; Lowe, D.B.; Shearer, M.H.; Winn, R.E.; Jumper, C.A.; Kennedy, R.C. 2010: Vaccines and immunotherapeutics for the treatment of malignant disease. Clinical and Developmental Immunology 2010: 697158

Inchauspé, G.; Michel, M.L. 2007: Vaccines and immunotherapies against hepatitis B and hepatitis C viruses. Journal of Viral Hepatitis 14(Suppl 1): 97-103

Nosanchuk, J.D.; Taborda, C.P. 2013: Vaccines and immunotherapy against fungi: the new frontier. Frontiers in Microbiology 4: 6

Morgensztern, D.; Goodgame, B.; Govindan, R. 2010: Vaccines and immunotherapy for non-small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 5(12 Suppl 6: S463-S465

Kotton, C.N. 2010: Vaccines and inflammatory bowel disease. Digestive Diseases 28(3): 525-535

Ott, P.A.; Fritsch, E.F.; Wu, C.J.; Dranoff, G. 2014: Vaccines and melanoma. Hematology/Oncology Clinics of North America 28(3): 559-569

Sinyakov, M.S.; Avtalion, R.R. 2009: Vaccines and natural antibodies: a link to be considered. Vaccine 27(14): 1985-1986

Beevi, L.; Hedge, S.; Kashyap, R.; Kumar, A. 2009: Vaccines and periodontal diseases--an insight. Dental Update 36(10): 635-638

Rasmussen, S.A.; Watson, A.K.; Kennedy, E.D.; Broder, K.R.; Jamieson, D.J. 2014: Vaccines and pregnancy: past, present, and future. Seminars in Fetal and Neonatal Medicine 19(3): 161-169

Esposito, S.; Serra, D.; Gualtieri, L.; Cesati, L.; Principi, N. 2009: Vaccines and preterm neonates: why, when, and with what. Early Human Development 85(10 Suppl): S43-S45

Casals-Sánchez, J.L.; Casals Vázquez, C.; Vázquez Sánchez, M.Á.; Giménez Basallote, S. 2013: Vaccines and preventive activities in patients with inflammatory arthritis. Semergen 39(7): 382-385

Bosurgi, R. 2011: Vaccines and public health in Europe. LANCET. Infectious Diseases 11(5): 352

Schaffner, W. 2012: Vaccines and public policy. Human Vaccines and Immunotherapeutics 8(6): 702-705

Sánchez-Tembleque, M.ía.D.; Corella, C.; Pérez-Calle, J.L. 2013: Vaccines and recommendations for their use in inflammatory bowel disease. World Journal of Gastroenterology 19(9): 1354-1358

Lee, T.Sze.Mun.; Baumgart, K.W. 2012: Vaccines and risk of lymphoedema--a case report of a breast cancer patient. Australian Family Physician 41(6): 404-406

Germain, R.N. 2010: Vaccines and the future of human immunology. Immunity 33(4): 441-450

Langer-Gould, A.; Qian, L.; Tartof, S.Y.; Brara, S.M.; Jacobsen, S.J.; Beaber, B.E.; Sy, L.S.; Chao, C.; Hechter, R.; Tseng, H.F. 2014: Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurology 71(12): 1506-1513

Aita, K. 2009: Japan approves brain death to increase donors: will it work?. Lancet 374(9699): 1403-1404

Kollaritsch, H.; Paulke-Korinek, M.; Holzmann, H.; Hombach, J.; Bjorvatn, B.; Barrett, A. 2012: Vaccines and vaccination against tick-borne encephalitis. Expert Review of Vaccines 11(9): 1103-1119

Anonymous 2013: Vaccines and vaccination against yellow fever. WHO position paper -- June 2013. Releve Epidemiologique Hebdomadaire 88(27): 269-283

Barreto, M.L.; Pilger, D.; Pereira, S.M.; Genser, B.; Cruz, A.A.; Cunha, S.S.; Sant'Anna, C.; Hijjar, M.A.; Ichihara, M.Y.; Rodrigues, L.C. 2014: Causes of variation in BCG vaccine efficacy: examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses. Vaccine 32(30): 3759-3764

Okwor, I.; Uzonna, J. 2009: Vaccines and vaccination strategies against human cutaneous leishmaniasis. Human Vaccines 5(5): 291-301

Horzinek, M.C.; Thiry, E. 2009: Vaccines and vaccination: the principles and the polemics. Journal of Feline Medicine and Surgery 11(7): 530-537

Speil, C.; Rzepka, R. 2011: Vaccines and vaccine adjuvants as biological response modifiers. Infectious Disease Clinics of North America 25(4): 755-772

Sejvar, J. 2014: Vaccines and viral / toxin-associated neurologic infections. Handbook of Clinical Neurology 123: 719-744

Moszynski, P. 2012: Vaccines are essential in campaigns against HIV and TB, say researchers. Bmj 344: E3625

Taylor, L.E.; Swerdfeger, A.L.; Eslick, G.D. 2014: Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine 32(29): 3623-3629

Stéphenne, J. 2011: Vaccines as a global imperative--a business perspective. Health Affairs 30(6): 1042-1048

Orbach, H.; Tanay, A. 2009: Vaccines as a trigger for myopathies. Lupus 18(13): 1213-1216

Zardo, G.P.; Farah, F.áv.P.; Mendes, F.G.; Franco, C.A.G.D.S.; Molina, G.V.M.; Melo, G.N.d.; Kusma, S.Z. 2014: Vaccines as an agent for immunization against HPV. Ciencia and Saude Coletiva 19(9): 3799-3808

Barinskiĭ, I.F.; Alimbarova, L.M.; Lazarenko, A.A.; Makhmudov, F.R.; Sergeev, O.V. 2014: Vaccines as an approach to the immunocorrection in herpetic infections. Voprosy Virusologii 59(1): 5-11

Alatrash, G.; Molldrem, J.J. 2011: Vaccines as consolidation therapy for myeloid leukemia. Expert Review of Hematology 4(1): 37-50

Durrant, L.G.; Pudney, V.; Spendlove, I.; Metheringham, R.Louise. 2010: Vaccines as early therapeutic interventions for cancer therapy: neutralising the immunosuppressive tumour environment and increasing T cell avidity may lead to improved responses. Expert Opinion on Biological Therapy 10(5): 735-748

Rotow, J.; Gameiro, S.R.; Madan, R.A.; Gulley, J.L.; Schlom, J.; Hodge, J.W. 2010: Vaccines as monotherapy and in combination therapy for prostate cancer. Clinical and Translational Science 3(3): 116-122

Volkin, D.B.; Middaugh, C.R. 2010: Vaccines as physically and chemically well-defined pharmaceutical dosage forms. Expert Review of Vaccines 9(7): 689-691

Chaturvedi, S. 2010: Vaccines as tools to reduce ARi burden: merits and some inherent verticality in the debate. Indian Pediatrics 47(1): 33-37

Mahmoud, A.; Levin, M. 2007: Vaccines at the turn of the 21st century: a new era for immunization in public health. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 11(Suppl 2): S1-S2

Stephens, D.S.; Ahmed, R.; Orenstein, W.A. 2014: Vaccines at what price?. Vaccine 32(9): 1029-1030

Farkas, A.M.; Finn, O.J. 2010: Vaccines based on abnormal self-antigens as tumor-associated antigens: immune regulation. Seminars in Immunology 22(3): 125-131

Thomas, S.; Luxon, B.A. 2013: Vaccines based on structure-based design provide protection against infectious diseases. Expert Review of Vaccines 12(11): 1301-1311

Ardiani, A.; Higgins, J.P.; Hodge, J.W. 2010: Vaccines based on whole recombinant Saccharomyces cerevisiae cells. Fems Yeast Research 10(8): 1060-1069

Moe, G.R.; Bhandari, T.S.; Flitter, B.A. 2009: Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against neisseria meningitidis groups B and C. Journal of Immunology 182(10): 6610-6617

Hu, B.; Dai, B.; Wang, P. 2010: Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity. Vaccine 28(41): 6675-6683

Pirson, C.; Vipond, J.; Hall, Y.; Williams, A.; Vordermeier, H.Martin. 2011: Vaccines designed to protect against Mycobacterium tuberculosis infection may aid the identification of novel vaccine constructs and diagnostic antigens for bovine tuberculosis. Veterinary Microbiology 148(2-4): 232-237

Johnson, K.E. 2010: Vaccines during pregnancy: an interview with Kenneth E. Johnson, DO. Journal of the American Osteopathic Association 110(2 Suppl. 1): S21-S22

Aldhamen, Y.A.; Seregin, S.S.; Schuldt, N.J.; Rastall, D.P.W.; Liu, C.-J.J.; Godbehere, S.; Amalfitano, A. 2012: Vaccines expressing the innate immune modulator EAT-2 elicit potent effector memory T lymphocyte responses despite pre-existing vaccine immunity. Journal of Immunology 189(3): 1349-1359

Perez, F.; Bonomo, R.A. 2014: Vaccines for Acinetobacter baumannii: thinking "out of the box". Vaccine 32(22): 2537-2539

Wiysonge, C.Shey.; Waggie, Z.; Rhoda, L.; Hussey, G. 2009: Vaccines for Africa (VACFA) website--an innovative immunisation advocacy tool. South African Medical Journal 99(5): 275

Hafner, L.M.; McNeilly, C. 2008: Vaccines for Chlamydia infections of the female genital tract. Future Microbiology 3(1): 67-77

Nicholas, R.A.J.; Ayling, R.D.; McAuliffe, L. 2009: Vaccines for Mycoplasma diseases in animals and man. Journal of Comparative Pathology 140(2-3): 85-96

Khanna, M.; Gupta, A. 2010: Vaccines for Pandemic Influenza a H1N1 (2009): Where do we Stand?. Indian Journal of Virology: An Official Organ of Indian Virological Society 21(1): 90-91

Priebe, G.P.; Goldberg, J.B. 2014: Vaccines for Pseudomonas aeruginosa: a long and winding road. Expert Review of Vaccines 13(4): 507-519

Paessler, S.; Weaver, S.C. 2009: Vaccines for Venezuelan equine encephalitis. Vaccine 27(Suppl 4): D80-D85

Altindiş, E. 2010: Vaccines for all: Institut Pasteur vaccinology course, 2010. Expert Review of Vaccines 9(9): 1023-1026

Linhart, B.; Valenta, R. 2012: Vaccines for allergy. Current Opinion in Immunology 24(3): 354-360

Finn, O.J. 2014: Vaccines for cancer prevention: a practical and feasible approach to the cancer epidemic. Cancer Immunology Research 2(8): 708-713

Knuf, M.; Kieninger-Baum, D.; Habermehl, P. 2009: Vaccines for children and adolescents. MMW Fortschritte der Medizin 151(14): 28-31; quiz 32

O'Grady, K.-A.F.; Chang, A.B.; Grimwood, K. 2014: Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations. Expert Review of Respiratory Medicine 8(1): 43-55

Von Seidlein, L. 2007: Vaccines for cholera control: does herd immunity play a role. Plos Medicine 4(11): E331

Orson, F.M.; Kinsey, B.M.; Singh, R.A.K.; Wu, Y.; Kosten, T.R. 2009: Vaccines for cocaine abuse. Human Vaccines 5(4): 194-199

Kabaker, K.; Shell, K.; Kaufman, H.L. 2011: Vaccines for colorectal cancer and renal cell carcinoma. Cancer Journal 17(5): 283-293

Bernstein, D.I. 2011: Vaccines for cytomegalovirus. Infectious Disorders Drug Targets 11(5): 514-525

Schaetti, C. 2009: Vaccines for enteric diseases: update on recent developments. Expert Review of Vaccines 8(12): 1653-1655

Chen, W.H.; El-Kamary, S.S. 2012: Vaccines for enteric infections. Current Opinion in Gastroenterology 28(1): 18-23

Wheeler, C.J.; Black, K.L. 2011: Vaccines for glioblastoma and high-grade glioma. Expert Review of Vaccines 10(6): 875-886

Zhu, W.; Chen, C.-J.; Thomas, C.E.; Anderson, J.E.; Jerse, A.E.; Sparling, P.F. 2011: Vaccines for gonorrhea: can we rise to the challenge?. Frontiers in Microbiology 2: 124

Schmaljohn, C. 2009: Vaccines for hantaviruses. Vaccine 27 Suppl. 4: D61-D64

Schmaljohn, C.S. 2012: Vaccines for hantaviruses: progress and issues. Expert Review of Vaccines 11(5): 511-513

Nath, A.K.; Thappa, D.M. 2009: Vaccines for human papillomavirus infection: a critical analysis. Indian Journal of Dermatology Venereology and Leprology 75(3): 245-253; Quiz 254

Spellberg, B. 2011: Vaccines for invasive fungal infections. F1000 Medicine Reports 3: 13

Schroeder, J.; Aebischer, T. 2011: Vaccines for leishmaniasis: from proteome to vaccine candidates. Human Vaccines 7 Suppl: 10-15

Hirschowitz, E.A.; Hiestand, D.M.; Yannelli, J.R. 2006: Vaccines for lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 1(1): 93-104

Thera, M.A.; Plowe, C.V. 2012: Vaccines for malaria: how close are we?. Annual Review of Medicine 63: 345-357

Demicheli, V.; Rivetti, A.; Debalini, M.G.; Di Pietrantonj, C. 2012: Vaccines for measles, mumps and rubella in children. Cochrane Database of Systematic Reviews 2: Cd004407

Hendriksz, T.; Malouf, P.; Foy, J.E. 2011: Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidelines for adults. Journal of the American Osteopathic Association 111(10 Suppl. 6): S10-S12

Kaufman, H.L. 2012: Vaccines for melanoma and renal cell carcinoma. Seminars in Oncology 39(3): 263-275

Artenstein, A.W. 2009: Vaccines for military use. Vaccine 27(Suppl 4): D16-D22

Lam, S.; Jodlowski, T.Z. 2009: Vaccines for older adults. Consultant Pharmacist: the Journal of the American Society of Consultant Pharmacists 24(5): 380-391

Soares, K.C.; Zheng, L.; Edil, B.; Jaffee, E.M. 2012: Vaccines for pancreatic cancer. Cancer Journal 18(6): 642-652

Ridgers, N.D.; Timperio, A.; Brown, H.; Ball, K.; Macfarlane, S.; Lai, S.K.; Richards, K.; Mackintosh, K.A.; McNarry, M.A.; Foster, M.; Salmon, J. 2018: Wearable Activity Tracker use Among Australian Adolescents: Usability and Acceptability Study. Jmir Mhealth and Uhealth 6(4): E86

Hampson, A.W. 2008: Vaccines for pandemic influenza. the history of our current vaccines, their limitations and the requirements to deal with a pandemic threat. Annals of the Academy of Medicine Singapore 37(6): 510-517

Keitel, W.A.; Atmar, R.L. 2009: Vaccines for pandemic influenza: summary of recent clinical trials. Current Topics in Microbiology and Immunology 333: 431-451

Gall, S.A. 2008: Vaccines for pertussis and influenza: recommendations for use in pregnancy. Clinical Obstetrics and Gynecology 51(3): 486-497

Sato, H.K. 2012: Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Sao Paulo Medical Journal 130(2): 133

Macartney, K.; Heywood, A.; McIntyre, P. 2014: Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews 6: Cd001833

Otero, L.B.; Ho, M.Q. 2009: Vaccines for postexposure prophylaxis against varicella (chicken pox). American Family Physician 80(5): 455

Kostova, P.; Zlatkov, V. 2007: Vaccines for precancer and cancer of the uterine cervix. II. Therapeutic HPV vaccines. Akusherstvo i Ginekologiia 46(8): 31-35

Zlatkov, V.; Kostova, P. 2007: Vaccines for precancer and cancer of uterine cervix. I. Prophylactic HPV vaccines. Akusherstvo i Ginekologiia 46(7): 27-31

Schiøler, K.L.; Samuel, M.; Wai, K.L. 2007: Vaccines for preventing Japanese encephalitis. Cochrane Database of Systematic Reviews 2007(3): Cd004263

Donegan, S.; Bellamy, R.; Gamble, C.L. 2009: Vaccines for preventing anthrax. Cochrane Database of Systematic Reviews 2009(2): Cd006403

Graves, P.M.; Deeks, J.J.; Demicheli, V.; Jefferson, T. 2010: Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected). Cochrane Database of Systematic Reviews 2010(8): Cd000974

Ahmed, T.; Bhuiyan, T.R.; Zaman, K.; Sinclair, D.; Qadri, F. 2013: Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database of Systematic Reviews 2013(7): Cd009029

Johansen, H.Krogh.; Gøtzsche, P.C. 2013: Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.. Cochrane Database of Systematic Reviews 2013(6): Cd001399

Jefferson, T.O.; Rivetti, D.; Di Pietrantonj, C.; Rivetti, A.; Demicheli, V. 2007: Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews 2007(2): Cd001269

Jefferson, T.; Di Pietrantonj, C.; Rivetti, A.; Bawazeer, G.A.; Al-Ansary, L.A.; Ferroni, E. 2010: Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews 2010(7): Cd001269

Demicheli, V.; Jefferson, T.; Al-Ansary, L.A.; Ferroni, E.; Rivetti, A.; Di Pietrantonj, C. 2014: Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews 2014(3): Cd001269

Jefferson, T.; Rivetti, A.; Di Pietrantonj, C.; Demicheli, V.; Ferroni, E. 2012: Vaccines for preventing influenza in healthy children. Cochrane Database of Systematic Reviews 2012(8): Cd004879

Cates, C.J.; Jefferson, T.O.; Rowe, B.H. 2008: Vaccines for preventing influenza in people with asthma. Cochrane Database of Systematic Reviews 2008(2): Cd000364

Cates, C.J.; Rowe, B.H. 2013: Vaccines for preventing influenza in people with asthma. Cochrane Database of Systematic Reviews 2013(2): Cd000364

Dharmaraj, P.; Smyth, R.L. 2009: Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2009(4): Cd001753

Dharmaraj, P.; Smyth, R.L. 2014: Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2014(3): Cd001753

Jefferson, T.; Di Pietrantonj, C.; Al-Ansary, L.A.; Ferroni, E.; Thorning, S.; Thomas, R.E. 2010: Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews 2010(2): Cd004876

Moberley, S.A.; Holden, J.; Tatham, D.P.; Andrews, R.M. 2008: Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews 2008(1): Cd000422

Moberley, S.; Holden, J.; Tatham, D.Paul.; Andrews, R.M. 2013: Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews 2013(1): Cd000422

Soares-Weiser, K.; Maclehose, H.; Bergman, H.; Ben-Aharon, I.; Nagpal, S.; Goldberg, E.; Pitan, F.; Cunliffe, N. 2012: Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database of Systematic Reviews 2012(2): Cd008521

Soares-Weiser, K.; Maclehose, H.; Bergman, H.; Ben-Aharon, I.; Nagpal, S.; Goldberg, E.; Pitan, F.; Cunliffe, N. 2012: Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database of Systematic Reviews 11: Cd008521

Metzger, W.; Mordmueller, B.G. 2007: Vaccines for preventing smallpox. Cochrane Database of Systematic Reviews 2007(3): Cd004913

Demicheli, V.; Debalini, M.Grazia.; Rivetti, A. 2009: Vaccines for preventing tick-borne encephalitis. Cochrane Database of Systematic Reviews 2009(1): Cd000977

Fraser, A.; Goldberg, E.; Acosta, C.J.; Paul, M.; Leibovici, L. 2007: Vaccines for preventing typhoid fever. Cochrane Database of Systematic Reviews 2007(3): Cd001261

Anwar, E.; Goldberg, E.; Fraser, A.; Acosta, C.J.; Paul, M.; Leibovici, L. 2014: Vaccines for preventing typhoid fever. Cochrane Database of Systematic Reviews 2014(1): Cd001261

Cheuk, D.K.; Chiang, A.K.; Lee, T.L.; Chan, G.C.; Ha, S.Y. 2011: Vaccines for prophylaxis of viral infections in patients with hematological malignancies. Cochrane Database of Systematic Reviews 3: Cd006505

Fruth, U.; Broutet, N.; Deal, C.; Dodet, B.; Meheus, A. 2014: Vaccines for sexually transmitted infections: past, present and future. Vaccine 32(14): 1525-1526

Delany, I.; Rappuoli, R.; De Gregorio, E. 2014: Vaccines for the 21st century. Embo Molecular Medicine 6(6): 708-720

Simancas-Racines, D.; Guerra, C.V.; Hidalgo, R. 2013: Vaccines for the common cold. Cochrane Database of Systematic Reviews 6: Cd002190

Del Giudice, G.; Weinberger, B.; Grubeck-Loebenstein, B. 2015: Vaccines for the elderly. Gerontology 61(3): 203-210

Verma, R.; Khanna, P.; Chawla, S. 2014: Vaccines for the elderly need to be introduced into the immunization program in India. Human Vaccines and Immunotherapeutics 10(8): 2468-2470

Girard, M.P. 2009: Vaccines for the future. Annales Pharmaceutiques Francaises 67(3): 203-212

Costa, C.Henrique.Nery.; Peters, N.C.; Maruyama, S.Regina.; de Brito, E.Cardoso.; Santos, I.Kinney.Ferreira.de.Miranda.; Ali, N.; de Brito, E.Cardoso.; Brodskyn, Cáudia.; Campos-Neto, Aônio.; Carvalho, E.M.; Chang, K.Poo.; Costa, C.Henrique.Nery.; Fernandes, A.Paula.; Fujiwara, R.; Gazzinelli, R.; Goto, H.; Grimaldi, G.; Kaye, P.; Kedzierski, L.; Khamesipour, A.; Maia, C.; Maruyama, S.Regina.; McMaster, W.Robert.; Mendonça, S.C..F.; de Janeiro, R.; Nakhasi, H.Lal.; Peters, N.C.; Piazza, F.; Quinnell, R.; Reis, A.Barbosa.; Santos, I.K.Ferreira..de.Miranda.; Santos, M.; Santos-Gomes, G.; Shaw, J.; 2011: Vaccines for the leishmaniases: proposals for a research agenda. Plos Neglected Tropical Diseases 5(3): E943

Isaacs, D. 2011: Vaccines for the poor: meningococcal A conjugate vaccine in Africa. Journal of Paediatrics and Child Health 47(1-2): 66

Thomas, S.J.; Endy, T.P. 2011: Vaccines for the prevention of dengue: development update. Human Vaccines 7(6): 674-684

Das, J.K.; Tripathi, A.; Ali, A.; Hassan, A.; Dojosoeandy, C.; Bhutta, Z.A. 2013: Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus. Bmc Public Health 13 Suppl. 3: S11

Bartlett, B.L.; Tyring, S.K. 2009: Vaccines for the prevention of infectious diseases with mucocutaneous manifestations. Dermatologic Therapy 22(2): 95-96

Gridelli, C.; Rossi, A.; Maione, P.; Ferrara, M.L.; Castaldo, V.; Sacco, P.C. 2009: Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy. Oncologist 14(9): 909-920

Mellstedt, H.åk.; Vansteenkiste, J.; Thatcher, N. 2011: Vaccines for the treatment of non-small cell lung cancer: investigational approaches and clinical experience. Lung Cancer 73(1): 11-17

Brown, E.; Ma, C.; Acharya, J.; Ma, B.; Wu, J.; Li, J. 2014: Controlling dielectric and relaxor-ferroelectric properties for energy storage by tuning Pb0.92La0.08Zr0.52Ti0.48O3 film thickness. Acs Applied Materials and Interfaces 6(24): 22417-22422

Ward, B.J. 2001: Vaccines for travelling minors: the 'shot' heard around the world. Paediatrics and Child Health 6(4): 190-193

Gupta, S.K. 2011: Vaccines for type 1 diabetes in the late stage of clinical development. Indian Journal of Pharmacology 43(4): 485

Martin, L.B. 2012: Vaccines for typhoid fever and other salmonelloses. Current Opinion in Infectious Diseases 25(5): 489-499

De la Fuente, J.é 2012: Vaccines for vector control: exciting possibilities for the future. Veterinary Journal 194(2): 139-140

Falzarano, D.; Feldmann, H. 2013: Vaccines for viral hemorrhagic fevers--progress and shortcomings. Current Opinion in Virology 3(3): 343-351

Demicheli, V.; Barale, A.; Rivetti, A. 2013: Vaccines for women to prevent neonatal tetanus. Cochrane Database of Systematic Reviews 2013(5): Cd002959

Shah, N.K. 2012: Vaccines in India: further discussion. Health Affairs 31(5): 1129

Kato, T. 2007: Vaccines in Japan. Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl 2(Part 1): 637-638

Søborg, C.; Mølbak, K.år.; Doherty, T.M.; Ulleryd, P.; Brooks, T.; Coenen, C.; van der Zeijst, B. 2009: Vaccines in a hurry. Vaccine 27(25-26): 3295-3298

McKinnon, C. 1998: Vaccines in cancer therapy. Idrugs: the Investigational Drugs Journal 1(2): 172-174

Ragan, P.; Duffy, D.M. 2012: Vaccines in childhood: strategies to address the concerns of parents. Jaapa: Official Journal of the American Academy of Physician Assistants 25(10): 22-26

Apostolopoulos, V. 2011: Vaccines in clinical trials: cancer. Expert Review of Vaccines 10(6): 711-712

Barnes, E.; Pollard, A.J. 2011: Vaccines in clinical trials: infectious disease. Expert Review of Vaccines 10(5): 555-557

Magel, G.D.; Mendoza, N.; Digiorgio, C.M.; Haitz, K.A.; Lapolla, W.J.; Tyring, S.K. 2011: Vaccines in dermatological diseases. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 146(3): 225-233

Brandler, S.; Tangy, F. 2013: Vaccines in development against West Nile virus. Viruses 5(10): 2384-2409

Cox, M.M.J. 2007: Vaccines in development against avian influenza. Minerva Medica 98(2): 145-153

Riley, E.; Dasari, V.; Frishman, W.H.; Sperber, K. 2008: Vaccines in development to prevent and treat atherosclerotic disease. Cardiology in Review 16(6): 288-300

Sutton, E.A.; Hayney, M.S. 2007: Vaccines in development: what does the future hold?. Journal of the American Pharmacists Association: Japha 47(6): 775-776

Tarrés, A.; Allué, X. 2013: Vaccines in history, or a history of vaccines. Anales de Pediatria 79(1): 1-2

Tamma, P. 2010: Vaccines in immunocompromised patients. Pediatrics in Review 31(1): 38-40

De Pas, T.; Giovannini, M.; Rescigno, M.; Catania, C.; Toffalorio, F.; Spitaleri, G.; Delmonte, A.; Barberis, M.; Spaggiari, L.; Solli, P.; Veronesi, G.; De Braud, F. 2012: Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials. Critical Reviews in Oncology/Hematology 83(3): 432-443

Healy, C.M. 2012: Vaccines in pregnant women and research initiatives. Clinical Obstetrics and Gynecology 55(2): 474-486

Galicchio, M.F.; Ornani, A.; Bezrodnik, L.; Di Giovanni, D.; Raccio, A.G.óm.; Paz, R.én.; Regairaz, L.; Belardinelli, G.; Basile, N.; Oleastro, M.ía.; Ornani, A.; Ruprecht, B.ár.; Rosenzweig, S.; Zelazko, M.; Liberatore, D.; Galicchio, M.F.; Pérez, N.és.; Cantisano, C.; Díaz, H.éc.; Riganti, C.G.; Gentile, Án.; Bazán, V.; Uboldi, A.; Marcó del Pont, J.é; Califano, G. 2010: Vaccines in primary immunodeficiencies patients. Archivos Argentinos de Pediatria 108(5): 454-464

Kelley, N.S.; Osterholm, M.T. 2013: Vaccines in the 21st century: a cautionary tale. South Dakota Medicine: the Journal of the South Dakota State Medical Association Spec No: 127-128

Wittich, F.W. 1915: Vaccines in the Treatment of Bacterial Diseases of the Lungs Complicating Pulmonary Tuberculosis and their Preparation. Canadian Medical Association Journal 5(4): 289-297

Shorter, D.; Kosten, T.R. 2011: Vaccines in the Treatment of Substance Abuse. Focus 9: 25-30

Ballow, M. 2012: Vaccines in the assessment of patients for immune deficiency. Journal of Allergy and Clinical Immunology 130(1): 283-4.E5

Do, T.H.; Chen, Y.; Nguyen, V.T.; Phisitkul, S. 2010: Vaccines in the management of hypertension. Expert Opinion on Biological Therapy 10(7): 1077-1087

Pickering, L.K.; Walton, L.R. 2013: Vaccines in the pipeline: the path from development to use in the United States. Pediatric Annals 42(8): 146-152

Clemens, J.D. 2011: Vaccines in the time of cholera. Proceedings of the National Academy of Sciences of the United States of America 108(21): 8529-8530

Bennett, L. 2013: Vaccines in trials for nicotine cessation therapy. Jaapa: Official Journal of the American Academy of Physician Assistants 26(9): 55-56

McVey, S.; Shi, J. 2010: Vaccines in veterinary medicine: a brief review of history and technology. Veterinary Clinics of North America. Small Animal Practice 40(3): 381-392

Yang, Y.; Gao, W. 2019: Wearable and flexible electronics for continuous molecular monitoring. Chemical Society Reviews 48(6): 1465-1491

Nilsson, J.; Fredrikson, G.N.; Björkbacka, H.; Chyu, K.-Y.; Shah, P.K. 2009: Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease. Journal of Internal Medicine 266(3): 221-231

Britton, S. 2013: Vaccines must have a minimal amount of side effects. Serious side effects threatens public trust. Lakartidningen 110(16): 816

Crighton, P. 2011: Vaccines need a shot in the arm. Australian Nursing Journal 18(10): 40-41

Ozdemir, V.; Pang, T.; Knoppers, B.M.; Avard, D.; Faraj, S.A.; Zawati, M.'n.H.; Kolker, E. 2011: Vaccines of the 21st century and vaccinomics: data-enabled science meets global health to spark collective action for vaccine innovation. Omics: a Journal of Integrative Biology 15(9): 523-527

Morabia, A.; Costanza, M.C. 2009: Vaccines or vitamins: alternative medicines?. Preventive Medicine 49(2-3): 75-76

Campos-Outcalt, D.; Jeffcott-Pera, M.; Carter-Smith, P.; Schoof, B.K.; Young, H.F. 2010: Vaccines provided by family physicians. Annals of Family Medicine 8(6): 507-510

Sadri, B.; Goswami, D.; Sala de Medeiros, M.; Pal, A.; Castro, B.; Kuang, S.; Martinez, R.V. 2018: Wearable and Implantable Epidermal Paper-Based Electronics. Acs Applied Materials and Interfaces 10(37): 31061-31068

Ateudjieu, J.; Stoll, B.; Nguefack-Tsague, G.; Tchangou, C.; Genton, B. 2014: Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): a randomized controlled trial. Vaccine 32(43): 5662-5668

Peng, Z. 2009: Vaccines targeting IgE in the treatment of asthma and allergy. Human Vaccines 5(5): 302-309

Dhodapkar, M.V.; Dhodapkar, K.M. 2011: Vaccines targeting cancer stem cells: are they within reach?. Cancer Journal 17(5): 397-402

Taha, M.-K.; Deghmane, A.E. 2012: Vaccines targeting serogroup B meningococci. LANCET. Infectious Diseases 12(8): 578-579

Smith, H.A.; McNeel, D.G. 2011: Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells. Journal of ImmunoTherapy 34(8): 569-580

Matejuk, A.; Leng, Q.; Chou, S.-T.; Mixson, A.J. 2011: Vaccines targeting the neovasculature of tumors. Vascular Cell 3(1): 7

Von Bubnoff, A. 2010: Vaccines to antibodies: grow up!. Iavi Report: Newsletter on International Aids Vaccine Research 14(4): 4-9

Hess, J.A.; Zhan, B.; Bonne-Année, S.; Deckman, J.M.; Bottazzi, M.Elena.; Hotez, P.J.; Klei, T.R.; Lustigman, S.; Abraham, D. 2014: Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model. International Journal for Parasitology 44(9): 637-646

Bevins, R.A.; Wilkinson, J.L.; Sanderson, S.D. 2008: Vaccines to combat smoking. Expert Opinion on Biological Therapy 8(4): 379-383

Bethony, J.M.; Cole, R.N.; Guo, X.; Kamhawi, S.; Lightowlers, M.W.; Loukas, A.; Petri, W.; Reed, S.; Valenzuela, J.G.; Hotez, P.J. 2011: Vaccines to combat the neglected tropical diseases. Immunological Reviews 239(1): 237-270

Schiller, J.T.; Lowy, D.R. 2010: Vaccines to prevent infections by oncoviruses. Annual Review of Microbiology 64: 23-41

Madhi, S.A.; Levine, O.S.; Hajjeh, R.; Mansoor, O.D.; Cherian, T. 2008: Vaccines to prevent pneumonia and improve child survival. Bulletin of the World Health Organization 86(5): 365-372

Hawkes, S.; Kismödi, E.; Larson, H.; Buse, K. 2014: Vaccines to promote and protect sexual health: policy challenges and opportunities. Vaccine 32(14): 1610-1615

Loucq, C. 2013: Vaccines today, vaccines tomorrow: a perspective. Clinical and Experimental Vaccine Research 2(1): 4-7

Conner, K.; Wuu, A.; Maldonado, V.; Bartlett, B.L.; Tyring, S.K. 2009: Vaccines under study: non-HIV vaccines. Dermatologic Therapy 22(2): 168-185

Walson, P.D. 2013: Vaccines update in Clinical Therapeutics. Clinical Therapeutics 35(2): 105

Inada, T.; Kubo, K.; Shingu, K. 2009: Vaccines using dendritic cells, differentiated with propofol, enhance antitumor immunity in mice. Immunopharmacology and Immunotoxicology 31(1): 150-157

Khurana, S.; Chearwae, W.; Castellino, F.; Manischewitz, J.; King, L.R.; Honorkiewicz, A.; Rock, M.T.; Edwards, K.M.; Del Giudice, G.; Rappuoli, R.; Golding, H. 2010: Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Science Translational Medicine 2(15): 15ra5

Clapp, T.; Siebert, P.; Chen, D.; Jones Braun, L. 2011: Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability. Journal of Pharmaceutical Sciences 100(2): 388-401

Weaver, E.A. 2014: Vaccines within vaccines: the use of adenovirus types 4 and 7 as influenza vaccine vectors. Human Vaccines and Immunotherapeutics 10(3): 544-556

Avila-Aguero, M.L.; Brea-del Castillo, Jé.; Falleiros-Arlant, L.Helena. 2013: Vaccines without borders to Latin America. Expert Review of Vaccines 12(11): 1239-1240

Chaturvedi, S. 2013: Vaccines, Social Mobilization, or any other Game changer: Polio Eradication is an Unfinished Narrative. Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive and Social Medicine 38(2): 67-69

Redondo Calderón, J.é L.ís. 2008: Vaccines, biotechnology and their connection with induced abortion. Cuadernos de Bioetica: Revista Oficial de la Asociacion Espanola de Bioetica y Etica Medica 19(66): 321-353

Dentzer, S. 2011: Vaccines, children, and fulfilling human potential. Health Affairs 30(6): 1006

Berg, A.T. 2007: Vaccines, encephalopathies, and mutations. Epilepsy Currents 7(2): 40-42

Koydemir, H.C.; Ozcan, A. 2018: Wearable and Implantable Sensors for Biomedical Applications. Annual Review of Analytical Chemistry 11(1): 127-146

Adalja, A.A. 2011: Vaccines, immunity, whooping cough, and mumps. Biosecurity and Bioterrorism: Biodefense Strategy Practice and Science 9(1): 9-11

Homma, A.; Martins, R.de.Menezes.; Leal, M.da.Luz.Fernandes.; Freire, M.da.Silva.; Couto, A.Roberto. 2011: Vaccines, immunization and technological innovation: an update. Ciencia and Saude Coletiva 16(2): 445-458

Warpakowski, A. 2009: Vaccines, molecular scissors, fusion inhibitors. what does HIV therapy of the future look like?. MMW Fortschritte der Medizin 151(46): 22-23

Rappuoli, R.; Pizza, M.; Del Giudice, G.; De Gregorio, E. 2014: Vaccines, new opportunities for a new society. Proceedings of the National Academy of Sciences of the United States of America 111(34): 12288-12293

Chast, F. 2012: Vaccines, public health and social care. Annales Pharmaceutiques Francaises 70(6): 307-308

Moulin, A-Marie. 2007: Vaccines, the modern state and societies. Medecine Sciences: M/S 23(4): 428-434

Rae, M.; Kerridge, I. 2011: Vaccines--but not as we know them: an ethical evaluation of HPV vaccination policy in Australia. Australian and New Zealand Journal of Public Health 35(2): 176-179

Chintha, K.K.; Indic, P.; Chapman, B.; Boyer, E.W.; Carreiro, S. 2018: Wearable Biosensors to Evaluate Recurrent Opioid Toxicity After Naloxone Administration: a Hilbert Transform Approach. Proceedings of the . Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences 2018: 3247-3252

Anonymous 2009: Vaccines. Group launches first H1N1 trial for HIV-infected pregnant women. Aids Policy and Law 24(12): 1

Bradshaw, M.J.; Farrow, S.; Motl, R.W.; Chitnis, T. 2017: Wearable biosensors to monitor disability in multiple sclerosis. Neurology. Clinical Practice 7(4): 354-362

Alfonsi, V.; D'Ancona, P.; Giambi, C.; Rota, M.C. 2011: Vaccines. Inequalities in vaccination offer in Italy: how to get over regional offer differences?. Epidemiologia e Prevenzione 35(5-6 Suppl 2: 84-87

Ferrer Aguareles, Jé.Luis.; Ruiz Muñoz, E. 2011: Vaccines. Official calendar of vaccinations in the infancy and the adolescence. Revista de Enfermeria 34(10): 8-14

Tse, M.Tsuey. 2011: Vaccines: Early and late protection from TB. Nature reviews. Immunology 11(3): 161

Koh, H.K. 2011: Vaccines: a model for prevention. Public Health Reports 126 Suppl. 2: 1-2

Abarca V, K. 2007: Vaccines: adverse events surveillance. Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de Infectologia 24(1): 53-56

Pazdur, M.P.; Jones, J.L. 2007: Vaccines: an innovative approach to treating cancer. Journal of Infusion Nursing: the Official Publication of the Infusion Nurses Society 30(3): 173-178

Byington, C.L. 2014: Vaccines: can transparency increase confidence and reduce hesitancy?. Pediatrics 134(2): 377-379

Plotkin, S.A. 2008: Vaccines: correlates of vaccine-induced immunity. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47(3): 401-409

Grabenstein, J.D. 2008: Vaccines: countering anthrax: vaccines and immunoglobulins. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 46(1): 129-136

Plotkin, S.A.; Rees, J. 2014: Vaccines: facing complex problems with the promise of immunology. Expert Review of Vaccines 13(8): 939-941

Paul, Y. 2010: Vaccines: for whose benefit?. Indian Journal of Medical Ethics 7(1): 30-31

Rueckert, C.; Guzmán, C.A. 2012: Vaccines: from empirical development to rational design. Plos Pathogens 8(11): E1003001

Bruhn, C. 2009: Vaccines: from seed virus to approval. Deutsche Medizinische Wochenschrift 134(48): P44

Nau, J.-Y. 2012: Vaccines: intradermal, poliomyelitis, aluminum. Revue Medicale Suisse 8(364): 2308-2309

Bertrand, J.J. 2007: Vaccines: producers in countries of the Southern hemisphere. Medecine Tropicale: Revue du Corps de Sante Colonial 67(4): 347-350

Rappuoli, R. 2014: Vaccines: science, health, longevity, and wealth. Proceedings of the National Academy of Sciences of the United States of America 111(34): 12282

Launay, O.; Hoch, D.; Saint-Sardos, C.; Guillemot, D.; Ameye, V.ér.; Billon, N.; Boelle, P.-Y.; Courtois, J.; Dervaux, B.ît.; Diaz, I.; Fagot, J.-P.; Floret, D.; Fritzell, B.; Gernigon, G.ël.; Jouan-Flahault, C.; Lassale, C.; Le Louet, H.é; Levy-Bruhl, D.; Meyer, F.ço.; Muller, S.; Soubeyrand, B.ît.; Teisseire, B. 2010: Vaccines: specific features, simulation of impact and medico-economic modelling. Therapie 65(4): 357-365; 347-355

Plotkin, S.A. 2009: Vaccines: the fourth century. Clinical and Vaccine Immunology: Cvi 16(12): 1709-1719

Heaton, P.M.; Ciarlet, M. 2007: Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 45(12): 1618-1624

Anonymous 1925: Vaccinia and Variola. American Journal of Public Health 15(12): 1093-1095

Wang, J.-Y.; Yeh, C.-L.; Chou, H.-C.; Yang, C.-H.; Fu, Y.-N.; Chen, Y.-T.; Cheng, H.-W.; Huang, C.-Y.F.; Liu, H.-P.; Huang, S.-F.; Chen, Y.-R. 2011: Vaccinia H1-related phosphatase is a phosphatase of ErbB receptors and is down-regulated in non-small cell lung cancer. Journal of Biological Chemistry 286(12): 10177-10184

D'Costa, S.M.; Bainbridge, T.W.; Kato, S.E.; Prins, C.; Kelley, K.; Condit, R.C. 2010: Vaccinia H5 is a multifunctional protein involved in viral DNA replication, postreplicative gene transcription, and virion morphogenesis. Virology 401(1): 49-60

Andrewes, C.H.; Elford, W.J.; Niven, J.S.F. 1948: Vaccinia and ectromelia in the mouse. British Journal of Experimental Pathology 29(4): 329-335

Pavon-Eternod, M.; David, A.; Dittmar, K.; Berglund, P.; Pan, T.; Bennink, J.R.; Yewdell, J.W. 2013: Vaccinia and influenza A viruses select rather than adjust tRNAs to optimize translation. Nucleic Acids Research 41(3): 1914-1921

Carter, C.J.C. 2012: Vaccinia and other viruses with available vaccines show marked homology with the HIV-1 envelope glycoprotein: the prospect of using existing vaccines to stem the AIDS pandemic. Immunopharmacology and Immunotoxicology 34(2): 222-231

Maqsood, M. 1948: Vaccinia in claves. Indian Veterinary Journal 24(5): 342-344

Pritchett, J.H.; Reese, D.S. 1947: Vaccinia involving the eyelid; report of case. Journal of the Medical Association of Georgia 36(12): 478

Strug, I.; Calvo-Calle, J.M.; Green, K.M.; Cruz, J.; Ennis, F.A.; Evans, J.E.; Stern, L.J. 2008: Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor. Journal of Proteome Research 7(7): 2703-2711

Morgan, G.W.; Hollinshead, M.; Ferguson, B.J.; Murphy, B.J.; Carpentier, D.C.J.; Smith, G.L. 2010: Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion export. Plos Pathogens 6(2): E1000785

Rozelle, D.K.; Filone, C.Marie.; Dower, K.; Connor, J.H. 2014: Vaccinia reporter viruses for quantifying viral function at all stages of gene expression. Journal of Visualized Experiments: Jove 2014(87)

Wang, D.-R.; Hsiao, J.-C.; Wong, C.-H.; Li, G.-C.; Lin, S.-C.; Yu, S.S.-F.; Chen, W.; Chang, W.; Tzou, D.-L.M. 2014: Vaccinia viral protein A27 is anchored to the viral membrane via a cooperative interaction with viral membrane protein A17. Journal of Biological Chemistry 289(10): 6639-6655

Yang, S.J.; Hruby, D.E. 2007: Vaccinia virus A12L protein and its AG/A proteolysis play an important role in viral morphogenic transition. Virology Journal 4: 73

Satheshkumar, P.S.; Weisberg, A.S.; Moss, B. 2013: Vaccinia virus A19 protein participates in the transformation of spherical immature particles to barrel-shaped infectious virions. Journal of Virology 87(19): 10700-10709

Chang, S.-J.; Chang, Y.-X.; Izmailyan, R.; Tang, Y.-L.; Chang, W. 2010: Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells. Journal of Virology 84(17): 8422-8432

Howard, A.R.; Senkevich, T.G.; Moss, B. 2008: Vaccinia virus A26 and A27 proteins form a stable complex tethered to mature virions by association with the A17 transmembrane protein. Journal of Virology 82(24): 12384-12391

Rehm, K.E.; Connor, R.F.; Jones, G.J.B.; Yimbu, K.; Roper, R.L. 2010: Vaccinia virus A35R inhibits MHC class II antigen presentation. Virology 397(1): 176-186

Breiman, A.; Smith, G.L. 2010: Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein. Journal of General Virology 91(Part 7): 1823-1827

Wang, Y.; Flesch, I.E.A.; Tscharke, D.C. 2009: Vaccinia virus CD8+ T-cell dominance hierarchies cannot be altered by prior immunization with individual peptides. Journal of Virology 83(17): 9008-9012

Druck Shudofsky, A.M.; Silverman, J.E.Y.; Chattopadhyay, D.; Ricciardi, R.P. 2010: Vaccinia virus D4 mutants defective in processive DNA synthesis retain binding to A20 and DNA. Journal of Virology 84(23): 12325-12335

Guerra, S.; Cáceres, A.; Knobeloch, K-Peter.; Horak, I.; Esteban, M. 2008: Vaccinia virus E3 protein prevents the antiviral action of ISG15. Plos Pathogens 4(7): E1000096

Myskiw, C.; Arsenio, J.; van Bruggen, R.; Deschambault, Y.; Cao, J. 2009: Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways. Journal of Virology 83(13): 6757-6768

Campbell, S.; Hazes, B.; Kvansakul, M.; Colman, P.; Barry, M. 2010: Vaccinia virus F1L interacts with Bak using highly divergent Bcl-2 homology domains and replaces the function of Mcl-1. Journal of Biological Chemistry 285(7): 4695-4708

Gerlic, M.; Faustin, B.; Postigo, A.; Yu, E.C.-W.; Proell, M.; Gombosuren, N.; Krajewska, M.; Flynn, R.; Croft, M.; Way, M.; Satterthwait, A.; Liddington, R.C.; Salek-Ardakani, S.; Matsuzawa, S.-i.; Reed, J.C. 2013: Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation. Proceedings of the National Academy of Sciences of the United States of America 110(19): 7808-7813

Dobson, B.M.; Procter, D.J.; Hollett, N.A.; Flesch, I.E.A.; Newsome, T.P.; Tscharke, D.C. 2014: Vaccinia virus F5 is required for normal plaque morphology in multiple cell lines but not replication in culture or virulence in mice. Virology 456-457: 145-156

Da Silva, M.; Upton, C. 2009: Vaccinia virus G8R protein: a structural ortholog of proliferating cell nuclear antigen (PCNA). Plos one 4(5): E5479

Gholami, S.; Chen, C-Hao.; Lou, E.; Belin, L.J.; Fujisawa, S.; Longo, V.A.; Chen, N.G.; Gönen, M.; Zanzonico, P.B.; Szalay, A.A.; Fong, Y. 2014: Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancer. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 28(2): 676-682

Gholami, S.; Chen, C.-H.; Belin, L.J.; Lou, E.; Fujisawa, S.; Antonacci, C.; Carew, A.; Chen, N.G.; De Brot, M.; Zanzonico, P.B.; Szalay, A.A.; Fong, Y. 2013: Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer. Breast Cancer Research: Bcr 15(2): R26

Gholami, S.; Chen, C-Hao.; Lou, E.; De Brot, M.; Fujisawa, S.; Chen, N.G.; Szalay, A.A.; Fong, Y. 2012: Vaccinia virus GLV-1h153 is effective in treating and preventing metastatic triple-negative breast cancer. Annals of Surgery 256(3): 437-445

Hofmann, E.; Grummt, F.; Szalay, A.A. 2011: Vaccinia virus GLV-1h237 carrying a Walker a motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts. International Journal of Oncology 38(3): 871-878

Satheshkumar, P.S.; Weisberg, A.; Moss, B. 2009: Vaccinia virus H7 protein contributes to the formation of crescent membrane precursors of immature virions. Journal of Virology 83(17): 8439-8450

Meng, X.; Jiang, C.; Arsenio, J.; Dick, K.; Cao, J.; Xiang, Y. 2009: Vaccinia virus K1L and C7L inhibit antiviral activities induced by type i interferons. Journal of Virology 83(20): 10627-10636

Maruri-Avidal, L.; Weisberg, A.S.; Moss, B. 2011: Vaccinia virus L2 protein associates with the endoplasmic reticulum near the growing edge of crescent precursors of immature virions and stabilizes a subset of viral membrane proteins. Journal of Virology 85(23): 12431-12441

Izmailyan, R.; Chang, W. 2008: Vaccinia virus WR53.5/F14.5 protein is a new component of intracellular mature virus and is important for calcium-independent cell adhesion and vaccinia virus virulence in mice. Journal of Virology 82(20): 10079-10087

Talavera, A.; Rodriguez, J.M. 1992: Vaccinia virus as an expression vector. Methods in Molecular Biology 8: 219-233

Mann, B.A.; Huang, J.H.; Li, P.; Chang, H.-C.; Slee, R.B.; O'Sullivan, A.; Anita, M.; Yeh, N.; Klemsz, M.J.; Brutkiewicz, R.R.; Blum, J.S.; Kaplan, M.H. 2008: Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type i and type Ii interferons. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 28(6): 367-380

Ghebremariam, Y.T.; Engelbrecht, G.; Tyler, M.; Lotz, Zë.; Govender, D.; Kotwal, G.J.; Kahn, D. 2010: Vaccinia virus complement control protein (VCP) improves kidney structure and function following ischemia/reperfusion injury in rats. Journal of Surgical Research 159(2): 747-754

Rehm, K.E.; Connor, R.F.; Jones, G.J.B.; Yimbu, K.; Mannie, M.D.; Roper, R.L. 2009: Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II. Immunology 128(3): 381-392

Schmidt, F.I.; Mercer, J. 2012: Vaccinia virus egress: actin OUT with clathrin. Cell Host and Microbe 12(3): 263-265

Benhnia, M.Rafii-El-Idrissi.; McCausland, M.M.; Moyron, J.; Laudenslager, J.; Granger, S.; Rickert, S.; Koriazova, L.; Kubo, R.; Kato, S.; Crotty, S. 2009: Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement. Journal of Virology 83(3): 1201-1215

Froggatt, G.C.; Smith, G.L.; Beard, P.M. 2007: Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response. Journal of General Virology 88(Pt 7): 1917-1921

Smith, G.L.; Benfield, C.T.O.; Maluquer de Motes, C.; Mazzon, M.; Ember, S.W.J.; Ferguson, B.J.; Sumner, R.P. 2013: Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. Journal of General Virology 94(Part 11): 2367-2392

Assis, F.L.; Borges, I.A.; Mesquita, V.S.; Ferreira, P.C.; Trindade, G.S.; Kroon, E.G.; Abrahão, J.S. 2013: Vaccinia virus in household environment during bovine vaccinia outbreak, Brazil. Emerging Infectious Diseases 19(12): 2045-2047

He, Y.; Fisher, R.; Chowdhury, S.; Sultana, I.; Pereira, C.P.; Bray, M.; Reed, J.L. 2014: Vaccinia virus induces rapid necrosis in keratinocytes by a STAT3-dependent mechanism. Plos one 9(11): E113690

Yen, J.; Golan, R.; Rubins, K. 2009: Vaccinia virus infection and temporal analysis of virus gene expression: Part 2. Journal of Visualized Experiments: Jove 26: 1-4

Yen, J.; Golan, R.; Rubins, K. 2009: Vaccinia virus infection and temporal analysis of virus gene expression: Part 3. Journal of Visualized Experiments: Jove 2009(26)

Anonymous 2010: Vaccinia virus infection after sexual contact with a military smallpox vaccinee -Washington, 2010. Mmwr. Morbidity and Mortality Weekly Report 59(25): 773-775

Abrahão, J.ôn.S.; Silva-Fernandes, A.é T.; Lima, L.S.; Campos, R.K.; Guedes, M.I.M.C.; Cota, M.M.G.; Assis, F.L.; Borges, I.A.; Souza-Júnior, M.F.; Lobato, Z.él.I.P.; Bonjardim, C.áu.A.; Ferreira, P.C.P.; Trindade, G.S.; Kroon, E.G. 2010: Vaccinia virus infection in monkeys, Brazilian Amazon. Emerging Infectious Diseases 16(6): 976-979

Hughes, C.M.; Blythe, D.; Li, Y.; Reddy, R.; Jordan, C.; Edwards, C.; Adams, C.; Conners, H.; Rasa, C.; Wilby, S.; Russell, J.; Russo, K.S.; Somsel, P.; Wiedbrauk, D.L.; Dougherty, C.; Allen, C.; Frace, M.; Emerson, G.; Olson, V.A.; Smith, S.K.; Braden, Z.; Abel, J.; Davidson, W.; Reynolds, M.; Damon, I.K. 2011: Vaccinia virus infections in martial arts gym, Maryland, USA, 2008. Emerging Infectious Diseases 17(4): 730-733

Sumner, R.P.; Maluquer de Motes, C.; Veyer, D.L.; Smith, G.L. 2014: Vaccinia virus inhibits NF-κB-dependent gene expression downstream of p65 translocation. Journal of Virology 88(6): 3092-3102

Oyoshi, M.K.; Elkhal, A.; Kumar, L.; Scott, J.E.; Koduru, S.; He, R.; Leung, D.Y.M.; Howell, M.D.; Oettgen, H.C.; Murphy, G.F.; Geha, R.S. 2009: Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response. Proceedings of the National Academy of Sciences of the United States of America 106(35): 14954-14959

De Oliveira, T.ér.M.L.; Rehfeld, I.S.; Siqueira, J.M.F.; Abrahão, J.ôn.S.; Campos, R.K.; dos Santos, A.éi.K.R.; Cerqueira, M.ôn.M.O.P.; Kroon, E.G.; Lobato, Z.él.I.P. 2010: Vaccinia virus is not inactivated after thermal treatment and cheese production using experimentally contaminated milk. Foodborne Pathogens and Disease 7(12): 1491-1496

Bisht, H.; Weisberg, A.S.; Moss, B. 2008: Vaccinia virus l1 protein is required for cell entry and membrane fusion. Journal of Virology 82(17): 8687-8694

Jacobs, N.; Bartlett, N.W.; Clark, R.H.; Smith, G.L. 2008: Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection. Journal of General Virology 89(Part 11): 2877-2881

Moloughney, J.G.; Monken, C.E.; Tao, H.; Zhang, H.; Thomas, J.D.; Lattime, E.C.; Jin, S. 2011: Vaccinia virus leads to ATG12–ATG3 conjugation and deficiency in autophagosome formation. Autophagy 7(12): 1434-1447

Jesus, D.Murta.; Moussatche, N.; Condit, R.C. 2014: Vaccinia virus mutations in the L4R gene encoding a virion structural protein produce abnormal mature particles lacking a nucleocapsid. Journal of Virology 88(24): 14017-14029

Nichols, A.C.; Yoo, J.; Um, S.; Mundi, N.; Palma, D.A.; Fung, K.; Macneil, S.D.; Koropatnick, J.; Mymryk, J.S.; Barrett, J.W. 2014: Vaccinia virus outperforms a panel of other poxviruses as a potent oncolytic agent for the control of head and neck squamous cell carcinoma cell lines. Intervirology 57(1): 17-22

Chen, Y.; Honeychurch, K.M.; Yang, G.; Byrd, C.M.; Harver, C.; Hruby, D.E.; Jordan, R. 2009: Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis. Virology Journal 6: 44

Lin, Y-C.James.; Evans, D.H. 2010: Vaccinia virus particles mix inefficiently, and in a way that would restrict viral recombination, in coinfected cells. Journal of Virology 84(5): 2432-2443

Fahy, A.S.; Clark, R.H.; Glyde, E.F.; Smith, G.L. 2008: Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. Journal of General Virology 89(Part 10): 2377-2387

Ember, S.W.J.; Ren, H.; Ferguson, B.J.; Smith, G.L. 2012: Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence. Journal of General Virology 93(Part 10): 2098-2108

Unterholzner, L.; Sumner, R.P.; Baran, M.; Ren, H.; Mansur, D.S.; Bourke, N.M.; Randow, F.; Smith, G.L.; Bowie, A.G. 2011: Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. Plos Pathogens 7(9): E1002247

Johnston, S.C.; Ward, B.M. 2009: Vaccinia virus protein F12 associates with intracellular enveloped virions through an interaction with A36. Journal of Virology 83(4): 1708-1717

Zhai, D.; Yu, E.; Jin, C.; Welsh, K.; Shiau, C.-w.; Chen, L.; Salvesen, G.S.; Liddington, R.; Reed, J.C. 2010: Vaccinia virus protein F1L is a caspase-9 inhibitor. Journal of Biological Chemistry 285(8): 5569-5580

Benfield, C.T.O.; Ren, H.; Lucas, S.J.; Bahsoun, B.; Smith, G.L. 2013: Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. Journal of General Virology 94(Part 7): 1647-1657

Ferguson, B.J.; Benfield, C.T.O.; Ren, H.; Lee, V.H.; Frazer, G.L.; Strnadova, P.; Sumner, R.P.; Smith, G.L. 2013: Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. Journal of General Virology 94(Part 9): 2070-2081

Graham, S.C.; Bahar, M.W.; Cooray, S.; Chen, R.A.-J.; Whalen, D.M.; Abrescia, N.G.A.; Alderton, D.; Owens, R.J.; Stuart, D.I.; Smith, G.L.; Grimes, J.M. 2008: Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. Plos Pathogens 4(8): E1000128

Andrade, A.A.; Brasil, B.S.A.F.; Pereira, A.C.T.C.; Ferreira, P.C.; Kroon, E.G.; Bonjardim, C.áu.A. 2010: Vaccinia virus regulates expression of p21WAF1/Cip1 in A431 cells. Memorias do Instituto Oswaldo Cruz 105(3): 269-277

Fontaine, K.A.; Camarda, R.; Lagunoff, M. 2014: Vaccinia virus requires glutamine but not glucose for efficient replication. Journal of Virology 88(8): 4366-4374

Midgley, C.M.; Putz, M.M.; Weber, J.N.; Smith, G.L. 2008: Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax. Journal of General Virology 89(Part 12): 2992-2997

Bengali, Z.; Townsley, A.C.; Moss, B. 2009: Vaccinia virus strain differences in cell attachment and entry. Virology 389(1-2): 132-140

Mercer, J.; Knébel, S.; Schmidt, F.I.; Crouse, J.; Burkard, C.; Helenius, A. 2010: Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry. Proceedings of the National Academy of Sciences of the United States of America 107(20): 9346-9351

Deng, L.; Dai, P.; Parikh, T.; Cao, H.; Bhoj, V.; Sun, Q.; Chen, Z.; Merghoub, T.; Houghton, A.; Shuman, S. 2008: Vaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3. Journal of Virology 82(21): 10735-10746

Jacobs, B.L.; Langland, J.O.; Kibler, K.V.; Denzler, K.L.; White, S.D.; Holechek, S.A.; Wong, S.; Huynh, T.; Baskin, C.R. 2009: Vaccinia virus vaccines: past, present and future. Antiviral Research 84(1): 1-13

Wu, X.; Meng, X.; Yan, B.; Rose, L.; Deng, J.; Xiang, Y. 2012: Vaccinia virus virion membrane biogenesis protein A11 associates with viral membranes in a manner that requires the expression of another membrane biogenesis protein, A6. Journal of Virology 86(20): 11276-11286

Maluquer de Motes, C.; Schiffner, T.; Sumner, R.P.; Smith, G.L. 2014: Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues. Journal of General Virology 95(Part 9): 2038-2049

Cheltsov, A.V.; Aoyagi, M.; Aleshin, A.; Yu, E.C.-W.; Gilliland, T.; Zhai, D.; Bobkov, A.A.; Reed, J.C.; Liddington, R.C.; Abagyan, R. 2010: Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention. Journal of Medicinal Chemistry 53(10): 3899-3906

Megid, J.; Borges, I.A.; Abrahão, J.S.; Trindade, G.S.; Appolinário, C.M.; Ribeiro, M.ár.G.; Allendorf, S.D.; Antunes, J.ão.M.A.P.; Silva-Fernandes, A.é T.; Kroon, E.G. 2012: Vaccinia virus zoonotic infection, São Paulo State, Brazil. Emerging Infectious Diseases 18(1): 189-191

Poon, L.L.M.; Leung, Y.H.C.; Nicholls, J.M.; Perera, P.-Y.; Lichy, J.H.; Yamamoto, M.; Waldmann, T.A.; Peiris, J.S.M.; Perera, L.P. 2009: Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. Journal of Immunology 182(5): 3063-3071

Gammon, D.B.; Gowrishankar, B.; Duraffour, S.; Andrei, G.; Upton, C.; Evans, D.H. 2010: Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis. Plos Pathogens 6(7): E1000984

Waibler, Z.; Anzaghe, M.; Frenz, T.; Schwantes, A.; Pöhlmann, C.; Ludwig, H.; Palomo-Otero, M.; Alcamí, A.; Sutter, G.; Kalinke, U. 2009: Vaccinia virus-mediated inhibition of type i interferon responses is a multifactorial process involving the soluble type i interferon receptor B18 and intracellular components. Journal of Virology 83(4): 1563-1571

Stritzker, J.; Kirscher, L.; Scadeng, M.; Deliolanis, N.C.; Morscher, S.; Symvoulidis, P.; Schaefer, K.; Zhang, Q.; Buckel, L.; Hess, M.; Donat, U.; Bradley, W.G.; Ntziachristos, V.; Szalay, A.A. 2013: Vaccinia virus-mediated melanin production allows MR and optoacoustic deep tissue imaging and laser-induced thermotherapy of cancer. Proceedings of the National Academy of Sciences of the United States of America 110(9): 3316-3320

Terajima, M.; Orphin, L.; Leporati, A.M.; Pazoles, P.; Cruz, J.; Rothman, A.L.; Ennis, F.A. 2008: Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans. Human Immunology 69(12): 815-825

Grigoryev, D.N.; Howell, M.D.; Watkins, T.N.; Chen, Y.-C.; Cheadle, C.; Boguniewicz, M.; Barnes, K.C.; Leung, D.Y.M. 2010: Vaccinia virus-specific molecular signature in atopic dermatitis skin. Journal of Allergy and Clinical Immunology 125(1): 153-159.E28

Ferreira, J.M.S.; Abrahão, J.ôn.S.; Drumond, B.ân.P.; Oliveira, F.M.; Alves, P.A.; Pascoal-Xavier, M.A.ôn.; Lobato, Z.él.I.ês.P.; Bonjardim, C.áu.A.ôn.; Ferreira, P.C.és.P.; Kroon, E.G. 2008: Vaccinia virus: shedding and horizontal transmission in a murine model. Journal of General Virology 89(Part 12): 2986-2991

Walsh, S.R.; Dolin, R. 2011: Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors. Expert Review of Vaccines 10(8): 1221-1240

Condit, R.C. 2007: Vaccinia, Inc.--probing the functional substructure of poxviral replication factories. Cell Host and Microbe 2(4): 205-207

Kwon, J.-S.; Yoon, J.; Kim, Y.-J.; Kang, K.; Woo, S.; Jung, D.-I.; Song, M.K.; Kim, E.-H.; Kwon, H.-I.; Choi, Y.K.; Kim, J.; Lee, J.; Yoon, Y.; Shin, E.-C.; Youn, J.-W. 2014: Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection. European Journal of Immunology 44(8): 2360-2369

Dey, B.; Berger, E.A. 2003: Vaccinia-based reporter gene cell-fusion assays to quantitate functional interactions of HIV envelope glycoprotein with receptors. Current Protocols in Immunology Chapter 12: Unit 12.10

Postigo, A.; Martin, M.C.; Dodding, M.P.; Way, M. 2009: Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection. Cellular Microbiology 11(8): 1208-1218

Mutsafi, Y.; Zauberman, N.; Sabanay, I.; Minsky, A. 2010: Vaccinia-like cytoplasmic replication of the giant Mimivirus. Proceedings of the National Academy of Sciences of the United States of America 107(13): 5978-5982

Salzano, M.; Vázquez-Cedeira, M.; Sanz-García, M.; Valbuena, A.; Blanco, S.; Fernández, I.F.; Lazo, P.A. 2014: Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response. Oncotarget 5(7): 1770-1778

Sanz-García, M.; Monsalve, D.M.; Sevilla, A.; Lazo, P.A. 2012: Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage. Journal of Biological Chemistry 287(28): 23757-23768

Choi, Y.H.; Park, C.-H.; Kim, W.; Ling, H.; Kang, A.; Chang, M.W.; Im, S.-K.; Jeong, H.-W.; Kong, Y.-Y.; Kim, K.-T. 2010: Vaccinia-related kinase 1 is required for the maintenance of undifferentiated spermatogonia in mouse male germ cells. Plos one 5(12): E15254

Kim, S.; Park, D.-Y.; Lee, D.; Kim, W.; Jeong, Y.-H.; Lee, J.; Chung, S.-K.; Ha, H.; Choi, B.-H.; Kim, K.-T. 2014: Vaccinia-related kinase 2 mediates accumulation of polyglutamine aggregates via negative regulation of the chaperonin TRiC. Molecular and Cellular Biology 34(4): 643-652

Brain, R.T.; O'Donovan, W.J. 1929: Vaccinial Condylomata. British journal of venereal diseases 5(3): 229-230

Sakoschansky, E.; Trenchard, H.J. 1939: Vaccinial Encephalitis. British Medical Journal 1(4093): 1229-1230

Adler, K. 1969: Vaccinial therapy of verrucae. Canadian Medical Association Journal 100(12): 585

Feshani, A.Monavar.; Kouhsari, S.Monatasser.; Mohammadi, S. 2011: Vaccinium arctostaphylos, a common herbal medicine in Iran: molecular and biochemical study of its antidiabetic effects on alloxan-diabetic Wistar rats. Journal of Ethnopharmacology 133(1): 67-74

Oprea, E.; Ruta, L.L.; Nicolau, I.; Popa, C.V.; Neagoe, A.D.; Farcasanu, I.C. 2014: Vaccinium corymbosum L. (blueberry) extracts exhibit protective action against cadmium toxicity in Saccharomyces cerevisiae cells. Food Chemistry 152: 516-521

Pérez-López, F.R.; Haya, J.; Chedraui, P. 2009: Vaccinium macrocarpon: an interesting option for women with recurrent urinary tract infections and other health benefits. Journal of Obstetrics and Gynaecology Research 35(4): 630-639

Matsunaga, N.; Chikaraishi, Y.; Shimazawa, M.; Yokota, S.; Hara, H. 2010: Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis in Vitro and in Vivo. Evidence-Based Complementary and Alternative Medicine: Ecam 7(1): 47-56

Helmstädter, A.; Schuster, N. 2010: Vaccinium myrtillus as an antidiabetic medicinal plant--research through the ages. Die Pharmazie 65(5): 315-321

Sadowska, B.; Paszkiewicz, M.łg.; Podsędek, A.; Redzynia, M.łg.; Różalska, B. 2014: Vaccinium myrtillus leaves and Frangula alnus bark derived extracts as potential antistaphylococcal agents. Acta Biochimica Polonica 61(1): 163-169

Hanson, C.V. 2011: Vaccinogenicity. Aids 25(5): 581-584

Hendriks, J.; Holleman, M.; Hamidi, A.; Beurret, M.; Boog, C. 2013: Vaccinology capacity building in Europe for innovative platforms serving emerging markets. Human Vaccines and Immunotherapeutics 9(4): 932-936

Altindis, E. 2013: Vaccinology in the 21st century. Current Topics in Medicinal Chemistry 13(20): 2533-2534

Rinaudo, C.D.; Telford, J.L.; Rappuoli, R.; Seib, K.L. 2009: Vaccinology in the genome era. Journal of Clinical Investigation 119(9): 2515-2525

Siegrist, C-A. 2008: Vaccinology update for 2008: what's new in Switzerland?. Revue Medicale Suisse 4(139): 72-75

Siegrist, C.-A. 2009: Vaccinology: which catch-up plans for patients with unknown or incomplete immunizations?. Revue Medicale Suisse 5(185): 63-68

Poland, G.A.; Ovsyannikova, I.G.; Kennedy, R.B.; Haralambieva, I.H.; Jacobson, R.M. 2011: Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. Omics: a Journal of Integrative Biology 15(9): 625-636

Poland, G.A.; Oberg, A.L. 2010: Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology. Vaccine 28(20): 3509-3510

Poland, G.A.; Kennedy, R.B.; Ovsyannikova, I.G. 2011: Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?. Plos Pathogens 7(12): E1002344

Loukas, A.; Gaze, S.; Mulvenna, J.P.; Gasser, R.B.; Brindley, P.J.; Doolan, D.L.; Bethony, J.M.; Jones, M.K.; Gobert, G.N.; Driguez, P.; McManus, D.P.; Hotez, P.J. 2011: Vaccinomics for the major blood feeding helminths of humans. Omics: a Journal of Integrative Biology 15(9): 567-577

Poland, G.A.; Kennedy, R.B.; McKinney, B.A.; Ovsyannikova, I.G.; Lambert, N.D.; Jacobson, R.M.; Oberg, A.L. 2013: Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. Seminars in Immunology 25(2): 89-103

Haralambieva, I.H.; Poland, G.A. 2010: Vaccinomics, predictive vaccinology and the future of vaccine development. Future Microbiology 5(12): 1757-1760

De la Fuente, J.é; Merino, O. 2013: Vaccinomics, the new road to tick vaccines. Vaccine 31(50): 5923-5929

Semenov, B.F.; Zverev, V.V. 2010: Vaccinoprophylaxis of chronic somatic diseases exacerbations in groups of risk. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1: 86-92

Bachl, M. 2008: Vacillating between openness and clear position. Krankenpflege. Soins Infirmiers 101(5): 24-26

Lee, S.-K.; Li, W.; Ryu, S.-E.; Rhim, T.; Ahnn, J. 2010: Vacuolar (H+)-ATPases in Caenorhabditis elegans: what can we learn about giant H+ pumps from tiny worms?. Biochimica et Biophysica Acta 1797(10): 1687-1695

Chintagari, N.R.; Mishra, A.; Su, L.; Wang, Y.; Ayalew, S.; Hartson, S.D.; Liu, L. 2010: Vacuolar ATPase regulates surfactant secretion in rat alveolar type Ii cells by modulating lamellar body calcium. Plos one 5(2): E9228

Li, C.; Xia, Y. 2012: Vacuolar ATPase subunit H is essential for the survival and moulting of Locusta migratoria manilensis. Insect Molecular Biology 21(4): 405-413

Marceau, F.ço.; Bawolak, M.-T.ér.ès.; Bouthillier, J.; Morissette, G. 2009: Vacuolar ATPase-mediated cellular concentration and retention of quinacrine: a model for the distribution of lipophilic cationic drugs to autophagic vacuoles. Drug Metabolism and Disposition: the Biological Fate of Chemicals 37(12): 2271-2274

Shine, L.; Kilty, C.; Gross, J.; Kennedy, B. 2014: Vacuolar ATPases and their role in vision. Advances in Experimental Medicine and Biology 801: 97-103

Pittman, J.K. 2011: Vacuolar Ca(2+) uptake. Cell Calcium 50(2): 139-146

Xiao, Y.-T.; Xiang, L.-X.; Shao, J.-Z. 2008: Vacuolar H(+)-ATPase. International Journal of Biochemistry and Cell Biology 40(10): 2002-2006

Schachtschabel, D.; Arentshorst, M.; Lagendijk, E.L.; Ram, A.F.J. 2012: Vacuolar H(+)-ATPase plays a key role in cell wall biosynthesis of Aspergillus niger. Fungal Genetics and Biology: Fg and B 49(4): 284-293

Sennoune, S.R.; Martinez-Zaguilan, R. 2012: Vacuolar H(+)-ATPase signaling pathway in cancer. Current Protein and Peptide Science 13(2): 152-163

Saw, N.M.N.; Kang, S.-Y.A.; Parsaud, L.; Han, G.A.; Jiang, T.; Grzegorczyk, K.; Surkont, M.; Sun-Wada, G.-H.; Wada, Y.; Li, L.; Sugita, S. 2011: Vacuolar H(+)-ATPase subunits Voa1 and Voa2 cooperatively regulate secretory vesicle acidification, transmitter uptake, and storage. Molecular Biology of the Cell 22(18): 3394-3409

Saroussi, S.; Nelson, N. 2009: Vacuolar H(+)-ATPase-an enzyme for all seasons. Pflugers Archiv: European Journal of Physiology 457(3): 581-587

Byun, Y.J.; Lee, S.-B.; Lee, H.O.; Son, M.J.; Kim, H.-S.; Kwon, O.-J.; Jeong, S.-W. 2011: Vacuolar H+ -ATPase c protects glial cell death induced by sodium nitroprusside under glutathione-depleted condition. Journal of Cellular Biochemistry 112(8): 1985-1996

Hendrix, A.; Sormunen, R.; Westbroek, W.; Lambein, K.; Denys, H.; Sys, G.; Braems, G.; Van den Broecke, R.; Cocquyt, V.; Gespach, C.; Bracke, M.; De Wever, O. 2013: Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. International Journal of Cancer 133(4): 843-854

Kim, H.; Kim, A.; Cunningham, K.W. 2012: Vacuolar H+-ATPase (V-ATPase) promotes vacuolar membrane permeabilization and nonapoptotic death in stressed yeast. Journal of Biological Chemistry 287(23): 19029-19039

Gong, F.; Alzamora, R.; Smolak, C.; Li, H.; Naveed, S.; Neumann, D.; Hallows, K.R.; Pastor-Soler, N.úr.M. 2010: Vacuolar H+-ATPase apical accumulation in kidney intercalated cells is regulated by PKA and AMP-activated protein kinase. American Journal of Physiology. Renal Physiology 298(5): F1162-F1169

Sasazawa, Y.; Futamura, Y.; Tashiro, E.; Imoto, M. 2009: Vacuolar H+-ATPase inhibitors overcome Bcl-xL-mediated chemoresistance through restoration of a caspase-independent apoptotic pathway. Cancer Science 100(8): 1460-1467

Shirakawa, M.; Ueda, H.; Shimada, T.; Nishiyama, C.; Hara-Nishimura, I. 2009: Vacuolar SNAREs function in the formation of the leaf vascular network by regulating auxin distribution. Plant and Cell Physiology 50(7): 1319-1328

Iwaki, T.; Sekito, T.; Kakinuma, Y. 2010: Vacuolar amino acid transporter Avt5p is responsible for lithium uptake in Schizosaccharomyces pombe. Bioscience Biotechnology and Biochemistry 74(8): 1719-1721

Higaki, T.; Kadota, Y.; Goh, T.; Hayashi, T.; Kutsuna, N.; Sano, T.; Hasezawa, S.; Kuchitsu, K. 2008: Vacuolar and cytoskeletal dynamics during elicitor-induced programmed cell death in tobacco BY-2 cells. Plant Signaling and Behavior 3(9): 700-703

Kowalska, M.; Galuszka, P.; Frébortová, J.; Šebela, M.; Béres, T.; Hluska, T.áš; Šmehilová, M.ár.; Bilyeu, K.D.; Frébort, I. 2010: Vacuolar and cytosolic cytokinin dehydrogenases of Arabidopsis thaliana: heterologous expression, purification and properties. Phytochemistry 71(17-18): 1970-1978

Novikova, G.V.; Tournaire-Roux, C.; Sinkevich, I.A.; Lityagina, S.V.; Maurel, C.; Obroucheva, N. 2014: Vacuolar biogenesis and aquaporin expression at early germination of broad bean seeds. Plant Physiology and Biochemistry (Paris) 82: 123-132

Cagnac, O.; Aranda-Sicilia, M.N.; Leterrier, M.; Rodriguez-Rosales, M.-P.; Venema, K. 2010: Vacuolar cation/H+ antiporters of Saccharomyces cerevisiae. Journal of Biological Chemistry 285(44): 33914-33922

Minina, E.A.; Smertenko, A.P.; Bozhkov, P.V. 2014: Vacuolar cell death in plants: Metacaspase releases the brakes on autophagy. Autophagy 10(5): 928-929

Tsuchiyama, S.; Kennedy, B.K. 2012: Vacuolar dynamics and replicative aging. Cell Cycle 11(15): 2778-2779

Ge, X.; d'Avignon, D.André.; Ackerman, J.J.H.; Collavo, A.; Sattin, M.; Ostrander, E.L.; Hall, E.L.; Sammons, R.Douglas.; Preston, C. 2012: Vacuolar glyphosate-sequestration correlates with glyphosate resistance in ryegrass (Lolium spp.) from Australia, South America, and Europe: a 31P NMR investigation. Journal of Agricultural and Food Chemistry 60(5): 1243-1250

Zhu, X.; Richael, C.; Chamberlain, P.; Busse, J.S.; Bussan, A.J.; Jiang, J.; Bethke, P.C. 2014: Vacuolar invertase gene silencing in potato (Solanum tuberosum L.) improves processing quality by decreasing the frequency of sugar-end defects. Plos one 9(4): E93381

Schönknecht, G.; Trebacz, K. 2008: Vacuolar ion channels in the liverwort Conocephalum conicum. Plant Signaling and Behavior 3(6): 404-405

Isayenkov, S.; Isner, J.C.; Maathuis, F.J.M. 2010: Vacuolar ion channels: Roles in plant nutrition and signalling. Febs Letters 584(10): 1982-1988

Ryan, A.M.; Ryan, J.; Wan-Ahmed, M.; Hardiman, O.; Farrell, M.A.; McNamara, B.; Sweeney, B.J. 2009: Vacuolar leucoencephalopathy and pulvinar sign in association with coeliac disease. BMJ Case Reports

Sharma, V.; Strack, D. 1985: Vacuolar localization of 1-sinapolglucose: L-malate sinapoyltransferase in protoplasts from cotyledons of Raphanus sativus. Planta 163(4): 563-568

Scarpante, E.; Palus, V.; Summers, B.A.; Caine, A.; Cherubini, G.B. 2013: Vacuolar meningioma: a new and rare variant of canine meningioma. Veterinary Record 173(20): 502

Izawa, S.; Ikeda, K.; Miki, T.; Wakai, Y.; Inoue, Y. 2010: Vacuolar morphology of Saccharomyces cerevisiae during the process of wine making and Japanese sake brewing. Applied Microbiology and Biotechnology 88(1): 277-282

Stacpoole, S.R.L.; Phadke, R.; Jacques, T.S.; Revesz, T.; Plant, G.T. 2009: Vacuolar myelopathy associated with optic neuropathy in an HIV-negative, immunosuppressed liver transplant recipient. Journal of Neurology Neurosurgery and Psychiatry 80(5): 581-583

Bizaare, M.; Dawood, H.; Moodley, A. 2008: Vacuolar myelopathy: a case report of functional, clinical, and radiological improvement after highly active antiretroviral therapy. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 12(4): 442-444

King, J.; LeCouteur, R.A.; Aleman, M.; Williams, D.C.; Moore, P.F.; Guo, L.T.; Mizisin, A.P.; Shelton, G.D. 2009: Vacuolar myopathy in a dog resembling human sporadic inclusion body myositis. Acta Neuropathologica 118(5): 711-717

Haydon, M.J.; Kawachi, M.; Wirtz, M.; Hillmer, S.; Hell, R.üd.; Krämer, U. 2012: Vacuolar nicotianamine has critical and distinct roles under iron deficiency and for zinc sequestration in Arabidopsis. Plant Cell 24(2): 724-737

Roy, C.R. 2012: Vacuolar pathogens value membrane integrity. Proceedings of the National Academy of Sciences of the United States of America 109(9): 3197-3198

Levine, S.; Saltzman, A.; Ginsberg, S.D. 2011: Vacuolar pathology in the median eminence of the hypothalamus after hyponatremia. Journal of Neuropathology and Experimental Neurology 70(2): 151-156

Linhart, R.; Wong, S.A.; Cao, J.; Tran, M.; Huynh, A.; Ardrey, C.; Park, J.M.; Hsu, C.; Taha, S.; Peterson, R.; Shea, S.; Kurian, J.; Venderova, K. 2014: Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2). Molecular Neurodegeneration 9: 23

Zhang, Y.; Chen, S.; Xiao, Q.; Cao, L.; Liu, J.; Rong, T.-Y.; Ma, J.-F.; Wang, G.; Wang, Y.; Chen, S.-D. 2012: Vacuolar protein sorting 35 Asp620Asn mutation is rare in the ethnic Chinese population with Parkinson's disease. Parkinsonism and Related Disorders 18(5): 638-640

Liu, Y.; Lv, L.; Xue, Q.; Wan, C.; Ni, T.; Chen, B.; Liu, Y.; Zhou, Y.; Ni, R.; Mao, G. 2013: Vacuolar protein sorting 4B, an ATPase protein positively regulates the progression of NSCLC via promoting cell division. Molecular and Cellular Biochemistry 381(1-2): 163-171

Kolesnikova, L.; Strecker, T.; Morita, E.; Zielecki, F.; Mittler, E.; Crump, C.; Becker, S. 2009: Vacuolar protein sorting pathway contributes to the release of Marburg virus. Journal of Virology 83(5): 2327-2337

Rivero, M.R.; Miras, S.L.; Feliziani, C.; Zamponi, N.; Quiroga, R.; Hayes, S.F.; Rópolo, A.S.; Touz, M.C. 2012: Vacuolar protein sorting receptor in Giardia lamblia. Plos one 7(8): E43712

Eisenach, C.; Baetz, U.; Martinoia, E. 2014: Vacuolar proton pumping: more than the sum of its parts?. Trends in Plant Science 19(6): 344-346

Muto, Y.; Segami, S.; Hayashi, H.; Sakurai, J.; Murai-Hatano, M.; Hattori, Y.; Ashikari, M.; Maeshima, M. 2011: Vacuolar proton pumps and aquaporins involved in rapid internode elongation of deepwater rice. Bioscience Biotechnology and Biochemistry 75(1): 114-122

Peng, J.-S.; Gong, J.-M. 2014: Vacuolar sequestration capacity and long-distance metal transport in plants. Frontiers in Plant Science 5: 19

Mori, T.; Saruta, Y.; Fukuda, T.; Prak, K.; Ishimoto, M.; Maruyama, N.; Utsumi, S. 2009: Vacuolar sorting behaviors of 11S globulins in plant cells. Bioscience Biotechnology and Biochemistry 73(1): 53-60

Wang, H.; Tse, Y.C.; Law, A.H.Y.; Sun, S.S.M.; Sun, Y.-B.; Xu, Z.-F.; Hillmer, S.; Robinson, D.G.; Jiang, L. 2010: Vacuolar sorting receptors (VSRs) and secretory carrier membrane proteins (SCAMPs) are essential for pollen tube growth. Plant Journal: for Cell and Molecular Biology 61(5): 826-838

Scheuring, D.; Schöller, M.; Kleine-Vehn, J.ür.; Löfke, C. 2015: Vacuolar staining methods in plant cells. Methods in Molecular Biology 1242: 83-92

Obroucheva, N.V.; Lityagina, S.V.; Novikova, G.V.; Sin'kevich, I.A. 2012: Vacuolar status and water relations in embryonic axes of recalcitrant Aesculus hippocastanum seeds during stratification and early germination. Aob Plants 2012: Pls008

Palmer, G.E. 2011: Vacuolar trafficking and Candida albicans pathogenesis. Communicative and Integrative Biology 4(2): 240-242

Shimada, T.; Hara-Nishimura, I. 2008: Vacuolar transport in higher plants. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 53(16 Suppl): 2313-2319

Burla, B.; Pfrunder, S.; Nagy, R.ék.; Francisco, R.M.; Lee, Y.; Martinoia, E. 2013: Vacuolar transport of abscisic acid glucosyl ester is mediated by ATP-binding cassette and proton-antiport mechanisms in Arabidopsis. Plant Physiology 163(3): 1446-1458

Morita, M.; Shitan, N.; Sawada, K.; Van Montagu, M.C.E.; Inzé, D.; Rischer, H.; Goossens, A.; Oksman-Caldentey, K.-M.; Moriyama, Y.; Yazaki, K. 2009: Vacuolar transport of nicotine is mediated by a multidrug and toxic compound extrusion (MATE) transporter in Nicotiana tabacum. Proceedings of the National Academy of Sciences of the United States of America 106(7): 2447-2452

Carqueijeiro, I.ês.; Noronha, H.; Duarte, P.íc.; Gerós, H.ân.; Sottomayor, M. 2013: Vacuolar transport of the medicinal alkaloids from Catharanthus roseus is mediated by a proton-driven antiport. Plant Physiology 162(3): 1486-1496

Sekito, T.; Chardwiriyapreecha, S.; Sugimoto, N.; Ishimoto, M.; Kawano-Kawada, M.; Kakinuma, Y. 2014: Vacuolar transporter Avt4 is involved in excretion of basic amino acids from the vacuoles of Saccharomyces cerevisiae. Bioscience Biotechnology and Biochemistry 78(6): 969-975

Martinoia, E.; Meyer, S.; De Angeli, A.; Nagy, R.ék. 2012: Vacuolar transporters in their physiological context. Annual Review of Plant Biology 63: 183-213

Maathuis, F.J.M. 2011: Vacuolar two-pore K+ channels act as vacuolar osmosensors. New Phytologist 191(1): 84-91

Yamaki, S.; Romani, R. 1987: Vacuolar yield and alteration with aging of suspension-cultured cells from pear fruit. Plant Cell Reports 6(3): 244-247

Jaiswal, M.K.; Katara, G.K.; Mallers, T.; Chaouat, G.; Gilman-Sachs, A.; Beaman, K.D. 2014: Vacuolar-ATPase isoform a2 regulates macrophages and cytokine profile necessary for normal spermatogenesis in testis. Journal of Leukocyte Biology 96(2): 337-347

Gollhofer, J.; Timofeev, R.; Lan, P.; Schmidt, W.; Buckhout, T.J. 2014: Vacuolar-Iron-Transporter1-Like proteins mediate iron homeostasis in Arabidopsis. Plos one 9(10): E110468

Wang, J.; Binks, T.; Warr, C.G.; Burke, R. 2014: Vacuolar-type H(+)-ATPase subunits and the neurogenic protein big brain are required for optimal copper and zinc uptake. Metallomics: Integrated Biometal Science 6(11): 2100-2108

Gharanei, S.; Zatyka, M.; Astuti, D.; Fenton, J.; Sik, A.; Nagy, Z.; Barrett, T.G. 2013: Vacuolar-type H+-ATPase V1A subunit is a molecular partner of Wolfram syndrome 1 (WFS1) protein, which regulates its expression and stability. Human Molecular Genetics 22(2): 203-217

Sun-Wada, G.-H.; Wada, Y. 2013: Vacuolar-type proton pump ATPases: acidification and pathological relationships. Histology and Histopathology 28(7): 805-815

Sun-Wada, G.-h.; Wada, Y. 2010: Vacuolar-type proton pump ATPases: roles of subunit isoforms in physiology and pathology. Histology and Histopathology 25(12): 1611-1620

Wieczorek, H.; Beyenbach, K.W.; Huss, M.; Vitavska, O. 2009: Vacuolar-type proton pumps in insect epithelia. Journal of Experimental Biology 212(Part 11): 1611-1619

Uemura, T.; Morita, M.T.; Ebine, K.; Okatani, Y.; Yano, D.; Saito, C.; Ueda, T.; Nakano, A. 2010: Vacuolar/pre-vacuolar compartment Qa-SNAREs VAM3/SYP22 and PEP12/SYP21 have interchangeable functions in Arabidopsis. Plant Journal: for Cell and Molecular Biology 64(5): 864-873

Kalanetra, K.M.; Nelson, D.C. 2010: Vacuolate-attached filaments: highly productive Ridgeia piscesae epibionts at the Juan de Fuca hydrothermal vents. Marine Biology 157(4): 791-800

Dursun, N.; Feng, J.; Basturk, O.; Bandyopadhyay, S.; Cheng, J.D.; Adsay, V.N. 2010: Vacuolated cell pattern of pancreatobiliary adenocarcinoma: a clinicopathological analysis of 24 cases of a poorly recognized distinctive morphologic variant important in the differential diagnosis. Virchows Archiv: An International Journal of Pathology 457(6): 643-649

Yildirim, Z.Keskin.; Buyukavci, M. 2008: Vacuolated cells in bone marrow aspirate of children with neuroblastoma. Pediatric Hematology and Oncology 25(7): 665-672

Chevalier, C.; Detry, G. 2012: Vacuolated lymphocytes and abnormal eosinophils in GM1 gangliosidosis, type 1. British Journal of Haematology 156(3): 293

Radhakrishnan, K.; Goel, H.; Barnes, C. 2010: Vacuolated lymphocytes–a diagnostic clue. European Journal of Haematology 85(5): 460-461

Wallbutton, S.; Kasraie, J. 2010: Vacuolated oocytes: fertilization and embryonic arrest following intra-cytoplasmic sperm injection in a patient exhibiting persistent oocyte macro vacuolization--case report. Journal of Assisted Reproduction and Genetics 27(4): 183-188

Palframan, S.L.; Kwok, T.; Gabriel, K. 2012: Vacuolating cytotoxin a (VacA), a key toxin for Helicobacter pylori pathogenesis. Frontiers in Cellular and Infection Microbiology 2: 92

Raju, D.; Hussey, S.; Ang, M.; Terebiznik, M.R.; Sibony, M.; Galindo-Mata, E.; Gupta, V.; Blanke, S.R.; Delgado, A.; Romero-Gallo, J.; Ramjeet, M.S.; Mascarenhas, H.; Peek, R.M.; Correa, P.; Streutker, C.; Hold, G.; Kunstmann, E.; Yoshimori, T.; Silverberg, M.S.; Girardin, S.E.; Philpott, D.J.; El Omar, E.; Jones, N.L. 2012: Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 142(5): 1160-1171

Memon, A.A.; Hussein, N.R.; Miendje Deyi, V.ér.Y.; Burette, A.; Atherton, J.C. 2014: Vacuolating cytotoxin genotypes are strong markers of gastric cancer and duodenal ulcer-associated Helicobacter pylori strains: a matched case-control study. Journal of Clinical Microbiology 52(8): 2984-2989

Kim, J.M.; Kim, J.S.; Lee, J.Y.; Kim, Y.-J.; Youn, H.-J.; Kim, I.Y.; Chee, Y.J.; Oh, Y.-K.; Kim, N.; Jung, H.C.; Song, I.S. 2007: Vacuolating cytotoxin in Helicobacter pylori water-soluble proteins upregulates chemokine expression in human eosinophils via Ca2+ influx, mitochondrial reactive oxygen intermediates, and NF-kappaB activation. Infection and Immunity 75(7): 3373-3381

Lainey, E.; Ogier, H.él.èn.; Fenneteau, O. 2008: Vacuolation of neutrophils and acanthocytosis in child with medium chain acyl-CoA dehydrogenase deficiency. British Journal of Haematology 140(6): 595

Rogers-Cotrone, T.; Burgess, M.P.; Hancock, S.H.; Hinckley, J.; Lowe, K.; Ehrich, M.F.; Jortner, B.S. 2010: Vacuolation of sensory ganglion neuron cytoplasm in rats with long-term exposure to organophosphates. Toxicologic Pathology 38(4): 554-559

Skae, F.M. 1894: Vacuolation of the Nuclei of Nerve Cells in the Cortex. British Medical Journal 1(1742): 1075-1076

Liu, Y.Y.; Zhao, X.M.; Liu, F.Y.; Tian, N. 2001: Vacuole formation and endothelial damage in microvessels after ischemia reperfusion. Zhongguo Ying Yong Sheng Li Xue Za Zhi 17(1): 55-57

Alibhoy, A.A.; Chiang, H.-L. 2011: Vacuole import and degradation pathway: Insights into a specialized autophagy pathway. World Journal of Biological Chemistry 2(11): 239-245

Calvo-Garrido, J.; Carilla-Latorre, S.; Lázaro-Diéguez, F.; Egea, G.; Escalante, R. 2008: Vacuole membrane protein 1 is an endoplasmic reticulum protein required for organelle biogenesis, protein secretion, and development. Molecular Biology of the Cell 19(8): 3442-3453

Calvo-Garrido, J.; Carilla-Latorre, S.; Escalante, R. 2008: Vacuole membrane protein 1, autophagy and much more. Autophagy 4(6): 835-837

Kajikawa, M.; Shoji, T.; Kato, A.; Hashimoto, T. 2011: Vacuole-localized berberine bridge enzyme-like proteins are required for a late step of nicotine biosynthesis in tobacco. Plant Physiology 155(4): 2010-2022

Sousa, M.J.ão.; Azevedo, F.áv.; Azevedo, F.áv.ìa.; Pedras, A.; Pedras, A.; Marques, C.; Coutinho, O.P.; Preto, A.; Gerós, H.ân.; Chaves, S.R.; Côrte-Real, M. 2011: Vacuole-mitochondrial cross-talk during apoptosis in yeast: a model for understanding lysosome-mitochondria-mediated apoptosis in mammals. Biochemical Society Transactions 39(5): 1533-1537

Meirowsky, E. 1948: Vacuoles in Paget's disease. Experimental Medicine and Surgery 6(2-3): 203-212

Jortner, B.; Rogers-Cotrone, T. 2011: Vacuoles in dorsal root Ganglia neurons: some questions. Toxicologic Pathology 39(2): 451-453

Wada, Y. 2013: Vacuoles in mammals: a subcellular structure indispensable for early embryogenesis. Bioarchitecture 3(1): 13-19

Siavoshi, F.; Saniee, P. 2014: Vacuoles of Candida yeast as a specialized niche for Helicobacter pylori. World Journal of Gastroenterology 20(18): 5263-5273

Yaksh, T.L. 2010: Vacuoles: a hollow threat?. Canadian Journal of Anaesthesia 57(3): 195-200

Bielaszewska, M.; Bauwens, A.; Greune, L.; Kemper, B.ör.; Dobrindt, U.; Geelen, J.M.; Kim, K.S.; Schmidt, M.A.; Karch, H. 2009: Vacuolisation of human microvascular endothelial cells by enterohaemorrhagic Escherichia coli. Thrombosis and Haemostasis 102(6): 1080-1092

Wu, X.; Steigelman, K.A.; Bonten, E.; Hu, H.; He, W.; Ren, T.; Zuo, J.; d'Azzo, A. 2010: Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice. Biochimica et Biophysica Acta 1802(2): 259-268

Boonen, M.; van Meel, E.; Oorschot, V.; Klumperman, J.; Kornfeld, S. 2011: Vacuolization of mucolipidosis type Ii mouse exocrine gland cells represents accumulation of autolysosomes. Molecular Biology of the Cell 22(8): 1135-1147

Riviello, E.D.; Wang, K.C.; Hochman, M.E.; Sariban, A.; Da Rocha, R.C.; Dogaru, G.; Christopher, K. 2009: Vacuolization of tubules in gadolinium-associated acute renal failure. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 113(1): 108-115

Ashrafi, F.; Nematbakhsh, M.; Nasri, H.; Talebi, A.; Hosseini, S.M.; Ashrafi, M. 2013: Vacuolization, dilatation, hyaline cast, debris or degeneration: which one is the most correlated item to score the kidney damage pathologically in Cisplatin induced nephrotoxicity model?. Nephro-Urology Monthly 5(4): 918-920

Barnard, R.D.; Van Hala, L. 1946: Vacutainer for collection of citrated blood in tests for syphilis; recalcification of plasma by gypsum; inactivation of serum with clots. American Journal of Clinical Pathology 10(5): 173-175

Burd, W.; O'rourke, A. 1946: Vacutainer for collection of citrated blood; with a note on determination of presumptive sedimentation rates. American Journal of Clinical Pathology 10(5): 171

Barker, D.E. 1948: Vacutome; a new machine for obtaining split thickness skin grafts. Plastic and Reconstructive Surgery 3(4): 492-501

Pepe, G.; Magalini, S.; Callari, C.; Persiani, R.; Lodoli, C.; Gui, D. 2014: Vacuum Assisted Closure (VAC) therapyTM as a swiss knife multi-tool for enteric fistula closure: tips and tricks: a pilot study. European Review for Medical and Pharmacological Sciences 18(17): 2527-2532

Sinha, K.; Chauhan, V.D.; Maheshwari, R.; Chauhan, N.; Rajan, M.; Agrawal, A. 2013: Vacuum Assisted Closure Therapy versus Standard Wound Therapy for Open Musculoskeletal Injuries. Advances in Orthopedics 2013: 245940

Altschul, B. 2007: Vacuum Cerenkov radiation in Lorentz-violating theories without CPT violation. Physical Review Letters 98(4): 041603

Hass, G.; Ramsey, J.B. 1969: Vacuum Deposition of Dielectric and Semiconductor Films by a CO(2) Laser. Applied Optics 8(6): 1115-1118

Whitehead, W.L.; Breger, I.A. 1950: Vacuum Differential Thermal Analysis. Science 111(2881): 279-281

Hakala, T.K.; Toppari, J.J.; Kuzyk, A.; Pettersson, M.; Tikkanen, H.; Kunttu, H.; Törmä, P. 2009: Vacuum Rabi splitting and strong-coupling dynamics for surface-plasmon polaritons and rhodamine 6G molecules. Physical Review Letters 103(5): 053602

Yu, Y.-C.; Liu, J.-F.; Zhuo, X.-L.; Chen, G.; Jin, C.-J.; Wang, X.-H. 2013: Vacuum Rabi splitting in a coupled system of single quantum dot and photonic crystal cavity: effect of local and propagation Green's functions. Optics Express 21(20): 23486-23497

Toida, H.; Nakajima, T.; Komiyama, S. 2013: Vacuum Rabi splitting in a semiconductor circuit QED system. Physical Review Letters 110(6): 066802

Barker, R.; Cox, B.; Mackie, T.R.; Masson, P. 2013: Vacuum Seed Sowing Manifold: a novel device for high-throughput sowing of Arabidopsis seeds. Plant Methods 9(1): 41

Hughes, R.H.; Heumier, T.A.; Griffin, P.M. 1981: Vacuum UV and soft x-ray optical emissions from electron impact on metals. Applied Optics 20(8): 1350-1354

Laporte, P.; Subtil, J.L.; Bon, M.; Damany, H. 1981: Vacuum UV high-performance spectrophotometric setup for use in the 105-200-nm wavelength range. Applied Optics 20(12): 2133-2138

Orth, F.B.; Ginter, M.L.; Yoshino, K.; Brown, C.M. 1986: Vacuum UV performance of a new 6.65-m concave diffraction grating with 4800 grooves/mm. Applied Optics 25(13): 2218

Boursey, E.; Damany, H. 1974: Vacuum Ultraviolet High Resolution Spectroscopy Using a BRV Continuum Source. Applied Optics 13(3): 589-592

Rupp, W.; Plotsker, V. 1993: Vacuum activated polishing laps produce smooth aspheric surfaces. Applied Optics 32(7): 1048-1050

Liapis, C.D.; Moulakakis, K.G. 2013: Vacuum and mesh-mediated fascial traction for closure of the open abdomen after abdominal aortic aneurysm repair. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 45(6): 595

Björck, M. 2012: Vacuum and mesh-mediated fascial traction for primary closure of open abdomen in critically ill surgical patients (Br J Surg 2012; 99: 1725-1732). British journal of surgery 99(12): 1732-1733

Lisowski, W.; Keim, E.G. 2010: Vacuum annealing phenomena in ultrathin TiDy/Pd bi-layer films evaporated on Si(100) as studied by TEM and XPS. Analytical and Bioanalytical Chemistry 396(8): 2797-2804

Vladescu, A.; Kiss, A.; Braic, M.; Cotrut, C.M.; Drob, P.; Balaceanu, M.; Vasilescu, C.; Braic, V. 2008: Vacuum arc deposition of nanostructured multilayer coatings for biomedical applications. Journal of Nanoscience and Nanotechnology 8(2): 733-738

Willcox, T.W. 2013: Vacuum assist: angel or demon CON. Journal of Extra-Corporeal Technology 45(2): 128-132

Ekéus, C.; Högberg, U.; Norman, M. 2014: Vacuum assisted birth and risk for cerebral complications in term newborn infants: a population-based cohort study. Bmc Pregnancy and Childbirth 14: 36

Dzieciuchowicz, L.; Espinosa, G.; Grochowicz, L. 2009: Vacuum assisted closure (VAC) in the treatment of advanced diabetic foot. Cirugia Espanola 86(4): 213-218

Balogh, G.áb.; Garbera, I.án.; Ifj Balogh, G.áb.; Pápai Székely, Z. 2011: Vacuum assisted closure (VAC) of pyothorax with bronchial fistula following radiotherapy, pneumonectomy and thoraco-myoplasty. Magyar Sebeszet 64(2): 89-93

Kandula, T.; Roake, J.A.; Lewis, D.R. 2007: Vacuum assisted closure devices in the elderly--a word of caution. New Zealand Medical Journal 120(1263): U2752

Nakai, Y.; Wariishi, S.; Hori, T.; Hata, A. 2009: Vacuum assisted closure for postoperative mediastinitis using a portable aspirator. Kyobu Geka. Japanese Journal of Thoracic Surgery 62(2): 108-111

Karatepe, O.; Eken, I.; Acet, E.; Unal, O.; Mert, M.; Koc, B.; Karahan, S.; Filizcan, U.; Ugurlucan, M.; Aksoy, M. 2011: Vacuum assisted closure improves the quality of life in patients with diabetic foot. Acta Chirurgica Belgica 111(5): 298-302

Bemelman, W.A. 2009: Vacuum assisted closure in coloproctology. Techniques in Coloproctology 13(4): 261-263

Pérez Domínguez, L.; Pardellas Rivera, H.; Cáceres Alvarado, N.; López Saco, A.; Rivo Vázquez, A.; Casal Núñez, E. 2012: Vacuum assisted closure in open abdomen and deferred closure: experience in 23 patients. Cirugia Espanola 90(8): 506-512

Beno, M.; Martin, J.; Sager, P. 2011: Vacuum assisted closure in vascular surgery. Bratislavske Lekarske Listy 112(5): 249-252

Andrabi, S.I.H.; Ahmad, J.; Rathore, M.A.; Yousaf, M. 2007: Vacuum assisted closure of laparostomy wounds "a novel technique". Journal of Ayub Medical College Abbottabad: Jamc 19(3): 89-92

Schintler, M.; Maier, A.; Matzi, V.; Smolle-Jüttner, F.M. 2004: Vacuum assisted closure system in the management of cervical anastomotic leakage after gastric pull-up. Interactive Cardiovascular and Thoracic Surgery 3(1): 92-94

Fleck, T.; Simon, P.; Burda, G.; Wolner, E.; Wollenek, G. 2006: Vacuum assisted closure therapy for the treatment of sternal wound infections in neonates and small infants. Interactive Cardiovascular and Thoracic Surgery 5(3): 285-288

Zhou, M.; Qi, B.; Yu, A.; Pan, Z.; Zhu, S.; Deng, K.; Tao, S. 2013: Vacuum assisted closure therapy for treatment of complex wounds in replanted extremities. Microsurgery 33(8): 620-624

Sánchez-Cabezón, C.; Montes-Olangua, M.Isabel.; García-Suarez, S.; García-Carretero, R. 2013: Vacuum assisted closure therapy in dehiscence of abdominal wound after cesarean section treated in a hospital-at-home. Enfermeria Clinica 23(2): 73-78

Novelli, G.; Catanzaro, S.; Canzi, G.; Sozzi, D.; Bozzetti, A. 2014: Vacuum assisted closure therapy in the management of cervico-facial necrotizing fasciitis: a case report and review of the literature. Minerva Stomatologica 63(4): 135-144

Tamhankar, A.P.; Ravi, K.; Everitt, N.J. 2009: Vacuum assisted closure therapy in the treatment of mesh infection after hernia repair. Surgeon: Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 7(5): 316-318

Polzer, H.; Mutschler, W. 2012: Vacuum assisted closure therapy. Management of a severe blast injury to the lower limb. Der Unfallchirurg 115(9): 792-797

Apelqvist, J.; Armstrong, D.G.; Augustin, M.; Baharestani, M.; Banwell, P.; Dalla Paola, L.; Deva, A.; Ennis, W.; Fish, J.; Fleischmann, W.; Gupta, S.; Gustafsson, R.; Harding, K.; Horch, R.E.; Ingemansson, R.; Jukema, G.; Mahoney, J.; Mouës, C.; Price, P.; Agreda, J.Soldevilla.; Song, C.; Téot, L.; Trueman, P.; Vowden, K.; Vowden, P.; Wild, T. 2008: Vacuum assisted closure: recommendations for use. A consensus document. International Wound Journal 5 Suppl. 4: Iii

Chang, X.; Chedraui, P.; Ross, M.G.; Hidalgo, L.; Peñafiel, J. 2007: Vacuum assisted delivery in Ecuador for prolonged second stage of labor: maternal-neonatal outcome. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 20(5): 381-384

Nordmyr, J.; Svensson, S.; Björck, M.; Acosta, S. 2009: Vacuum assisted wound closure in patients with lower extremity arterial disease. the experience from two tertiary referral-centres. International Angiology: a Journal of the International Union of Angiology 28(1): 26-31

Domingos Hadamitzky, C.; Schulte, S.; Horsch, S. 2007: Vacuum assisted wound closure in postoperative periprosthetic groin infections: a new gold standard?. Journal of Cardiovascular Surgery 48(4): 477-483

Kauer, F.; Kendler, M.; Maschke, J.; Simon, J.C.; Wetzig, T. 2007: Vacuum assisted wound closure on the scalp. Journal der Deutschen Dermatologischen Gesellschaft 5(5): 419-421